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ABSTRACT OF THE DISSERTATION 
 
Estimation and incorporation of organ-specific biomechanical information into radiotherapy 
treatment planning 
 
by 
 
Katelyn Elizabeth Hasse 
Doctor of Philosophy in Biomedical Physics 
University of California, Los Angeles, 2018 
Professor Daniel Abraham Low, Chair 
 
Radiotherapy is used to treat many cancers of the lung, liver, breast, and other anatomies. The goal 
of radiotherapy is to deliver high radiation doses to the target while sparing adjacent organs at risk.  
Accurate target definition is fundamental to ensuring a good outcome. Currently, only geometrical 
and anatomical information are acquired for purposes of target definition in radiotherapy treatment 
planning.  Functional imaging techniques can provide additional biological information about 
tumors and the surrounding organs that is often complementary to the information provided by 
anatomic imaging. While useful, common functional imaging modalities are not generally 
employed within the radiotherapy workflow, which inhibits their integration into radiotherapy 
treatment planning. 
Tissue biomechanical properties, such as elasticity, have been correlated to underlying tissue 
function. Towards this goal, a reliable elasticity estimation methodology, or elastography 
 iii 
approach, was formulated for obtaining organ-specific tissue elasticity using images acquired 
within the current radiotherapy workflow. The feasibility and accuracy of this methodology was 
verified for breast, liver, and lung anatomies. Patient-specific elasticity distributions were 
estimated for lung and liver cancer radiotherapy patients, and functional correlation avoidance 
treatment plans were retrospectively developed. Brief descriptions of the major contributions are 
given below.  
Using biomechanical, high-resolution breast geometry obtained from CT scans, a systematic 
assessment was performed to determine the feasibility of the elasticity estimation using clinically 
relevant displacement distributions. To simulate gravity induced breast deformation and mimic the 
chest-wall/breast tissue interface, the breast geometry was anchored at its base and allowed to 
deform between prone and supine patient positions. A forward iterative approach was used to solve 
the inverse elasticity problem. The feasibility and potential of the fast reconstruction of breast 
tissue elasticity using supine/prone patient postures was proven using these virtual phantom 
simulations.  
The breast elastography methodology was extended to enable the performance of lung 
elastography using the internal breathing-induced deformation. For a systematic analysis, a 
physics-based virtual lung phantom with CT source geometry and a heterogeneous voxel-to-voxel 
elasticity distribution was employed. Our results showed that the elastography approach estimated 
the elasticity with 92% of voxels converging within 0.5 mm of the ground-truth displacement and 
1 kPa of the ground-truth elasticity. This approach was extended to estimate and validate the 
elasticity distributions of 15 5DCT patient lung datasets and 11 patient 4DMR liver datasets. 
Overall, the results suggest that the lung elasticity can be measured with approximately 90% 
 iv 
convergence using routinely-acquired clinical 4D scans, indicating the potential for a lung and 
liver elastography implementation within the radiotherapy clinical workflow.   
Dose is a limiting factor for many imaging studies. As such, the feasibility of performing 
elastography using simulated lower dose CT scans was investigated. The results suggest that the 
original tube current-time product of 40 mAs scans can be reduced to 20 mAs without affecting 
the reliability of the elastography results. The relationship between elasticity and lung tissue 
function was investigated using 13 4DCT patients with known GOLD 2017 COPD status. 
Elasticity distributions proved to be an effective spatial indicator of lung pathophysiology and 
displayed the potential be translated into a binary indicator for diagnostic staging purposes. Finally, 
elastography results were used to retrospectively derive functional contours for 7 lung SBRT 
patients for treatment planning purposes. For consistency, both clinical and functional lung 
avoidance VMAT SBRT treatment plans were developed. The functional avoidance plans were 
able to successfully spare functional lung regions while maintaining target coverage and meeting 
all normal tissue constraints, suggesting that incorporating functional information into SBRT 
planning may facilitate improved patient outcome after radiotherapy.  
The works presented here provide a way to use conventional imaging to perform elastography 
within the radiotherapy workflow. The focus of this work concentrated on the lung anatomy but 
have been preliminarily expanded to the breast and liver. In our future investigation, the tools 
provided here can be extended to other anatomical sites and can provide a foundation for 
performing elastography and obtaining functional information for treatment planning purposes 
within the clinical radiotherapy workflow.  
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CHAPTER 1: INTRODUCTION TO THE DISSERTATION 
1.1 Motivation  
Radiation therapy is the treatment of choice for many cancers, including locally advanced stages 
of non-small cell lung cancer, liver metastases, and early stage breast cancer. Currently, 
radiotherapy treatment planning is based on anatomical imaging with a goal of treating the tumor 
while avoiding the normal tissue [1]. This assumes a homogenous radiation dose-response of 
normal tissue; however, it may not be the case that all normal tissues respond to radiotherapy the 
same. This work concentrations on introducing functional and biomechanical information into the 
treatment planning process to further expand the utility and effectiveness of radiotherapy while 
increasing patient quality of life.  
1.1.1 Functional information has the potential to be useful in radiotherapy. 
In current radiotherapy treatment planning, the potential risks of normal tissue irradiation are 
estimated based on the assumption of spatially uniform tissue function for a given organ [2]. 
However, patients referred to radiation therapy present with considerable spatial variations in a 
given organ’s function; furthermore, both the lung and liver anatomies are known to have spatially 
heterogeneous function distributions and parallel functional behaviors [2]. Peers have 
demonstrated that functional treatment planning can be used to preferentially avoid normal tissue 
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complications, since normal tissue function is not always reflected by anatomical imaging [3]. 
While clinical data and outcomes remain unknown, functional parameters such as perfusion and 
metabolism have been shown to correlate to better toxicity outcomes [4]. Specifically for the lungs, 
incorporating functional information such as ventilation and perfusion into treatment planning can 
reduce dose to highly functional regions. Radiotherapy that selectively avoids irradiating high-
functioning lung regions may reduce pulmonary toxicity and improve patient quality of life.  
Functional information has the potential to inform the radiotherapy process by highlighting 
functional changes during treatment and characterizing the extent of cancer and co-morbidities. 
Our underlying hypothesis is that it would be clinically beneficial to spare as much functioning 
normal tissue as possible during radiotherapy while ensuring adequate target coverage. This 
requires knowledge of the spatial-functional distributions for the anatomies in question. 
1.2 Background 
1.2.1 Current functional imaging techniques 
Functional imaging techniques have been developed to portray biological characteristics of tissue. 
For tumors, they can visualize important hallmarks of cancer such as blood perfusion, oxygenation, 
and energy metabolism. For normal tissues, functional imaging techniques can provide maps of 
function that can be used to preferentially guide the deposition of radiation to parts of an organ 
where baseline function is reduced or absent [3]. Several functional imaging techniques, including 
pulmonary function tests using spirometry, single photon emission CT (SPECT), and xenon CT 
ventilation imaging, have been investigated to evaluate and describe overall lung function [5, 6]. 
These imaging techniques generally represent either ventilation or perfusion maps of the lung [7, 
8].  
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For the liver, dynamic contrast enhanced computed tomography (DCE-CT), diffusion weighted 
magnetic resonance imaging (DW-MRI), single photon emission CT (SPECT), and positron 
emission tomography (PET)/CT have all shown promise for imaging liver metabolism and 
function [3]. All of these methods have illustrated the spatial heterogeneity of liver function, which 
is critical information for liver radiotherapy planning. Specifically, dynamic contrast enhanced 
MRI (DCE-MRI) quantitative parameters have been correlated with response rate and time to 
progression of colorectal metastases [9, 10].  
Most of the lung and liver functional imaging techniques mentioned here are not used routinely 
due to increased radiation burden, adverse contrast reaction, long scan time, and high cost. 
Moreover, these techniques would be difficult to implement into the radiotherapy workflow 
because of the additional equipment required. Therefore, the goal of this work is to acquire 
functional information using imaging data that is already employed within the radiotherapy 
workflow. 
1.2.2 Diseases that affect tissue function also affect biomechanical properties 
Cancer is a disease that alters normal tissue structure and function, creating a tumor 
microenvironment that plays a crucial role in the pathophysiology of the disease [11]. It is believed 
that normal tissue stroma respond analogously to the cellular processes that accompany wound 
repair in an effort to repair damage due to carcinoma cell invasion [12]. Research further suggests 
that increasing tumor aggressiveness is accompanied by increasing collage accumulation in local 
histologically benign tissue [13]. For example, breast and prostate cancers are characterized by 
elevated collage deposition [14, 15]. The increase in collage deposition leads to an increase in 
tissue stiffness; therefore, quantitative stiffness estimates may prove to be an effective biomarker 
for assessing tumor grade and identifying more aggressive cancers.  Furthermore, peers have 
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demonstrated that diagnostic discrimination of tissue malignancy may be possible using tissue 
elasticity as a metric [16, 17]. 
Tumor formation and degeneration may cause inflammation and fibrosis within stromal cells, 
which can substantially alter the elasticity of the tumor and surrounding tissues. The elastic 
modulus of lung tissue is known to change under the influence of non-carcinogenic pathologic 
processes such as inflammation and neoplasm as well [18]. For the lung, function is closely related 
to the mechanical properties of parenchyma; diseases of the lung that alter lung function often do 
so by altering the amounts of elastin and collagen, and hence the elasticity, of parenchymal tissue 
[19]. Chronic obstructive pulmonary disease (COPD), a progressive lung disease, is characterized 
by damaged parenchymal with altered mechanical properties and ventilation profiles. For example, 
the destruction of collagen and elastin fibers in emphysematous lung tissue decreases the strength 
and elastic recoil of the tissue, reducing the elastic modulus. Since changes in tissue stiffness have 
been well correlated with abnormal pathological processes, we hypothesize that imaging 
parameters related to tissue elasticity may provide an effective biomarker for differentiating 
functional regions of tissue.  
1.2.3 Elastography techniques 
Elastography is a non-invasive imaging technique for quantifying the local elasticity distribution 
in soft tissues [20, 21]. Elastography techniques can typically be described in three steps: 
deforming the tissue of interest, imaging the subsequent deformation, and calculating the 
corresponding mechanical properties [20, 22, 23]. Elastography is customarily performed with 
ultrasound (US) or MR. 
For the breast, elastography imaging techniques have been previously investigated by peers for 
differentiating benign from malignant disease, possibly reducing the overall number of breast 
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biopsies [24-26]. Popular breast elastography imaging techniques include shear wave 
elastography, where the speed of a shear wave throughout tissue provides a quantitative measure 
of lesion stiffness, and freehand elastography, where a handheld transducer is used to axially 
compress the tissue a few millimeters [17]. Both US- and MR-based implementations of these 
techniques have been shown as feasible ways to identify and characterize cancerous tumors in 
breast tissues, as malignant lesions exhibit considerably higher elasticity than the surrounding 
tissue [11, 18, 19]. Elastography techniques may also be able to quantify and characterize 
radiotherapy-associated changes in breast tissue, predicting the severe hardening and shrinkage 
that influence quality of life after breast radiotherapy [27]. 
The complexity of the lung anatomy, particularly the air in the lungs, renders conventional 
elastography techniques difficult to implement [28, 29]. Advanced techniques, such as magnetic 
resonance elastography (MRE) using hyperpolarized gases and optical coherence elastography 
using magnetic nanoparticles have been investigated to overcome the complications of the lung 
[30, 31].  Lung elastography has many potential radiotherapy clinical benefits, including the ability 
to discriminate between healthy and diseased tissue, visualize lung tissue changes, and detect 
pathological changes within the lungs. Furthermore, knowledge of material properties of lung 
tissue may lead to methodologies that correctly predict outcome and response to radiation therapy, 
calculate mechanical deformation of surrounding tissue caused by tumor growth, and predict tissue 
movement during radiation therapy treatments [32-34]. 
MRE has also been investigated for hepatocellular carcinoma patients. MRE uses synchronized 
cyclic shear wave displacement, encoded into the phase of the MR signal, to derive the elastic 
properties of tissue [35-38]. Recent MRE results have found that liver stiffness in patients with 
radiation-induced liver disease was significantly higher in patients without radiation-induced liver 
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disease, illustrating the complicated and potentially useful association between liver stiffness and 
hepatic pathophysiology [39, 40].  
Despite its usefulness and proven diagnostic accuracy [41, 42], elastography has not yet been 
systematically investigated within the radiotherapy context. 
1.2.4 Opportunities for elastography within a radiotherapy context 
For radiotherapy, elastography may improve the ability to visualize disease progression within the 
lungs and liver. Elastography is sensitive to tumor cell necrosis, edema, and fibrosis. Tissue 
elasticity is affected by radiation therapy, and it is plausible that elastography may be used to 
monitor tumor response and normal tissue toxicity [34].  
Within the context of radiotherapy, additional imaging modalities such as US and MR, which are 
typically used for elastography, raise the need to precisely register the new images with the 
treatment planning images, which has not yet been systematically addressed. The MR machinery 
and hyperpolarized noble gases commonly required for other elastography techniques are very 
rarely found within a radiotherapy suite. There is a key knowledge gap in developing elastography 
methods using imaging modalities that are already in use within the clinical radiotherapy 
workflow.  
Common lung radiotherapy imaging protocols require the acquisition of 4DCT images for 
treatment planning to account for lung tumor motion [43].  One focus of this dissertation was to 
formulate a methodology to perform lung elastography using only the deformation information 
that is available from the 4DCT data acquired during radiotherapy treatment planning. 4DCT-
based elastography will provide “free functional information”. Such “free functional information” 
can lead to improved treatment plans that spare the normal functioning lung tissues, reducing 
normal lung toxicity.  
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Liver elastography is typically performed with MRE [44]. However, MRE techniques are not 
standard of care for patients undergoing SBRT for liver tumors and require highly specialized 
equipment. To obtain functional elasticity information with the liver radiotherapy setup, a 
secondary focus of this dissertation was to perform 4DMR-based liver elastography using the 
images acquired from 0.35 T ViewRay machines used for liver SBRT. To our knowledge, 
elastography has not yet been performed using the 4D methodologies currently found within the 
radiotherapy treatment planning workflow for the lung and the liver.  
1.3 Specific Aims 
The ultimate goal of this dissertation is to facilitate the incorporation of functional elasticity 
information into a radiotherapy treatment planning workflow. To accomplish this, the following 
specific aims focused on developing key methodologies for obtaining and utilizing reliable patient-
specific tissue elasticity from imaging and deformation data acquired routinely within the lung, 
liver, and breast radiotherapy workflows.  
Specific Aim 1 (SA1): Perform systematic studies using virtual deformable anatomical phantoms 
and a biomechanical model to assess the feasibility of obtaining tissue elasticity information from 
deformation data.  
Specific Aim 2 (SA2): Utilize biomechanical model and deformation vector fields to obtain tissue 
elasticity information from 4D imaging.  
Specific Aim 3 (SA3): Incorporate functional and biomechanical information into treatment 
planning.  
Broader implications: The specific aims addressed in this dissertation provide a solution for 
obtaining functional information using images and deformation information acquired within the 
radiotherapy workflow for breast, lung, and liver anatomies. Ultimately, these works offer a 
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therapeutic tool that can be used to reduce functional tissue toxicity for the lung, liver, and breast 
anatomies. 
1.4 Overview 
Chapters 2 through 8 consist of edited manuscripts produced from the core projects of this 
dissertation that have been published, are under review, or are being prepared for submission. Each 
chapter contains a thorough introductory section that discusses the motivation for the project and 
prior work in the field; thus, the background material for each project was not included in this 
chapter.  
SA1 is addressed in Chapters 2 and 3. An algorithm for estimating elasticity distributions from the 
gravity-induced deformation of a virtual breast phantom is developed in Chapter 2. In Chapter 3, 
the elasticity estimation methodology is extended to the internal deformation of virtual lung 
phantoms, along with details of the challenges faced for the more complex anatomy. SA2 is 
addressed in Chapters 4, 5 and 6. In Chapter 4, the validated elasticity estimation methodology is 
applied to patient 4DCT data to estimate patient-specific elasticity distributions. Whether 
elastography results can be reliably obtained for low dose CT applications is explored in Chapter 
5. The elasticity estimation methodology is applied to patient 4DMR liver datasets in Chapter 6. 
Chapters 7 and 8 address SA3. In Chapter 7, the elasticity distribution is related to clinically 
relevant functional information, and in Chapter 8 , the elasticity distributions are retrospectively 
utilized to achieve functional avoidance treatment planning. The conclusions of the dissertation 
are presented in Chapter 9, and further avenues of interest for each project are also discussed.  
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CHAPTER 2: PERFORM SYSTEMATIC STUDIES USING 
VIRTUAL ANATOMICAL PHANTOMS AND A 
BIOMECHANICAL MODEL TO ASSESS THE FEASIBILITY OF 
OBTAINING TISSUE ELASTICITY INFORMATION FROM 
GRAVITY-INDUCED DEFORMATION DATA. 
Systematic feasibility analysis of a quantitative elasticity 
estimation for breast anatomy using supine/prone patient 
postures 
A version of this chapter has been published as a manuscript: Med Phys, Vol. 43, No. 3, 2016. doi: 10.1118/1.4941745 
2.1 Introduction 
Breast cancer is the most commonly diagnosed cancer for women in the United States, with about 
1 in 8 U.S. women developing invasive breast cancer over the course of her lifetime [1]. The 
general approach to early stage breast cancer treatment usually involves a lumpectomy, followed 
by post-operative radiotherapy, which significantly reduces the risk of cancer recurrence. Post-
operative breast radiotherapy can be challenging because of the deformable nature of the breast 
tissue. Day-to-day changes in breast anatomy and positioning present an obstacle when trying to 
attain an ideal and repeatable patient set-up. It has been previously documented that the breast 
alignment can vary by more than 5 mm in any dimension from one day to another without the use 
of immobilization devices [45]. Existing immobilization devices designed for rigid anatomies are 
not suitable for fixing the breast position. Engineering novel immobilization devices for precise 
and reproducible breast set up requires modeling of the breast deformation for given forces applied 
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to the breast surface [3]. Therefore, the first step in engineering such immobilization devices is a 
systematic development of subject-specific biomechanical breast models. 
High-resolution biomechanical physics-based models have been used to develop patient-specific 
representations of deforming anatomy [4]. Sophisticated biomechanical models can simulate 
deformations and physiological changes in different anatomies, creating a dynamic physical atlas 
[5]. Patient-specific biomechanical breast models are necessary in order to use material properties 
of soft tissue to correctly predict outcomes and response to radiation therapy, calculate mechanical 
deformation of surrounding tissue caused by tumor growth, and accurately model tissue movement 
during radiation therapy treatments [6-8]. Biomechanical models of the breast have also been used 
to more precisely locate cancerous tissue and simulate breast shape during a variety of clinical 
applications [2]. Biomechanical models must take into consideration the laws governing the 
mechanical properties of tissue—elastography is a non-invasive way to image the physical 
distribution of these properties [9]. Knowing the distribution of elastic properties throughout soft 
tissue can lead to design and development of immobilization devices in addition to yielding 
valuable biomechanical information in a patient-specific manner.  
A critical limitation in performing breast elastography within a radiotherapy setting is that the 
clinical breast radiotherapy protocols only involve prone and supine CT scans [46]. With 
additional MR and ultrasound imaging being unattainable within a clinical radiotherapy workflow, 
it is important to study the feasibility and accuracy of deriving breast tissue mechanical properties 
based on the two CT scans.  
The focus of this study is to formulate a methodology for performing breast elastography with 
subject specific clinical supine/prone CT data, and to systematically validate and quantify the 
accuracy of this methodology.  A linear elastic biomechanical model, which has been previously 
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used for representing head and neck deformations [5], will be employed as a deformation model 
to represent the breast anatomy. Each mass element of the model denotes a single voxel from the 
supine or prone CT image data.  The underlying elasticity is then estimated using a gradient descent 
binary search algorithm coupled with a fast-simulated annealing (FSA) based model parameter 
optimization. 
2.2 Materials and Methods 
The primary aim of this study was to formulate a method to estimate the Young’s moduli [47] 
associated with each voxel in the breast anatomy and to quantitatively assess the accuracy of the 
estimated values using virtual breast phantoms. From a mathematical perspective, reconstructing 
the elasticity distribution of tissue can be approached in either a direct or an inverse manner. The 
direct approach reconstructs an elastographic image by converting the strain value at each voxel 
to a relative Young’s modulus using a simple model constraint, such as Hooke’s Law [21]. This 
approach is limited, however, and has been shown to be inferior when compared to the inverse 
approach [48]. The inverse approach, or model-based method, is an iterative approach that allows 
for more reasonable and realistic model constraints. Peers have formulated the inverse elasticity 
problem as a parameter optimization problem with an objective to minimize the difference between 
measured displacement and that computed by a biomechanical model representing observed 
mechanical behavior [19].  
In our approach, we formulated breast elastography as an inverse problem. The supine-to-prone 
breast deformation is known to be gravity-induced [23, 24]. We used the observed tissue 
displacement between supine/prone postures as our measured ground-truth displacement. A 
biomechanical simulation was employed as the forward deformation model to evaluate the inverse 
breast elasticity problem, with its parameters being iteratively updated. It has been shown in [5] 
 12 
that the deformation of the biomechanical model acted upon by gravity matches the expected soft 
tissue response, indicating its potential for modeling the supine-to-prone breast deformation. 
Implementation of this model in a graphics processing unit (GPU) environment allowed for fast 
and accurate breast tissue elasticity estimations.  
In this section, we first present the GPU-based forward deformation model that was devised to 
represent the breast anatomy. We then present the inverse formulation that was used to estimate 
the breast tissue elasticity. Finally, we present our experiments in systematically assessing the 
accuracy of the estimated tissue elasticity. 
2.2.1 Forward problem.  
While the forward problem is previously discussed in [5], for clarity, we hereby present the model. 
2.2.1.1 Model initialization and geometry. The biomechanical model was constructed from 
clinically acquired or virtually constructed CT data. We defined deformation space as the virtual 
space where the model geometry can be instantiated and deformed. The model geometry was 
represented by mass elements corresponding to the center of each voxel of anatomy in the CT 
image. Mass elements were connected by mass-spring damping (MSD) connections in the 
deformation space. Connecting the mass elements with each other using a spring damper 
formulation ensured that the mass elements could deform in a physically realistic manner. The 
connections were established as follows: A local neighborhood search was performed in a 
parallelized manner around each mass element to find nearby elements. When a nearby element 
was within a threshold distance (determined by the voxel size of the input CT, approximately 3 
mm in our case) from the search element, an MSD connection was established and the nearby 
element became a connected element for the given search element. The rest length and orientation 
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of each connection was then recorded and assigned a Young’s modulus and a Poisson’s ratio as 
the final step in the model initialization.  
2.2.1.2 Forward deformation computation. The corrective forces on each mass element were 
calculated as a summation of tensile force, shear force, and a dashpot damping force. At rest state, 
the elastic internal corrective forces were set to zero. When deformed, the model’s mass elements 
were relocated to new positions inside the deformation space, which caused the internal corrective 
forces to be non-zero. For each mass element, a, the tensile force, 𝑓𝑌,𝑎𝑏 , shear force, 𝑓𝑆,𝑎𝑏, and the 
dashpot damping force, 𝑓𝑣,𝑎𝑏, were calculated for each connected element, b,  and summed to find 
internal corrective force, 𝑓𝑎: 
𝑓𝑎 =  ∑ (𝑓𝑌,𝑏 + 𝑓𝑆,𝑏 + 𝑓𝑣,𝑏)𝑏  .     ( 2-1 ) 
The elastic force acting between the two mass elements is described by: 
 𝑓⃑⃑⃑ ?⃑?,𝑎𝑏 =  ∑ (𝐸𝑎𝑏 ∗
𝛥𝐿𝑎𝑏
𝐿𝑎𝑏
) ,𝑏      ( 2-2 ) 
where 𝐸𝑎𝑏is the effective Young’s modulus acting between the two elements 𝑎 and 𝑏, and 𝐿𝑎𝑏 is 
the rest length distance, and 𝛥𝐿𝑎𝑏 is the change in length between the two elements. Since soft 
tissue is modeled as a linearly elastic material, Equation (2-2) is derived from the inverse 
relationship between Young’s modulus and displacement; for a constant force, if elastic modulus 
increases then displacement must decrease and vice versa [49]. 
The shear spring force (𝑓𝑆,𝑎𝑏) on element 𝑎 due to element 𝑏 is described by 
𝑓𝑆,𝑎𝑏 =  ∑ (𝑆𝑎𝑏 ∗
𝐿𝑎𝑏−𝛥𝐿𝑎𝑏
𝐿𝑎𝑏
) ,𝑏       ( 2-3 ) 
where 𝑆𝑎𝑏  is the shear moduli between elements 𝑎  and 𝑏 , set to 4 kPa for each voxel in our 
estimations, an approximation based on the relationship between shear modulus, Young’s 
 14 
modulus, and Poisson’s ratio and similar to values seen in [50, 51]. The dashpot damping force is 
calculated from the relative velocities ?⃗? of elements 𝑎 and 𝑏, and a local damping factor 𝜇𝑎𝑏  
𝑓𝑣,𝑎𝑏 =  ∑ (𝜇𝑎𝑏 ∗ (𝑣𝑏⃑⃑⃑⃑⃗ − 𝑣𝑎⃑⃑⃑⃑⃗)).𝑏      ( 2-4 ) 
Once the internal forces were computed, the new positions, 𝑥𝑎𝑛+1, and velocities, ?⃑?𝑎𝑛+1, of the mass 
elements were updated from the values ( 𝑥𝑎𝑛 , ?⃑?𝑎𝑛 ) at the previous iteration n, using Implicit 
(Backward) Euler integration. 
?⃑?𝑎
𝑛+1 = ?⃑?𝑎
𝑛 + (
𝑓𝑎
𝑚𝑎
+ ?⃑?) 𝛿 ,     ( 2-5 ) 
𝑥𝑎
𝑛+1 = 𝑥𝑎
𝑛 + ?⃑?𝑎
𝑛+1𝛿,      ( 2-6 ) 
where 𝛿 was the time step between iterations, 𝑚𝑎 was the mass of mass element a, and ?⃑? was 
acceleration due to gravity. 
The Euclidean distance between 𝑥𝑎𝑛 and 𝑥𝑎𝑛+1 for each mass element was taken to be the ground-
truth displacement for that mass element, and then the biomechanical model was reset with an 
initial guess elastic distribution. The iterative binary search optimization scheme was utilized until 
convergence occurred.  
2.2.2 Inverse analysis.  
Solving the inverse elasticity problem was accomplished by iteratively deforming the model from 
rest state, as described in the section above. A gradient-based binary search was used as an iterative 
optimization scheme to update the spatial-elastic distribution in order to minimize the discrepancy 
between ground-truth and computed mechanical response, or displacement, for each voxel, while 
a fast-simulated annealing algorithm was simultaneously employed to optimize model parameters. 
2.2.2.1 Iterative elasticity estimation.  The iterative scheme for recovering the Young’s modulus 
distribution was derived from the relationship between Young’s modulus and displacement [25]. 
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An elastic solid can be viewed as a series of mass elements connected by a grid of ideal linear 
elastic connections, where the elastic modulus acts on each mass element similarly to a material 
constant. Likewise, the resulting displacement can be related to the stiffness of the material as 
described in Equation (2.2). This equation illustrates that the elastic modulus and displacement are 
inversely related—if elastic modulus increases then displacement must decrease and vice versa. 
This principle defines the reasoning behind the iterative process for estimating elasticity.  
The general basis of our reconstruction technique is to minimize the difference between the 
ground-truth and calculated displacements. Given an initial Young’s modulus, the biomechanical 
model will provide theoretical estimates of mass element displacements. These displacements 
were then compared with ground-truth displacement vectors, and the Young’s modulus 
distribution was iteratively updated until the error was minimized. Intermittent mass element 
displacements were generated on a per voxel basis by updating the Young’s modulus values as 
described below. 
The initial (𝐸𝑎 ), minimum (𝐸𝑚𝑖𝑛,𝑎 ), and maximum (𝐸𝑚𝑎𝑥,𝑎 ) Young’s modulus values were 
initialized for each voxel, a, in the physics-based biomechanical model. The displacement 
differential was calculated with the following relation 
𝛥𝑑𝑎 = 𝑑0,𝑎 − 𝑑𝑎,       ( 2-7 ) 
where 𝑑0,𝑎 and 𝑑𝑎are the ground truth and calculated displacement of voxel a, respectively. The 
displacement differential was then used to update 𝐸𝑚𝑖𝑛,𝑎 and 𝐸𝑚𝑎𝑥,𝑎  as follows: 
𝑖𝑓 𝛥𝑑𝑎 < 0: {
𝐸𝑚𝑖𝑛,𝑎 = 𝐸𝑎
 𝐸𝑚𝑎𝑥,𝑎 = 𝐸𝑚𝑎𝑥,𝑎
    ( 2-8 ) 
𝑖𝑓 𝑑𝑎 > 0: {
 𝐸𝑚𝑖𝑛,𝑎 = 𝐸𝑚𝑖𝑛,𝑎
𝐸𝑚𝑎𝑥,𝑎 = 𝐸𝑎
     ( 2-9 ) 
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After the minimum and maximum values have been updated, a new trial solution was generated at 
each iteration by updating the Young’s modulus values  
𝐸𝑎 =
(𝐸𝑚𝑖𝑛,𝑎+ 𝐸𝑚𝑎𝑥,𝑎)
2
,      ( 2-10 ) 
where Ea now becomes the initial value for the next iteration. 
This iterative procedure is based upon the modified Gauss-Newton method [26, 27], which was 
chosen because it requires no assumption about the homogeneity of the tissue in question, the 
implementation is straightforward, and the convergence occurs within O(log n) iterations.  For our 
purposes, the range of Young’s modulus values is given by 𝐸𝑚𝑖𝑛,𝑎< 𝐸𝑎< 𝐸𝑚𝑎𝑥,𝑎 , where 𝐸𝑚𝑖𝑛,𝑎  and 
𝐸𝑚𝑎𝑥,𝑎 are typically 1 kPa and 200 kPa for living soft tissues [27]. Convergence was obtained 
when each voxel of tissue was within 1 mm of the ground-truth deformation. 
2.2.2.2 Fast-simulated annealing. Besides elasticity, another parameter of the biomechanical 
model that needs to be optimized is the number of iterations that the biomechanical model 
undergoes deformation. Iteration number refers to the deformation time for each iteration of the 
simulation. This is important because deformation time greatly impacts whether the system reaches 
an equilibrium state or whether the system is still in transition when the displacement values are 
recorded.  
Fast-simulated annealing (FSA) was chosen to optimize iteration number because even in the 
presence of noisy data, it may not find the optimum solution, but it will find a very good solution 
very quickly. The FSA algorithm generates randomized iteration number candidates, and checks 
if this candidate solution is better than the current solution. If so, the current solution is replaced 
with the candidate solution, but if not, the current solution is replaced with a given probability. 
This allows us to accept iteration numbers that are not ideal in order to explore more of the possible 
solution space. The probability decreases with a logarithmic temperature scheme until the system 
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converges or a set computation time has been exhausted. The lowered temperature limits the 
number of non-ideal iteration numbers that are accepted so that the solution is allowed to approach 
the global minimum. A flow chart describing the FSA process is shown in Figure 2-1. 
2.2.3 Numerical analysis.  
To enable a systematic study of the inverse analysis process, the biomechanical model was 
employed to generate a hemispherical geometry representing a breast in order to simulate the 
ground-truth displacement vectors. The hemispherical geometry was approximated from a volume 
rendered patient CT image of a breast in the prone position (Figure 2-2(a)). The chest-wall/breast 
tissue attachment interface is mimicked by anchoring the base of the hemisphere to prevent motion 
in the top layer of mass elements, which is illustrated in Figure 2-2(b). 
 
Figure 2-1: Flowchart depicting fast-simulated annealing process 
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Figure 2-2: Volume renderings of prone DICOM CT (a) and biomechanical simulation with anchored base of a 
128-voxel diameter hemisphere to mimic chest-wall interface (b). 
2.2.3.1 Virtual breast phantoms. Two different hemispherical geometries were constructed with 
1 mm3 voxels to represent different model resolutions. The lower resolution simulation contained 
100,000 voxels and had a 64 voxel diameter, while the higher resolution model contained about 
600,000 voxels with a 128 voxel diameter. A homogenous elastic modulus distribution of 20 kPa 
was initially used to represent a mixture of fatty and glandular breast tissue [22]. Spherical 
inhomogeneities with diameters of 5, 10, and 15 mm were placed within the geometry [29]. These 
spherical masses, representing breast tumors within the tissue, were used to signify ductal 
carcinomas in situ (DCIS), invasive ductal carcinomas (IDC), and fibroadenomas, with elasticity 
values of 75 kPa, 90 kPa, and 110 kPa respectively, as derived from the literature and shown in 
Table 2-1 below [30]. The breast geometry was divided into quadrants and for each distribution, a 
tumor was placed either in the center of the hemisphere or the center of one of the quadrants. 
Combining the different types, sizes, and locations of tumors along with the different image 
resolutions resulted in 90 different ground-truth elasticity distributions. The biomechanical breast 
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model was deformed in turn with each of these ground-truth elasticity distributions, with the 
resulting ground-truth displacements calculated as explained above.  
Table 2-1: Elasticity values for different components of breast tissue found from the literature [30]. 
Breast Tissue 
Type 
Fatty/Glandular 
Tissue 
(kPa) 
Fibrous 
Tissue 
(kPa) 
Ductal 
carcinoma in-
situ (kPa) 
Invasive ductal 
carcinoma 
(kPa) 
Tissue Elastic 
Modulus 
20 110 75 90 
 
2.2.3.2 Inverse analysis with no a priori information. After the ground-truth deformation was 
recorded, the estimated elasticity was reset to an initial guess elasticity distribution. Primarily, the 
elasticity was reset to a homogenous initial guess in which no assumptions were made about the 
anatomy in question. This initial guess was used in order to investigate the robustness of our 
methodology by showing that the system could converge regardless of the disparity between the 
initial guess and the ground-truth elastic distribution. The time and accuracy of the convergence 
for each ground-truth distribution were recorded and analyzed. 
2.2.3.3 Inverse analysis with a priori information. We then performed the same study using a 
priori information, which would be gained from the HU values obtained from the supine/prone 
CT images. For the purposes of our feasibility study, HU values were simulated and assigned to 
each voxel with values from the literature depending on whether the voxel represented normal 
fibroglandular tissue or was a part of one of our simulated spherical tumors [31]. These HU values 
were input into our simulation, and if the HU value for a voxel was above a certain threshold, that 
voxel was assigned a higher initial elastic modulus. It is expected that, using the a priori 
information, we can more precisely define the boundary of a tumor and decrease the computation 
time. 
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2.2.3.4 Fast-simulated annealing. A fast-simulated annealing (FSA) algorithm is used to optimize 
iteration number while the binary search to optimize elasticity is performed simultaneously, which 
is illustrated in Figure 2-3. To ascertain whether the fast-simulated annealing obtained an optimum 
solution, displacements were recorded for a random sample of the ground-truth elasticity 
distributions, and then the simulation attempted to recreate the ground-truth elasticity distributions 
both with and without the FSA optimization. For scenarios, when the FSA algorithm was not 
employed, the iteration number was set to 4000, which was the ground-truth iteration number.  
 
Figure 2-3: Illustration of the simultaneous binary search and FSA algorithms. The red lines indicate an FSA jump 
was performed, which the binary search process is illustrated by the points. 
2.2.3.5 Error metric. The metric used for quantifying the accuracy of the inverse analysis was a 
combination of both the estimated elasticity and the displacement error produced using the 
estimated elasticity. Higher elasticity values of the tumor voxels represent stiffer connections, so 
a small error in the elastic moduli did not as greatly increase the displacement error when compared 
to the more elastic interactions with the normal tissue voxels. To determine whether or not our 
elasticity accuracy will translate to the required clinical accuracy, we deformed the synthetic 
phantoms and plotted the maximum displacement versus elasticity for hemispheres with different 
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homogeneous elastic moduli distributions, and fit a curve to the plotted points, which is shown in 
Figure 2-4. The resulting equation is  
𝑑 ≅ 16.11 − 0.231297 ∗ 𝐸 + 0.00112246 ∗ 𝐸2 ,   ( 2-11 ) 
which fit the data with an R2 value of 0.996. Using this equation, we concluded that a displacement 
differential of 𝛥1 mm (or sub-millimeter clinical accuracy) corresponds to an elasticity differential 
of 𝛥0.5 kPa for voxels with elastic moduli falling somewhere in the normal tissue range (around 
15 – 25 kPa). Similarly, a displacement differential of 𝛥1  mm corresponds to an elasticity 
differential of 𝛥3kPa for voxels with higher elasticity values in the tumor range (around 70 – 100 
kPa). The values of 0.5 kPa and 3 kPa were approximated to 1 and 5 kPa for more robust binning, 
and were used to bin the elasticity differentials between estimated and ground truth elasticity 
distributions for the purposes of our study.  Other elastography estimation methods, such as 
combined ultrasound and FE models, strive for displacement error that is less than the smallest 
tumor diameter that can be found in breast tissue, which is around 3 mm [32]. For a direct 
comparison, the displacement accuracy that is less than 3 mm is also presented for individual cases 
in the following section.  
Besides looking at the results averaged over all of the distributions, we present the three other 
criteria that were also investigated: (a) relation between the use of a priori information and 
accuracy, (b) relation between the image resolution geometry and the accuracy, and (c) 
effectiveness of the FSA algorithm. A two-sample t-test was performed to analyze whether the 
statistical significance of the differences in the means of each population for each of the three 
criteria listed above. Volume renderings of the resultant and ground-truth elasticity distributions 
were also used to visually analyze the results as an addendum to the numerical results. The results 
gleaned from the systematic study are presented in the following section. 
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Figure 2-4: Displacement versus Young’s Modulus fitted plot 
2.3 Results 
In this section, we present the results obtained from the systematic study. To illustrate the aptitude 
of the forward model for representing gravity-induced soft-tissue deformations, the biomechanical 
simulation was used to establish geometry from a prone breast DICOM CT Figure 2-5(a & b) with 
a homogenous elasticity distribution. This geometry was then deformed with gravity to simulate 
the supine orientation Figure 2-5(c & d), illustrating that the model can accurately represent the 
soft-tissue deformation between prone and supine breast postures. Figure 2-5 shows DICOM CT 
(a & c) and biomechanically simulated (b & d) prone and supine breast positions. Figure 2-5(e) 
shows an overlay of images (c) and (d). ImageJ was used to perform an image comparison and the 
images were shown to be 85.23% similar. The mismatch between the two images, highlighted in 
yellow, can be explained by segmentation errors, as the breast was manually segmented from the 
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DICOM CT images, and intensity differences between the DICOM CT and the mass-elements in 
the biomechanical simulation.  
 
Figure 2-5: Prone DICOM CT (a) and biomechanically simulated (b) data. Supine DICOM CT (c) and 
biomechanically simulated (d) data. The biomechanically simulation shown in (b & d) was generated from the 
DICOM CT images which had a resolution of 134 x 144. Images (c) and (d) were overlaid in (e) to give a direct 
comparison of our simulation to the DICOM CT. 
2.3.1 Model resolution.  
To analyze the impact of the breast model resolution on the estimated elasticity, the simulation 
was performed with two different resolution of hemispheres. The lower resolution, 64 voxel 
diameter hemisphere converged on average with 98.87% of the voxels within 1 mm of the ground-
(a) (b) 
(c) (d) 
(e) 
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truth results. This corresponded to 92.02% of voxels being within 1 kPa of their ground truth 
elasticity values, and 96.92% of voxels converging within a 5 kPa window. The higher resolution, 
128 voxel diameter hemisphere converged on average with 96.19% of the voxels within 1 mm of 
the ground-truth displacement, resulting in 86.15% of voxels converging within a 1 kPa elasticity 
window and 98.38% converging within 5 kPa. These results are summarized in Table 2-2. A two-
sample t-test of 20 different images shows that the differences between the results of the lower and 
higher resolution datasets was not significant (P > 0.05). Though the average elasticity error for 
the 1 kPa bins in each instance seems to be dissimilar, the t-test considers a one-to-one 
correspondence between the values in the samples. For example, the elasticity error of every 
ground-truth elasticity distribution is compared between the lower and higher resolution cases. 
Because a multitude of distributions were considered, the differences between the average values 
were not significant. This implies that regardless of image resolution, we can produce results with 
similar accuracy, which is paramount to implementation in the clinical setting. More specifically, 
Table 2-3 shows examples of the results of lower and higher resolution datasets for a large fibroid 
in the center, a small IDC in Quadrant II, and a medium DCIS in Quadrant IV. These results again 
illustrate that for multiple tumor locations, regardless of tumor type or size, both the low and high 
resolution reconstructions produce similar elasticity distribution. Figure 2-6 shows volume 
renderings of a medium IDC located in quadrant II for both the low resolution (a) and the high 
resolution (b) hemispheres. Both cases are visually and numerically similar—the boundary 
between the differing elasticity values is well-differentiated for both low and high resolutions. The 
inverse elasticity algorithm is invariant to image resolution, further indicating that image resolution 
will not hinder the accuracy of our reconstruction. 
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Table 2-2: Overall results and results for simulations run with and without a priori information, with and with the 
FSA algorithm, and with lower and higher resolutions. 
 Elasticity Window Displacement Error 
Overall Results ±𝟏 𝒌𝑷𝒂 (%) ±𝟓 𝒌𝑷𝒂 (%) < 𝟏 𝒎𝒎 (%) 
 87.60 ± 3.18 97.15 ± 4.73 96.81 ± 3.62 
Averages ±𝟏 𝒌𝑷𝒂 (%) ±𝟓 𝒌𝑷𝒂 (%) < 𝟏 𝒎𝒎 (%) 
Mean of datasets 
without a priori 87.60 ± 4.42 97.15 ± 1.26 96.81 ± 3.62 
Mean of datasets with  
a priori 90.57 ± 3.23 98.15 ± 2.52 98.26 ± 2.82 
Averages ±𝟏 𝒌𝑷𝒂 (%) ±𝟓 𝒌𝑷𝒂 (%) < 𝟏 𝒎𝒎 (%) 
Mean of datasets 
without FSA 96.57 ± 2.38 98.75 ± 0.78 98.78 ± 1.01 
Mean of datasets with 
FSA 96.40 ± 1.14 97.88 ± 1.31 97.48 ± 1.72 
Averages ±𝟏 𝒌𝑷𝒂 (%) ±𝟓 𝒌𝑷𝑎 (%) < 1 𝒎𝒎 (%) 
Mean of datasets with 
Lower Resolution 92.02 ± 3.48 96.92 ± 1.32 98.87 ± 0.65 
Mean of datasets with 
Higher Resolution 86.15 ± 4.10 98.38 ± 2.41 96.19 ± 1.87 
 
Table 2-3: Example 64 and 128 voxel (lower and higher resolution) test cases for a large fibroid in the center of the 
hemisphere, a small IDC in quadrant II, and a medium DCIS in quadrant IV. 
 Elasticity Window Displacement Error Large Fibroid Center ±𝟏 𝒌𝑷𝒂 (%) ±𝟓 𝒌𝑷𝒂 (%) < 𝟏 𝒎𝒎 (%) < 𝟑 𝒎𝒎 (%) Lower Resolution 88.25 96.36 94.98 100.00 Higher Resoltuion 80.42 98.45 89.95 100.00 Small IDC Quadrant II ±𝟏 𝒌𝑷𝒂 (%) ±𝟓 𝒌𝑷𝒂 (%) < 𝟏 𝒎𝒎 (%) < 𝟑 𝒎𝒎 (%) Lower Resolution 85.28 98.85 96.58 100.00 Higher Resolution 86.91 98.12 94.92 100.00 Medium DCIS Quadrant IV ±𝟏 𝒌𝑷𝒂 (%) ±𝟓 𝒌𝑷𝒂 (%) < 𝟏 𝒎𝒎 (%) < 𝟑 𝒎𝒎 (%) Lower Resolution 74.86 99.31 99.83 100.00 Higher Resolution 75.89 99.22 99.19 100.00 
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Figure 2-6: Volume rendered comparison of a medium IDC in quadrant II within the (a) lower and (b) higher 
resolution hemisphere. 
2.3.2 A priori information.  
Two different initial guess distributions of elasticity values were investigated. The first required 
no a priori information about the underlying anatomy—the initial guess was set to a homogeneous 
elasticity value of 10 kPa. In the second case, a priori information was developed to be indicative 
of representative HU values that would come from the prone/supine CT scans taken in the clinic.  
Table 2-4: Table showing average values for low (64 voxel diameter) and high (128 voxel diameter) resolution 
hemispheres, both with and without a priori information. 
Hemisphere 
Size Elasticity Window 
Displacement 
Error 
Average 
Time  
Averages ±𝟏 𝒌𝑷𝒂 (%) ±𝟓 𝒌𝑷𝒂 (%) < 𝟏 𝒎𝒎(%) (s) 
64 voxel mean 89.76 ± 1.12 96.40 ± 4.73 98.67 ± 3.62 272.50 
± 236.12 
64 voxel 
with a priori 
mean 
94.27 ± 6.38 97.43 ± 3.37 99.07 ± 1.08 218.06 
± 216.17 
128 voxel 
mean 85.43 ± 4.37 97.89 ± 2.33 94.94 ± 4.09 
3345.38 
± 1618.00 
128 voxel 
with a priori 
mean 
86.87 ± 3.23 98.87± 2.52 97.44± 2.17 1595.69 
± 1012.2 
 
 
(a) (b) 
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Each ground-truth elasticity distribution was investigated starting with both types of initial guess. 
Table 2-2 shows the results averaged over every distribution both with and without the a priori 
initial guess. It can be seen that the a priori information increased the elasticity and displacement 
accuracy overall. Table 2-4 shows a further breakdown of these results in terms of image resolution 
along with the average time. 
Average time decreased appreciably, especially for the higher resolution hemisphere with 128 
voxel diameter where the average time decreased by about 30 minutes. Overall, both accuracy and 
computation time improved notably between simulations run with the homogenous initial guess 
and the a priori initial guess, which is also illustrated in Figure 2-7 for a random selection of 
ground-truth distributions.  
 
Figure 2-7: (a) shows a time comparison for distributions with and without a priori information for random 
distributions, while (b) shows an accuracy comparison for the same datasets. 
Figure 2-8 shows volume renderings of the ground-truth elasticity distribution (a), the resultant 
elasticity distribution when no a priori information was considered (b), and the resultant elasticity 
distribution when a priori information was used to form an initial guess (c) for a large IDC in 
Quadrant I. Visually, it can be seen that Figure 2-8(c) more closely matches the ground-truth 
distribution, without the distortion along the chest-wall and boundary distortions seen in Figure 2-
8(b). When the a priori information was not utilized, as in Figure 2-8(b), the magnitude 
(a) (b) 
 28 
discrepancies and edge distortions are clear, which both agrees with, and thus strengthens, our 
numerical results. 
 
Figure 2-8: Volume renderings of small IDC located in Quadrant II. Part (a) shows the ground-truth distribution, (b) 
shows the reconstruction with a random initial guess, and (c) shows the reconstruction using a priori information to 
make an informed initial guess 
Table 2-5 shows excerpts of the individual results for a large IDC in Quadrant II, a small fibroid 
in Quadrant I, and a medium DCIS in Quadrant III. These results are selected to illustrate that 
regardless of tumor type, location, or size, the addition of a priori information significantly 
improves the results. This is further illustrated when considering the statistical significance of the 
average accuracy values. When a priori information was used to form an initial guess, the average 
displacement accuracy for the lower and higher resolution hemispheres increased respectively 
from 94.94% and 98.67% to 97.44% and 99.07%. A two-sample t-test between 20 different 
distributions confirmed that the improvements resulting from the use of a priori information were 
significant (P < 0.05). These results suggest that taking advantage of a priori HU data obtained 
from the clinical CT scans can reduce the convergence time of our simulation while improving the 
accuracy of the resulting elastic distribution. 
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Table 2-5: Example of individual cases with and without a priori information for a large IDC in quadrant II, a small 
fibroid in quadrant I, and a medium DCIS in quadrant III. 
 Elasticity Window Displacement Error 
Large IDC Quadrant 
II ±𝟏 𝒌𝑷𝒂 (%) ±𝟓 𝒌𝑷𝒂 (%) < 𝟏 𝒎𝒎 (%) < 𝟑 𝒎𝒎 (%) 
Without a priori 86.43 97.68 88.30 100.00 
With a priori 96.90 98.25 100.00 100.00 
Small Fibroid 
Quadrant I ±𝟏 𝒌𝑷𝒂 (%) ±𝟓 𝒌𝑷𝒂 (%) < 𝟏 𝒎𝒎 (%) < 𝟑 𝒎𝒎 (%) 
Without a priori 72.20 99.62 90.02 100.00 
With a priori 81.24 99.64 96.47 100.00 
Medium DCIS 
Quadrant III ±𝟏 𝒌𝑷𝒂 (%) ±𝟓 𝒌𝑷𝒂 (%) < 𝟏 𝒎𝒎 (%) < 𝟑 𝒎 (%) 
Without a priori 80.86 92.29 68.38 100.00 
With a priori 91.20 99.03 95.49 100.00 
 
2.3.3 Fast-simulated annealing.  
For ground-truth displacement distributions, the ground-truth elasticity distribution was prescribed 
and the ground-truth iteration number was set to 4000 iteration steps to allow the breast simulation 
adequate time to deform. The ground truth iteration number was set to 4000 to allow the breast 
simulation adequate time to deform. The deformation of the particles was recorded for multiple 
iteration numbers, and at an iteration number of 4000, the maximum deformation increased by less 
than 0.01 mm, or 1% of our convergence criteria, indicating that the simulation had reached a state 
of equilibrium within 4000 iteration steps. 
The FSA algorithm returned an average iteration number value of 2960 ± 590 iteration steps. The 
small discrepancy between this result and the ground-truth iteration number occurs because the 
combination of iterative binary search and the FSA algorithm allows for multiple solutions. More 
relevant is the resulting displacement and elasticity accuracy for the simulation run both with and 
without the FSA algorithm. Table 2.2 lists the resulting estimations of average elasticity and 
displacement accuracy for the distributions computed both with and without the FSA algorithm.  
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The sub-millimeter convergence percentage of each instance (i.e. with and without FSA) was 
observed to be 97.45% and 98.78% respectively.  A two-sample t-test of 20 different distributions 
indicated that the difference between the mean values of each population was not significant (P > 
0.05), therefore use of the FSA algorithm allowed the iterative estimation process to converge 
correctly without reducing the integrity of the results. Figure 2-9 shows volume rendered elasticity 
distributions of the ground-truth (a) and estimated distributions with and without use of the FSA 
algorithm for a large IDC located in the center of the hemisphere (b & c). It can be seen that both 
instances (b&c) result in a very similar volume rendering, where the location of the IDC is located 
accurately with some small discrepancies around the boundary of the tumor. From the numerical 
and visual results, we can conclude that use of the FSA algorithm allows our simulation to 
converge correctly. This will allow for us to more easily transition to clinical data—we will not 
have any preconceived notions of iteration number yet we can still expect our simulation to 
determine accurate results.  
 
Figure 2-9: Volume rendering of a large IDC located in the center of hemisphere. Part (a) shows the ground-truth 
distribution, (b) shows the reconstruction without the use of the FSA algorithm, and (c) shows the reconstruction 
using the FSA algorithm. 
Comparing Figures 2-8(b) and 2-9(b), it can be seen that elasticity was reconstructed with similar 
discrepancies in each case, indicating that tumor location does not obstruct our elasticity 
reconstruction. The use of a priori information, however, greatly impacted the resultant 
(a) (b) (c) 
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distribution, as shown in Figure 2-8(c). A minor fact to note is that the Figure 2-9(a) is also much 
“brighter” than Figure 2-8(a)—because the tumor was located in the center instead of the upper 
back quadrant, the window/level of the volume reconstruction did not have to be changed in order 
to see it. 
Overall, our simulation converged with about 97% sub-millimeter accuracy. Though the errors 
were minimal, the largest elastic moduli discrepancies were seen around the boundary of the 
simulated tumors, and the largest displacement errors were seen both around the boundary of the 
tumor and the edge of the hemisphere. The use of a priori information greatly improved our results, 
while both use of the FSA algorithm and image resolution size do not affect the accuracy of our 
results. Tumor location also does not affect the accuracy of our outcome.  The implications of 
these results are further discussed in the following section. 
2.4 Discussion 
In this work, a methodology for performing breast elasticity estimation using deformation resulting 
from the transition between supine and prone patient postures was presented. The procedure was 
developed and systematically assessed using a biomechanical simulation representing a breast in 
the prone position with a spherical tumor located within the breast. In order to investigate the 
accuracy and robustness of the approach for any given scenario, the synthetic tumors were given 
elasticity values from the literature used to represent three different common breast tumors: ductal 
carcinoma’s in-situ, invasive ductal carcinomas, and fibroadenomas, and were positioned with 
different sizes throughout the breast tissue.  
The biomechanical breast simulation was based on a physics-based approach. This choice was 
motivated by the previously shown accuracy of the approach for head and neck applications that 
were readily transferrable to the breast [52]. In addition, this model was validated for simulating 
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motion caused by gravity, and the supine-to-prone deformation is known to be gravity-induced [5, 
23, 24]. The implementation of this approach in a GPU environment enabled a high-resolution 
biomechanical simulation in nearly real-time. Inversing the forward deformation model allowed 
us to obtain elasticity maps for patient-specific biomechanical models that will be useful for 
reducing positioning errors in adaptive radiotherapy. Using the well-validated constitutive model 
previously used for head and neck allowed us to purely focus on the accuracy and feasibility of 
the inverse analysis, rather than the model’s accuracy in regards to simulating gravity induced 
deformations. While the usage of such a GPU-based, biomechanical model has been recently 
validated for head and neck tissues, future studies will focus on the usage of such a model for 
breast tissue, which needs to be clinically validated using an extensive patient study. Model errors 
in such studies typically stem either from tissue elasticity estimation errors or from the model’s 
inability to represent the complex anatomical deformation. Having shown in this study that the 
tissue elasticity estimation errors will be minimal for this biomechanical model, future work will 
focus on a clinical study to enumerate the model’s ability to quantitatively represent the anatomy.  
While most deformable modeling efforts may be insensitive to soft tissue elasticity data, our 
approach has a direct relationship with the properties of soft tissue since it relies on the supine-to-
prone breast deformation, which is driven by gravity. The ground-truth displacements required for 
our methodology depend on the ability to register prone and supine breast images with a one-to-
one correspondence. Due to the large deformation induced to the breast tissue, image registration 
between these postures is a challenging problem. Various deformable image registration 
algorithms have been investigated by peers specifically for the prone-to-supine breast transition 
[33-35]. Future work will focus on further investigating a deformable image registration technique 
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that provides accurate ground-truth data and a one-to-one correspondence between breast tissue in 
the prone and supine positions.  
In our approach, we have employed a linear elastic deformation model to deform the breast 
anatomy from supine to prone patient posture. Such a deformation may be large enough to cite a 
need for hyperelastic model to represent the tissue behavior. Our future work will focus on 
extending the method to a hyperelastic regime. Such an analysis will require more patient postures 
to be imaged. 
The iterative binary search optimization algorithm, along with the FSA algorithm, allowed for the 
estimation of elastic properties for the biomechanical model based upon the deformation of each 
mass element. The performance of the algorithm was confirmed with the high elasticity and 
displacement accuracy that was achieved. The iterative optimization algorithm allowed each mass 
element to converge individually, so that even tumors with diameters as small as 5 mm were 
located accurately. While our simulation study used a simplified framework that modeled tumors 
spherically, the per voxel approach of our inverse analysis should allow sufficient delineation of 
irregular tumors shapes as well. We believe the algorithm has potential to recognize other items of 
interest that may be located within the breast that were not investigated here. Future work will 
investigate the accuracy of our approach for irregular tumor shapes and sizes, as well as for 
irregular breast shapes. 
Our results showed that an accuracy of 98% was achieved in estimating the ground truth elasticity. 
Because of the per-voxel nature of our approach, variations in the size of the tumor and the breast 
geometry had negligible impact on the accuracy of the estimation process. Our analysis indicated 
that the elasticity can be successfully reconstructed for tumors with a diameter as small as 5 mm 
and as large as 1.5 cm within the breast tissue. Changes in image resolution and geometry size 
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showed no significant impact on the resulting accuracy, indicating that the CT image resolution 
should not influence the resulting elasticity estimation.  The geometry size alternatives also 
indicated that the biomechanical simulation successfully represented different breast sizes.  
The elasticity information that we obtain through this methodology will be used to design a new 
immobilization device specifically for precise and reproducible breast positioning. Ideal breast 
geometry for radiotherapy is similar to that achieved in the prone orientation, without the 
discomfort and associated normal tissue doses [36]. With the robotic assistance of an 
immobilization device, this ideal position can be achieved in a more comfortable, supine 
orientation. Our high-resolution, physics-based breast model will act as a control module for such 
a robotic system, simulating patient-specific breast geometry and its deformation when interacting 
with the robotic system [3]. Future work will focus on improving the breast simulation to more 
realistically simulate the breast anatomy, eventually progressing to patient data. We believe this 
methodology can also be readily transitioned to other anatomies such as the lung, liver, and head 
and neck for radiotherapy applications.  
Because of the imaging techniques within current radiotherapy workflows, our current 
methodology uses DICOM CT images to construct the biomechanical model. Future work will 
focus on expanding this methodology to be coupled with US and MR measurements to further 
improve the model-guided elasticity estimation process.  Evolutionary algorithms will be 
investigated and their functionality compared to that of the FSA and binary search algorithms. 
These efforts are crucial in order to apply the methodology in clinical radiotherapy practice.  
2.5 Conclusion 
In this chapter, we presented a systematic study of a novel GPU-based inverse analysis 
methodology for breast tissues using supine/prone CT image datasets. The methodology was 
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investigated using a forward model, GPU-based, physics-based breast simulation that was 
iteratively deformed to represent the deformation of the breast between supine and prone 
orientations. The inverse analysis consisted of a gradient-based binary search optimization scheme 
that, coupled with a fast-simulated annealing algorithm, updated the spatial elasticity distribution 
of the breast tissue.  Our analysis showed that the methodology enables a 97% accuracy in 
elasticity estimation of homogeneous breast tissue and an embedded tumor with regards to our 
novel error metric only using the two postures. These results indicate that our methodology has 
the potential be readily applied with great accuracy to advance breast positioning techniques in 
clinical radiotherapy practice. In the following chapters, the elasticity estimation methodology will 
be expanded into the lung and liver anatomies.  
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CHAPTER 3: PERFORM SYSTEMATIC STUDIES USING 
VIRTUAL ANATOMICAL PHANTOMS AND A 
BIOMECHANICAL MODEL TO ASSESS THE FEASIBILITY OF 
OBTAINING TISSUE ELASTICITY INFORMATION FROM 
BREATHING-INDUCED DEFORMATION DATA. 
Feasibility and quantitative analysis of a biomechanical 
model-guided lung elastography for radiotherapy  
A version of this chapter has been published as a manuscript: BPEX, Vol. 3, No. 2,  025006, 2017. doi: 10.1088/2057-
1976/aa5d1c 
3.1 Introduction 
Radiation therapy is a clinical procedure that is commonly used to treat lung cancer, the leading 
cancer killer of men and women in the U.S.  [53, 54]. With the increasing focus on hypo-
fractionated therapy [55] and improving patient quality of life [56], there is a greater need to spare 
the normal lung regions and more precisely target the lung tumor. This requires an ability to 
precisely distinguish the regions inside the lung that function normally from those regions that are 
diseased.  
Measurement of lung tissue elasticity, or elastography, within a radiotherapy workflow forms the 
focus of this study. Currently, common lung radiotherapy imaging protocols require the acquisition 
of 4DCT images for treatment planning to account for the lung tumor motion [43].  The focus of 
this chapter is to formulate a methodology to perform lung elastography using only deformation 
information that would be available from 4DCT data acquired during radiotherapy treatment 
planning, and to systematically validate and quantify the feasibility and accuracy of this 
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methodology. In our lung elastography process, we focus on the identification of the Young’s 
modulus (E) for each voxel using displacement fields. Our approach formulates lung elastography 
as an inverse problem that is solved using an iterative optimization of physics-based model 
parameters. The advantage of this approach to lung elastography is that the forward model is 
formulated from well-established physical laws that relate biomechanical properties to measured 
mechanical response [20]. From a clinical perspective, the approach is applicable for radiotherapy 
as no additional imaging is required for the lung elastography process. Other co-existing disease 
states, such as COPD, can also be precisely characterized at a voxel-by-voxel level and can further 
improve radiotherapy treatment plans. In addition, the accuracy of the lung elastography 
measurements presented in this study enables the information to be used for tasks such as the 
normal tissue sparing treatment planning [57]. 
 Another key aspect of our approach is the usage of virtual lung phantoms for systematically 
quantifying the elastography accuracy. The need for such virtual lung phantoms stem from the fact 
that estimating a heterogeneous elasticity distribution is a multi-local minima problem; i.e., 
different elasticity distributions may end up providing the same displacement. Thus, for an 
elastography to be clinically applicable, we need to quantify the measured elasticity’s accuracy 
explicitly in addition to comparing the voxel displacements. The usage of virtual phantoms also 
enables us to systematically assess the estimation accuracy for variations in the tissue elasticity, 
boundary conditions (the range of motion in the other organs), and CT image noise.  
3.2 Methods 
The primary aim of this study was to devise a methodology to estimate the Young’s modulus 
(denoted by E) associated with each lung tissue voxel, and systematically assess and quantify the 
accuracy of the estimation. A systematic study is necessary to assess the feasibility of this approach 
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since ground-truth Young’s modulus values are not known for deformation values obtained from 
clinical 4D datasets. We formulated the inverse elasticity problem as a parameter-optimization 
problem, with an objective to determine the elasticity parameter that will minimize the difference 
between ground-truth displacement and that computed by the biomechanical model. In clinical 
implementations, the ground-truth displacement will be determined from deformable image 
registration techniques of 4DCT lung images, but for the purposes of our study, it is determined 
by the forward model described below. The inverse elasticity problem was solved by implementing 
a gradient descent optimization algorithm coupled with a novel convergence magnification 
approach that enables a high precision elasticity estimation. In our approach, we define the 
convergence criteria as the specific criteria, which the simulated deformation needs to meet in 
order for the underlying elasticity to be accepted as the lung’s accurate elasticity. For our purposes, 
convergence occurred when 95% of the voxels were within 0.5 mm of the ground-truth 
displacement. This will be further explained in section 3.  
The constitutive forward model used for this section was presented in §2.2.1, and the inverse 
analysis used in the iterative reconstruction was presented in §2.2.2. For brevity, here we will only 
present the updates to the algorithm that were used to transition from the breast to the lung 
anatomies.  
In this section, we first present the constitutive forward model (§3.2.1; previously described in 
§2.2.1) to solve the inverse elasticity problem. Next, we present the inverse analysis used in the 
iterative reconstruction (§3.2.2; previously described in §2.2.2). Finally, we present the novel 
locally heterogeneous convergence magnification method (§3.2.3). 
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3.2.1 Forward model 
From a physiological perspective, the lung, diaphragm, and the rib-cage deform during inhalation 
and exhalation, causing air to flow in and out and the lung to expand [58].  Modeling the lung 
deformation involves taking the diaphragm and rib-cage expansion as input and computing the 
lung anatomy’s expansion and contraction for the subsequent airflow [59]. The forward model 
presented here is focused on computing the lung tissue deformation for a given lung surface 
displacement that corresponds to a given lung elasticity distribution [59]. The forward model 
utilized in this methodology has been previously described in [52, 60] and specifically for lungs 
in [61]. For clarity purposes, a brief description of the constitutive equations for the forward model 
[52] is presented here.  
3.2.1.1 Model initialization and geometry. The biomechanical model of the lungs was constructed 
from clinically acquired source images as described in §2.2.1.1. The model geometry was 
represented by finite mass element nodes corresponding to the center of each voxel of anatomy in 
the CT image, and neighboring elements were connected to each other with linear elastic 
connections to ensure the mass elements could deform in a physically realistic manner. As patients 
are expected to breathe normally within a clinical radiotherapy setup, a locally heterogeneous 
distribution of linear elastic material properties and a Poisson’s ratio of 0.43 was used for this 
study [62-64]. Linear elastic constitutive laws were utilized because recent publications have found 
that linear elastic representations have been effective in describing normal lung tissue 
deformations typically observed in a 4DCT based lung motion [65]. Additionally, the effect of 
non-linear elastic properties are only significant at remote locations within the lung where the 
diaphragm-induced motion is most significantly attenuated [66]. Furthermore, a study 
investigating lung tumor motion during external beam radiotherapy found that a hyperelastic 
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constitutive model performs very similarly to the linear elastic constitutive law at the deformation 
magnitudes found within the lungs during normal breathing [67].  
3.2.1.2 Forward deformation computation. The forward deformation computation used in our 
approach has been previously described in §2.2.1.2. In our approach, we employ Hooke’s law as 
the constitutive equation, with the tissue elasticity represented by the Young’s modulus. The 
corrective forces on each mass element were calculated as a summation of tensile, shear, and a 
dashpot damping forces. Initially, the elastic internal corrective forces were set to zero; when 
deformed, the model’s mass elements were relocated to new positions inside the deformation 
space, causing the internal corrective forces to be non-zero.  
As the material is assumed to be linear, displacement is inversely related to the elastic modulus of 
the material—for a constant force, if elastic modulus increases then displacement must decrease 
and vice versa. Once the model reached a deformed state of equilibrium, the 3D Euclidean distance 
between initial and current positions (described in Equation (2-3)) for each mass element was taken 
to be the displacement for that mass element, denoted henceforth as 𝑑𝑎, and then the biomechanical 
model was reset to the initial un-deformed position. The forward model is implemented in a 
graphics processing unit (GPU) environment to allow for fast and accurate computations. 
3.2.1.3 Boundary constraints. In our approach, we formulated the diaphragm and rib-cage 
movements as boundary constraints for the lung deformation. Since the pleural cavity between the 
lung and the boundary constraints forms a hydrostatic seal, we translate the lung surface’s 
displacement as the constraint for the lung tissue’s elasticity estimation. The surface motion for 
each voxel of each section of the lung (i.e. apex, middle, or base) was constrained to values 
suggested from the literature  [68, 69] and will be investigated further in this study. The maximum 
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boundary motion was  2 – 16 mm depending on the lung section, and the strain was applied at a 
rate of 5 – 35 min-1. 
3.2.2 Inverse problem 
Solving the inverse elasticity problem was carried out in two steps: 1) estimating the displacement 
field from every voxel of pre- and post-displaced tissue for a given elasticity distribution, and 2) 
optimizing the elasticity distribution that best reproduces the observed displacement field [70]. In 
the first step, for simplicity, we simulated the surface deformation of the lungs by deforming the 
boundary of the lung outward from rest state. Lung tissue, an elastic material, was viewed as a 
series of finite mass elements connected by a grid of ideal, linear elastic connections. The boundary 
voxels were deformed according to §2.1.3, while the interior voxels were allowed to deform 
according to the elastic forces within the model. The deformation process was previously described 
in §2.1.2. 
The iterative scheme for recovering the spatial-elastic distribution was derived from the inverse 
relationship between Young’s modulus and displacement, as described in Equation (2.2) above 
[71]. The general basis of our reconstruction technique was to minimize the difference between 
ground-truth and calculated displacements. Given an initial Young’s modulus distribution, the 
biomechanical forward model provided theoretical estimates of mass element displacements. 
These displacements were then compared with ground-truth displacement vectors, and the 
Young’s modulus distribution was iteratively updated until the error was minimized. Intermittent 
mass element displacements were generated on a per voxel basis by updating the Young’s modulus 
values as described below. The initial (𝐸𝑎), minimum (𝐸𝑚𝑖𝑛,𝑎), and maximum (𝐸𝑚𝑎𝑥,𝑎) Young’s 
modulus values were initialized for each voxel, a, in the physics-based biomechanical model. For 
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lung elastography purposes, the Young’s modulus range is set to be from 1 kPa to 20 kPa, an 
extended approximation of values from the literature [72].  
The reconstruction process (Equations (2-5 – 2-8)) was repeated until a suitable stopping criterion 
was reached. For our purposes, reconstruction was terminated after 30 iterations or when 95% of 
the voxels in the biomechanical model had a displacement differential that was less than 0.5 mm. 
3.2.3 Locally heterogeneous convergence magnification 
The inherently subtle tissue motion of different parts of the lungs results in deformation vectors 
that are impractical for use in conventional model-guided tissue elastography. Deformation values 
at small values of strain carry little to no information about the non-homogeneous elasticity 
parameter [73]. Because of the relatively small boundary motion, the displacement magnitude, and 
thus displacement differential, of each voxel of lung tissue is well within the convergence criteria 
regardless of the trial elasticity solution [74, 75]. In order to adjust the reconstruction methodology 
to be more sensitive to subtle changes, a locally heterogeneous convergence magnification 
technique was formulated as follows.   
Let 𝑖 represent the index of a reference voxel, 𝐺(𝑖) represent the position of voxel 𝑖 in the ground-
truth 3D model, and 𝑃(𝑖)  represent the model generated position of the reference voxel. The 
convergence criteria can be defined as: 
‖|𝑃(𝑖)| − |𝐺(𝑖)|‖ < 𝜖,     ( 3-1 ) 
where 𝜖 is defined to be the error tolerance in mm. For the gradient descent approach to accurately 
compute the elasticity, two constraints need to be met. First, the convergence discussed in Equation 
(3-1) needs to be satisfied for all voxels. Second, the difference in the convergence of each voxel 
needs to be locally heterogeneous. The convergence criteria (Equation (3-1)) does not reflect this 
local heterogeneity. To incorporate it, we formulated the convergence criteria as follows. 
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Let 𝐼 represent all of the voxels in the ground-truth 3D model and 𝐽 represent all of the voxels in 
the model-generated target anatomy. Let 𝑀 represent a function that biomechanically deforms a 
given anatomy by a given force,  denoted as 𝑀(𝐼, 𝑖 , 𝑓𝜂⊂𝐼 , 𝐸′) to include all voxels I, an applied 
force 𝑓𝜂⊂𝐼  to a subset of voxels 𝜂 in 𝐼 (which will be used to enforce local heterogeneity), and a 
prescribed generic elasticity 𝐸′ that will remain the same throughout the entire process so that the 
added deformation is known.  Now, Equation (3-1) can be rewritten as 
‖(|𝑀(𝐽, 𝑃( 𝑖),𝑓𝜂⊂𝐼, 𝐸
′)| − |𝑀(𝐼, 𝐺( 𝑖),𝑓𝜂⊂𝐼, 𝐸
′)|)‖ < 𝜖,  ( 3-2 ) 
where ‖𝑀(J, P( 𝑖),𝑓𝜂⊂𝐼, 𝐸′)‖ denotes the magnitude of the model-generated deformation. This 
novel depiction of the convergence criteria now includes not only the 𝑖𝑡ℎ voxel position, but also 
the local neighborhood determined by 𝐼 for the ground-truth and 𝐽 for the deformed model and the 
amplified displacement discrepancies determined by the applied force 𝑓𝜂⊂𝐼 and the pre-assigned 
arbitrary elasticity 𝐸′, that is separate from the elasticity parameters being estimated from the 
inversion process. In this study, we define 𝑀 in a physics-based manner using the same lung 
boundary constraints and the implicit elasticity forces as employed for the estimation process. The 
applied force 𝑓𝜂⊂𝐼 is set to be a unidirectional force that deforms a specific subset of the lung tissue 
voxels in a specific direction according to the elastic forces in the model derived from 𝐸′. The 
value of 𝐸′ is set to be 30 kPa so that the magnitude of the force is about 9.8 𝑔∙𝑚
𝑠2
 and creates 
significant strain in every voxel.  
The applied force will unevenly magnify the voxel deformations, so that some voxels will be more 
sensitive to convergence than others. This locally heterogeneous magnification is useful because 
it amplifies voxel deformation along the force direction enough to allow some voxels to converge 
correctly. The resulting voxel displacements range from 4-25 mm depending on the location of the 
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voxel and the directionality of the force. The entire process is repeated with the unidirectional 
force being applied in different directions, which will allow a different subset (𝜂) of voxels to 
converge each time. The resultant elasticity distribution is then taken to be a union of the elasticity 
estimation subsets such that all voxels are accounted for. 
 
Figure 3-1. Simple geometrical illustration of novel convergence methodology. (a) shows sample convergence 
tolerance, (b) shows the undeformed geometry in blue and deformed geometry in green. (c) and (d) show sample 
reconstructions. (e) again shows the conventional deformation in green, and heterogeneous induced deformation in 
red. (f) and (g) show sample reconstructions, illustrating the magnification of small differences with our novel 
technique. 
Figure 3-1 illustrates an example application of this novel convergence methodology using a 
simple geometry of 5 particles connected to a boundary. Figure 3-1(a) illustrates an example 
tolerance, 𝜖.  Figure 3-1(b) illustrates the undeformed state, in blue, and the model after it has been 
deformed with the lung boundary constraints, 𝐺(𝑖), in green. It can be seen that the difference in 
position of most of undeformed and deformed particles is less than 𝜖.  Figure 3-1(c & d) show two 
different example model constructed deformations, 𝑃(𝑖), in orange, both of which will converge 
to satisfy Equation (3-1) as they are less than 𝜖 as well. It can be seen that the formulation is not 
sensitive to small deformations. Figure 3-1(e) shows the conventionally deformed particles (𝐺(𝑖)) 
in green, and the amplified differences introduced by  𝑀(𝐼, 𝐺( 𝑖),𝑓𝜂⊂𝐼, 𝐸′) in red. Because of the 
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amplified differences induced with a unidirectional force over all particles in the z-direction, the 
example reconstructed deformation, 𝑀(𝐽, 𝑃( 𝑖),𝑓𝜂⊂𝐼, 𝐸′)  shown in orange in Figure 3-1(f) will not 
converge under Equation (3-2), while Figure 3-1(g) will converge. It can be seen that using 
Equation (3-2), the small differences can be significantly magnified in an locally heterogeneous 
manner. Such a process enables a smoother and faster estimation of elasticity.  
To summarize, the inverse analysis, facilitated by the physics-based biomechanical model and 
novel locally heterogeneous convergence magnification approach is applied according to the 
following steps: Intermediate elasticity values are assigned to each voxel of the biomechanical 
model. The boundary of the lung is deformed outward. The inner voxels are allowed to deform 
and reach a state of equilibrium. To facilitate convergence and increase conditioning of the system, 
a prescribed unidirectional force is applied to the inner voxels of the lungs. The elasticity 
distribution is iteratively updated and new model deformations are obtained. This process is 
repeated until Equation (3-2) is satisfied and convergence occurs, as shown in Figure 3-2 below. 
Once the algorithm has converged with the initial unidirectional force, the biomechanical 
simulation is then run with the magnification force applied in another direction in order to induce 
different local heterogeneity and convergence. The union is then taken between the resultant 
elasticity distributions for the different forces and the elasticity value corresponding to the lowest 
displacement error is taken to be the optimal value.  
3.3 Quantitative Analysis 
It is important to quantify the accuracy with which the elasticity estimation method presented can 
be performed using deformation data that would be easily obtained 4DCT datasets. From a 
mechanics perspective, it is known that multiple distinct heterogeneous elasticity maps can result 
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in the same displacement distribution [76]. So a direct usage of clinical datasets will not provide a 
full quantitative analysis. In addition, inverting a forward model with a heterogeneous elasticity 
distribution is not a straightforward problem [77, 78]. Variations in the elasticity, boundary 
constraints, and image noise may lead to a lowered accuracy. To address this issue and enable a 
systematic study of the application of our methodology for lung elastography, a physics-based 
lung model with known tissue elasticity was employed to generate a virtual lung phantom [65].  
 
Figure 3-2: Flow chart depicting locally heterogeneous convergence magnification approach within elasticity 
reconstruction algorithm. 
3.3.1 Virtual lung phantom 
The virtual lung phantom geometry was obtained from anonymized lung CT geometry of both a 
right and left lung. Each lung phantom voxel was assigned a normal ground-truth Young's modulus 
based upon the HU value of the source CT, with elasticity values ranging between 1 and 20 kPa—
an extended approximation of the range of elastic modulus values for normal and fibrotic lung 
tissue [79, 80]. This resulted in a locally heterogeneous elasticity distribution, which was further 
modified to represent different diseased tissue that might be seen in lung radiotherapy cases.  The 
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virtual lung phantom was deformed from the initial source geometry to a target geometry based 
on the prescribed boundary constraints. Two different forward models were used to displace the 
virtual lung phantom: an elastostatic Green’s function model and the well-validated elastodynamic 
model used in the inversion process. The displacement of each voxel of the virtual lung phantom 
was taken to be the ground-truth displacement. Figure 3-2 summarizes the entire experimental 
process, from the development of the virtual lung phantom to the inverse analysis.  
3.3.2 Experimental process  
To enable a systematic study of the lung elastography methodology, the virtual lung phantom 
source datasets were segmented into 25 slice sections of the apical, middle, and basal regions, each 
slice with a resolution of 145x179 pixels. Each of the six sectioned lung regions (right apex, right 
middle, right base, left apex, left middle, and left base) were simulated using the physics-based 
biomechanical model and analyzed to evaluate the effect of geometry on the convergence of our 
methodology..  
 
Figure 3-3: Volume rendering of left (a) and right (b) simulated geometry of the lungs used in systematic study. 
Approximate apex, middle, and base sections are labeled. 
Figure 3-3 illustrates volume renderings of the left (a) and right (b) physics-based biomechanical 
lung models that were used to analyze the geometrical dependencies of our high precision lung 
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elastography methodology. The approximate locations of the 25-slice apex, middle, and base 
sections of each lung are also labeled for clarity 
To begin the systematic study, homogenous initial elasticity values were applied to the physics-
based biomechanical lung model. Ground-truth boundary deformation values were applied to the 
surface voxels of the biomechanical lung model. The inner voxels were allowed to deform 
according to the elastic forces within the model. The steady-state displacements were then 
magnified. Finally, the resulting deformation and reconstructed elasticity distributions were 
compared to the ground-truth numbers on a voxel-by-voxel basis. Along with average results, we 
sought to examine four other criteria: (a) accuracy improvement due to use of locally 
heterogeneous convergence magnification, (b) accuracy deviations due to relevant model 
variations, (c) relation between ground-truth elastic distribution and accuracy, and (d) relation 
between boundary expansion magnitude and accuracy. The following experiments describe the 
approaches used to examine criteria (a) – (d).   
3.3.2.1 Experiment 1: Assessing the locally heterogeneous convergence. To assess the function 
and necessity of this novel convergence criteria, the elasticity estimation was first performed using 
our conventional methodology (Equation (3-1)) with 𝜖 set to a small value of 0.5 𝜇m to see the 
effects of reducing 𝜖 to magnify displacement differences. Such a value of 𝜖 also acts as a global 
magnifier of the displacement convergence. Then, the locally heterogeneous convergence 
technique (Equation (3-2)) was utilized and the accuracy improvements were evaluated and 
quantitated for a small 𝜖 value of 0.5 mm. For simplicity, in this study, the locally heterogeneous 
convergence technique is performed twice for each case that is considered: once with 𝑓 in the z- 
and once with 𝑓 applied at a 45 degree angle between the x- and y-axes (referred to as the xy-
direction). The force that provided the least displacement error was taken to be optimal for each 
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voxel. If these accuracy improvements were significant, the results would indicate the need for 
the, locally heterogeneous convergence technique to garner useful elasticity information from 
clinical lung deformation values.  
3.3.2.2 Experiment 2: Assessing estimation accuracy for forward model variations. To assess 
the robustness of our methodology, two variations on the forward model were used to compute 
ground-truth displacement values. The conventional ground-truth displacement was taken from an 
elastodynamic forward model, previously well-validated in [52], in which the virtual lung phantom 
was deformed for 5000 timesteps. Secondly, an elastostatic forward model based on Green’s 
function [61] was also used to compute ground-truth displacement.  
Finally, to further validate the robustness of the model, random noise within r 5% (r 45 HU)  was 
added to the source images investigated for both the elastodynamic and elastostatic forward models 
used in this study. It has been shown that noise on clinical lung images generally averages around 
30 HU [81], so excessive noise was added for further validation. The original and “noisy” source 
images are shown below in Figure 3-4. Virtual phantoms were then generated for these “noisy” 
geometry and the resulting image pairs were then deformably registered using an in-house 
registration algorithm.  The resulting volumetric displacement was then used for estimating the 
elasticity. 
 
Figure 3-4: 2-D slices of base of left lung showing original (a) and “noisy” (b) source images 
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Reconstructed displacements computed using the elastodynamic forward model were then 
compared to each set of ground-truth displacement values mentioned above. If accurate elasticity 
estimations can obtained for forward model variations, it can be inferred that the elasticity 
estimation algorithm can be extended for use with clinical 4DCT datasets that has a similar noise. 
3.3.2.3 Experiment 3: Assessing the estimation accuracy for variations in the ground-truth 
elastic distribution. As each image dataset is expected to be inherently associated with a unique 
elasticity distribution, we assessed the accuracy in the estimation for different elasticity 
distributions. Normal ground-truth elasticity distributions were assigned to the biomechanical 
model as described above. Since our primary aim was to investigate lung elastography for 
radiotherapy purposes, spherical masses were included within the normal elasticity distributions 
for each lung region to represent emphysematous and cancerous regions respectively. 
Emphysematous tissue was investigated along with tumors because the risk of lung cancer in 
patients with COPD in two- to five-fold greater than those without COPD [82, 83]. A homogenous 
Young’s modulus value of 1 kPa was chosen to represent emphysema, as emphysema lowers the 
elastic modulus of tissue, while a homogenous Young’s modulus value of 25 kPa was chosen to 
represent malignant tumors, which are known to have a higher elasticity than the surrounding soft 
tissue [84, 85]. The cancerous tumors had a diameter of 7 mm, while the emphysematous regions 
had a diameter of 21 mm [86, 87]. The accumulation of the normal, cancerous, and emphysematous 
elasticity distributions for each lung region resulted in 18 total ground-truth elasticity distributions 
that were evaluated in this study.  
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Figure 3-5: 2-D slices of base of right lung showing ground-truth elasticity distributions representing normal (a), 
emphemsema (b), and cancerous (c) tissue. 
Figure 3-5 shows example ground-truth elasticity distributions for a 2-D slice of the base of the 
right lung. Figure 3-5(a) illustrates normal tissue, while an emphysematous region with low 
elasticity has been added in 3-5(b) and a stiff nodule representing a tumor has been added in 3-
5(c). Emphysematous and cancerous regions were added at different locations in each of the 6 
different geometries to evaluate whether or not the location of the abnormality affected the results. 
3.3.2.4 Experiment 4: Assessing the estimation accuracy for variations in the boundary 
constraints. In order to emulate air filling different regions of the lung, the boundary of the lungs 
was drawn outward along a normal vector with respect to the center of mass of the modeled lung 
section. The magnitude of the outward deformation was constrained based upon typical motion 
amplitudes derived from the literature, as shown in Table 3-1 [68, 69]. Three different boundary 
constraints were investigated for each lung region to examine the influence of boundary motion 
on the convergence of our methodology.  
Table 3-1: Boundary constraint based upon typical motion for apex, middle, and base regions of the lung [71, 72]. 
Boundary Constraint 
(BC) Lung Region 
 Apex Middle Base 
BC 1 (mm) 2 3 10 
BC 2 (mm) 4 6 13 
BC 3 (mm) 6 9 16 
 
 52 
These boundary expansions were illustrative of the low ventilation and subsequent low 
parenchymal expansion in the apex during different breathing stages, and the slightly larger 
expansion of the middle and basal regions of the lungs. It shall be noted, that while the surface 
particles of the lung were drawn outward, the inner voxels were allowed to deform according to 
the elastic forces in the model. 
3.4 Results 
In this section, we present the results obtained from the systematic study. The experiments were 
performed with apex, middle, and base sections of a right and a left lung, as shown in Figure 3-3 
above.  
As mentioned above, each of the virtual phantom generated dataset contained 25 slices with a 
resolution of 145x179 pixels. Finite mass elements were created for each voxel of lung tissue, 
which resulted in between 300,000 and 500,000 finite element nodes depending on the dataset. 
The elastodynamic biomechanical  lung model was deformed for 5000 timesteps during each 
iteration. Each iteration took about one minute to complete, and the whole system converged in 15 
– 30 minutes. Two elasticity estimations were completed for each dataset using an applied xy- and 
z-force, and the final elasticity estimation results were achieved within an hour of computation 
time.    
The average results for the measured elasticity are as listed in the geometry section of Table 3-2. 
On average, the right lung converged with an average of 99.98% of voxels within 0.5 mm of 
ground-truth displacement values. This ensued with 91.59% of voxels converging within 1 kPa of 
ground-truth elasticity. For the left lung, an average of 99.92% of voxels converged within 0.5 mm 
of ground-truth displacement, corresponding to 91.87% of voxels arising within 1 kPa of ground-
truth elasticity. A two-sample t-test was performed between 27 right and 27 left lung ground-truth 
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distributions, and confirmed that the differences between the convergence results of the right and 
left datasets were not significant (P > 0.05). Figure 3-6 highlights the geometrical differences 
between a 2-D slice of the right (a & b) and left (c & d) apex. Figure 3-6(a & c) show ground-truth 
elasticity distributions, while Figure 3-6(b & d) show our lung elastography results with the 
discrepancy (error > 1 kPa) highlighted in yellow. It should be noted the similarity between the 
novel reconstructions (b & d) and the corresponding ground-truth distributions (a & c)—both novel 
reconstructions are 95% similar to their ground-truth distributions, illustrating that the high 
accuracy of the elasticity estimation process is independent of the lung geometry’s complexity. 
We now present the results obtained from the experiments outlined above. 
 
Figure 3-6: 2-D slice of right (a & b) and left (c & d) apex. (a & c) show the ground-truth elasticity distributions, 
while (b & d) show elasticity reconstructions with the use of our novel convergence criteria. Elasticity discrepancies 
(error > 1 kPa) are highlighted in yellow 
3.4.1 Experiment 1: Assessing the locally heterogeneous convergence 
First, to reinforce the necessity of the locally heterogeneous convergence magnification approach, 
the convergence criteria 𝜖  from Equation (3-1) was reduced to 5 𝜇 m in an attempt to 
homogeneously magnify the displacement differences. While over 90.2% of voxels converged 
within 5 𝜇m, less than 5% of voxels converging within 1 kPa of the ground-truth data. 
Figure 3-7(a) illustrates the ground-truth elasticity distribution for a 2D-slice of the base of the 
middle left lung, while (b) shows the reconstruction with a modified 𝜖  of 5 𝜇 m. Since the 
methodology was unable to draw useful information from the subtle deformation of each voxel, it 
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converged to a low contrast, homogenous Young’s modulus estimation, as shown in Figure 3-7(b). 
For comparison, 3-7(c) again illustrates the inability of the conventional reconstruction (this time 
with a convergence criteria of 0.5 mm used as 𝜖  in Equation (3-1)) to estimate the elasticity 
distributions precisely. While high displacement accuracy is again achieved, similarly to Figure 3-
7(b), the resulting elasticity distribution is a low contrast, homogenous Young’s modulus 
estimation. Reducing epsilon does not improve the accuracy of the reconstruction using Equation 
(3-1). The reconstruction was much improved when the novel locally heterogeneous magnification 
technique was used, as shown in Figure 3-7(d). Therefore, we conclude that it is necessary to use 
Equation (3-2) to achieve good elasticity estimation results. For the rest of the systematic study, a 
global convergence criterion of 0.5 mm is utilized. 
 
Figure 3-7: Ground-truth (a), conventionally reconstructed elasticity with ϵ of 5 μm (b), conventionally 
reconstructed elasticity distribution with globally magnified convergence criteria of ϵ being 0.5 mm  (c), and 
reconstruction using novel locally heterogeneous convergence magnification approach (d) for a 2-D middle slice of 
the left lung 
To further reinforce the necessity of the locally heterogeneous convergence magnification 
approach, a two-sample t-test was performed to determine whether or not the differences observed 
between the results with and without the use of the technique were significant. With a mean 
displacement accuracy of 93.27% and 99.95%, and a mean elasticity accuracy of 77.05% without 
and 91.94% with the use of the novel technique, the two-sample t-test confirmed that the observed 
difference was significant (P < 0.05).  
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The improved accuracy of the methodology with the use of the novel technique is also documented 
in Figure 3-8. The subtle displacement error of the conventional technique, shown in green in 
Figure 3-8(a) leads to divergence in the elasticity estimation shown in green Figure 3-8(b). 
However, when the locally heterogeneous magnification method was applied, shown in blue, both 
the displacement and elasticity error converged correctly. Therefore, we concluded that use of the 
locally heterogeneous technique provided meaningful improvements to our methodology, and it is 
used for the rest of the systematic analysis. 
 
Figure 3-8: Displacement (a) and elasticity (b) error for methodology with and without convergence magnification 
approach. 
Table 3-2: Overall average results from systematic analysis, along with results broken down by performance 
analysis criteria. 
Performance Analysis 
Criteria – Average 
Results 
Displacement 
Accuracy  
< 0.5 mm (%) 
Elasticity Accuracy 
< 1 kPa  
(%) 
Overall Averages 99.95 91.95 
Geometry   
Right 99.98 91.59 
Left 99.92 91.87 
Ground-truth distribution   
Emphysema 99.95 91.90 
Cancerous Tumor 99.94 91.68 
Normal Tissue 99.95 91.62 
Boundary Constraint   
BC 1 99.97 93.81 
BC 2 99.98 90.87 
BC 3 99.90 90.56 
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3.4.2 Experiment 2: Assessing estimation accuracy for forward model variations 
Both an elastodynamic and elastostatic forward model were used to compute ground-truth 
displacement values. Elastodynamic ground-truth displacement values and elastostatic ground-
truth displacement values were calculated using the corresponding forward models. Reconstructed 
displacements computed using the elastodynamic forward model were then compared to each set 
of ground-truth displacement values mentioned above. The overall and average results for the 
elastodynamic ground-truth are discussed in the previous section. When the ground-truth data was 
recorded using an elastostatic forward model, without the novel convergence magnification 
technique 71.39% of voxels converged within 0.5 mm and 1 kPa . When the novel convergence 
technique was utilized, 86.17% of voxels converged. This indicates the potential of our approach 
to converge even when a different model is used to obtain ground-truth deformation values.  
Therefore, it is reasonable to assume our approach can extend to clinical deformation information. 
To determine the impact of SNR on estimation accuracy, random noise within ± 5% was added to 
each of the source images for both the elastodynamic and elastostatic forward models analyzed in 
the experiments above. It was found that without the novel convergence magnification technique, 
the 57.2% of the voxels converged within 0.5 mm and 1 kPa of the “noisy” ground-truth values. 
When the locally heterogeneous convergence magnification approach was utilized, however, 
73.3% of voxels converged within the aforementioned tolerance. This illustrates that our approach 
will obtain useful deformation information from image datasets with lower SNR.  These results 
are summarized in Table 3-3 below.  
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Table 3-3: Average results from systematic analysis of three different ground-truth forward models. 
Ground-truth 
forward model 
Accuracy w/o Novel 
Magnification (%) 
Accuracy w/ Novel 
Magnification (%)  
Elastodynamic 77.07 91.94 
Elastostatic 71.39 86.17 
“Noisy” 57.20 73.29 
 
For the remainder of the experiments, the elastodynamic forward model is used to obtain ground-
truth deformation values. 
3.4.3 Experiment 3: Assessing the estimation accuracy for variations in the ground-truth 
elastic distributions  
Table 3-2 lists the average results for the systematic analysis performed using the locally 
heterogeneous convergence magnification method. The results were also broken down by 
experimental category. As mentioned above, three different ground-truth elasticity distributions—
emphysematous, cancerous, and normal tissue—were investigated to analyze the robustness of our 
methodology. On average, the methodology converged with displacement accuracy values of 
99.95%, 99.94%, and 99.95% for emphysematous, cancerous, and normal tissue respectively. 
These results, presented in Table 3.2 above, corresponded to 91.90%, 91.68%, and 91.62% of 
voxels converging within 1 kPa of the ground-truth elasticity values. Figure 3-9 illustrates the 
robustness of the methodology for reproducing different ground-truth elasticity distributions. 
Figure 3-9(a) shows the conventional elasticity reconstruction, which was the same for normal, 
emphysematous, and cancerous ground-truth elasticity distributions. Discrepancies between the 
reconstruction and the normal ground-truth elastic distribution that are greater than 1 kPa are 
highlighted in yellow. It can be seen that initially, the reconstruction is very different from the 
ground-truth, with a similarity of less than 50%.  
 58 
Figure 3-9(b – d) show the novel elasticity reconstruction for normal, emphysematous, and 
cancerous tissue respectively, with the discrepancies (error > 1 kPa) between the reconstructed and 
ground-truth data highlighted in yellow. With similarity values of 92.73%, 93.44%, and 91.10%, 
it can be seen that use of the locally heterogeneous convergence magnification greatly improves 
the elasticity reconstruction, allowing for the visualization of emphysematous and cancerous 
regions within the lungs. It should be noted that for each lung geometry, cancerous and 
emphysematous regions were placed at different locations within the 2-D slices to ensure that the 
regions could be localized regardless of position. A two-sample t-test was performed between the 
mean values of 18 different emphysematous, 18 different cancerous, and 18 normal tissue 
distributions, and the observed difference was convincing enough to say that the average values of 
each ground-truth elasticity distribution did not differ significantly (P > 0.05). 
 
Figure 3-9: 2-D slice of middle right lung. (a) shows the conventional reconstruction for all 3 ground-truth elasticity 
distributions. (b) shows the novel reconstruction for normal tissue, (c) shows the reconstruction for normal tissue 
with emphysematous region, and (d) shows the reconstruction for normal tissue with tumor. Discrepancies (error > 1 
kPa) between the reconstructed and ground-truth distributions are highlighted in yellow. 
3.4.4 Experiment 4: Assessing the estimation accuracy for variations in the boundary 
constraints 
As previously noted, the outward motion of the lung boundary was constrained to three different 
values for each section of the lung as listed in Table 3-1. The resulting displacement and elasticity 
accuracy values of the methodology are listed in Table 3-4 below. Overall averages are listed for 
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the three different boundary constraints in Table 3-2 above. A two-sample t-test was performed on 
these values, and it was found that there were no significant differences between the results 
regardless of whether boundary constraint 1, 2, or 3 was used for each geometry. 
Table 3-4: Displacement and elasticity accuracy values for different geometries and boundary constraints. 
Lung Geometry - 
Boundary Constraint 
Displacement 
Accuracy  
< 0.5 mm (%) 
Elasticity 
Accuracy 
< 1 kPa (%) 
Apex – 2 mm 99.99 97.89 
Apex – 4 mm 99.99 97.55 
Apex – 6 mm 99.97 96.82 
Middle – 3 mm 99.92 94.17 
Middle – 6 mm 99.94 92.18 
Middle – 9 mm 99.95 90.07 
Base – 10 mm 99.98 89.37 
Base – 13 mm 99.99 82.86 
Base – 16 mm 99.78 84.80 
 
 
Figure 3-10: 2-D elasticity reconstruction of base of left lung. (a) shows conventional reconstruction, (b) shows 
novel reconstruction with 10-mm boundary constraint, and (c) shows novel reconstruction with 16-mm boundary 
constraint. Discrepancies (error > 1 kPa) between the reconstructed and ground-truth distributions are highlighted in 
yellow. 
Figure 3-10 further illustrates that the reconstruction converges similarly regardless of the 
boundary constraint magnitude. Figure 3-10(a) shows the conventional reconstruction of the base 
of the left lung, (b) shows the reconstruction when a 10-mm boundary constraint was applied, and 
(c) shows the reconstruction when a 16-mm boundary constraint was applied. Figure 3-10(a) is 
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over 50% different than the ground-truth, while 3-10(b) and 3-10(c) are only 6.07% and 6.34% 
different from the ground-truth respectively. The result supports the accuracy in estimating the 
lung elasticity for varying boundary constraints. 
In summary, our elasticity estimation converged with about 99% sub-millimeter accuracy, 
resulting in an elastic convergence of about 92%. We have shown that the use of the locally 
heterogeneous convergence magnification approach is necessary in the transition to apply our 
conventional elastography technique to lung anatomy. However, use of different ground-truth 
elasticity distributions and different boundary constraint magnitudes did not affect the convergence 
of our technique. While we mainly focus on ground-truth values obtained from an elastodynamic 
forward model, “noisy” and elastostatic forward models also produced reliable elasticity 
estimations.  
3.5 Discussion 
In this chapter, we presented a methodology for determining lung tissue elasticity using 
conventional CT imaging protocols performed within a radiotherapy workflow. The procedure 
was developed and assessed using a virtual lung phantom with simulated ground-truth elasticity 
and displacement values. A high-resolution biomechanical simulation was employed as an 
elastodynamic forward model to solve the inverse linear elasticity problem. To simulate breathing 
motion, lung surface displacements were applied as boundary constraints, while the inner lung 
voxels of the biomechanical model were allowed to deform according to the pre-assigned linear 
elasticity. A novel locally heterogeneous convergence magnification was then applied to allow our 
conventional elastography methodology to be sensitive to the subtle deformation of the interior 
lung tissue.  
 61 
The biomechanical model  was created with a physics-based approach to represent the interior lung 
tissue, a choice that was motivated by the previously shown accuracy of the simulation for head 
and neck and breast applications [52, 60].  Because of the successful simulation of other anatomies, 
along with the work of other researchers that suggested that the lung can be successfully modeled 
as a linear elastic material, the physics-based biomechanical model was expected to be able to 
accurately model the lung [88, 89]. Using this well-validated constitutive model allowed us to 
focus on the accuracy and feasibility of the model when applied to lung elastography. Such a well-
validated constitutive model is necessary as lung behavior differs drastically between in vivo and 
ex vivo environments,  so typical ex vivo validation experiments would probably prove infeasible 
and would need to be very carefully designed. When transitioning to clinical deformation data, 
potential differences in the numerical estimation may stem from sources such as the 4D image 
artifacts, cardiac motion, irregular breathing and hyperelastic lung behavior. Novel efforts, such 
as the 5D imaging protocol, have been employed to address imaging-related issues, which will 
enable the measurement of lung tissue elasticity within the radiotherapy setup to be a feasible 
approach. While elasticity estimation has been performed using elastostatic and “noisy” forward 
deformation models, other complicated physics-based models have also been used to represent 
lung deformation; it would also be worthwhile to perform the elasticity estimation technique using 
these models as a forward setup. 
For the systematic analysis, a forward model is employed that utilizes the same elastodynamic 
physics as the forward model used during the elasticity estimation process. This is necessary to 
systematically examine the accuracy of the elasticity estimation, as ground-truth elasticity values 
of lung tissue are not known. Though we are utilizing the same linear elastic constitutive model to 
deform and invert the biomechanical model, the iterative inverse process utilizes a gradient-based 
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binary search methodology and a locally heterogeneous convergence magnification technique that 
allow elasticity estimations to be obtained from any displacement information, regardless of the 
model used to generate the deformation data. Such an experiment was necessary in order to 
investigate the potential accuracy of the elasticity estimation algorithm. As our biomechanical 
simulation has been shown to accurately model tissue motion, it is our hypothesis that, when actual 
tissue motion vectors obtained from optical flow DIR techniques are used, our elasticity estimation 
algorithm will still be able to perform well. This is further represented by the convergence that was 
obtained using elastostatic and “noisy” ground-truth deformation values. Further studies will focus 
on extending the usage of such a model to incorporate clinical 4DCT lung deformation data 
obtained from optical flow deformable image registration techniques. Errors quantified during this 
approach will be correlated to the quantitative nature of the 4D imaging systems. The following 
chapter will focus on addressing the challenges associated with transitioning from virtual 
phantoms to clinical data.  
Unlike other elastography methods, the novel lung elastography method presented directly relates 
elasticity with the displacement of lung tissue in a clinically relevant manner. Initial results using 
the conventional elastography method presented in Chapter 3 (Hasse, Neylon [60]) indicated the 
need for an additional novel locally heterogeneous convergence magnification.  The conventional 
methodology resulted in high displacement accuracy, but no useful elasticity information was 
gleaned upon convergence, further highlighting the need for a systematic study with virtual lung 
phantoms and known ground-truth elasticity distributions. The novel technique provided added 
deformation to each voxel and amplified the differences in displacement error, stabilizing the 
elasticity estimation and allowing it to converge while maintaining the integrity of the solution. 
This allows our elasticity estimation methodology to be much more sensitive to the subtle changes 
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often seen in the interior tissue of the lungs. Future work will focus on addressing the general 
applicability of the proposed algorithm for solving more general inverse problems.  
Our results indicated that high accuracy can be obtained using deformation information gleaned 
from 4D lung datasets (e.g. 4DCT and 5D lung protocols). Variations in the lung geometry and 
ground-truth elasticity distribution resulted in insignificant differences in the resultant elasticity 
distributions, indicating the potential of the methodology to converge with clinical data, which 
may be more complex than the data used in our study. The convergence of the methodology 
irrespective of the boundary constraint demonstrates that, when applied to clinical data, the 
elasticity estimation technique should converge with any breathing stage that can be utilized to 
garner displacement data. Future work will investigate using deformation data from multiple 
breathing stages to more quickly estimate elasticity distributions. Further constraints on the 
boundary motion of the biomechanical model will also be investigated with respect to the physical 
motion of the lungs and the effect on estimation accuracy. In order to optimize the force applied 
to each voxel in the convergence magnification technique, the elasticity estimation process is 
completed multiple times for each dataset, and converges completely within an hour.  
The elasticity information we obtain through this methodology will be used to improve respiratory 
brachytherapy seed implantation and tumor tracking in radiotherapy. Knowing the elastic 
distribution and motion of the lung tissue can allow radiation therapists to increase dose to the lung 
tumors while sparing normal tissue, reducing clinical margins, and decreasing normal tissue 
toxicity. This methodology could also prove useful for patients with other lung diseases, such as 
COPD.  
Because 4DCT imaging techniques are currently used within lung radiotherapy workflows, lung 
tissue deformation data is known on a voxel-by-voxel basis and the construction of the 
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biomechanical model devised in this study can be easily integrated. While 4DCT image artifacts 
could cause errors in elasticity estimation, the recent push towards 5DCT imaging techniques 
could provide less noisy, artifact-free clinical ground-truth deformation data.  The usage of GPU 
based computations for the elasticity estimation enables the computations to be completed in 
reasonable timings.  
Since our focus was to bring lung elastography into the radiotherapy setup, a linear elastic model 
was employed for the elasticity estimation process. However, the linear elastic model of the lungs 
may be simplistic for representing complete lung behavior in those patients with COPD. In our 
future studies, the linear elastic assumptions will be expanded to hyperelastic constitutive laws to 
try and more accurately depict the mechanics of diseased lung tissue. The impact of different strain 
rates on the elasticity assumptions and estimations will also be investigated. For these future 
studies, a fast simulated annealing approach will be designed to estimate the lung’s hyperelasticity. 
The current imaging protocols will also need to be modified in order to better describe the 
hyperelastic lung behavior; for example, the incorporation of fast helical CT scans could provide 
more information about the lung deformation. 
3.6 Conclusions 
In this chapter, we present a systematic study of a novel inverse analysis elastography method for 
lung tissue using virtual lung phantoms and simulated deformation values. The methodology 
employed a forward physics-based biomechanical model of the lungs that was iteratively deformed 
to represent the deformation of lung tissue that occurs during the breathing cycle. A novel locally 
heterogeneous convergence magnification technique was applied in order to gain elasticity 
information from the subtle deformation of the interior voxels of the lungs. The inverse analysis 
consisted of a gradient descent based binary search optimization scheme to update the spatial 
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elasticity distribution of lung tissue according to the discrepancy between ground-truth and 
experimental deformation. Our analysis showed an average of 92 ± 5 % of voxels converged 
within 1 kPa of the ground-truth elasticity and within 0.5 mm of ground-truth deformation. These 
results indicate the potential of this methodology to be applied to clinical deformation data, which 
will be investigated in Chapter 4.  
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CHAPTER 4: UTILIZE BIOMECHANICAL MODEL AND 
DEFORMATION VECTOR FIELDS TO OBTAIN LUNG 
ELASTICITY INFORMATION FROM 4D IMAGING. 
Estimation and validation of patient-specific high-resolution 
lung elasticity derived from 4DCT 
A version of this chapter has been published as a manuscript: Med Phys, Vol. 45, No. 2,  025006, 2018. doi: 
10.1002/mp.12697 
4.1 Introduction 
Many lung diseases, including lung cancer, are associated with changes in lung tissue 
biomechanical properties [90]. For instance, pulmonary emphysema and fibrosis are known to be 
associated with changes in the parenchymal stiffness. Using excised tissue studies, it has been 
shown that localized changes in the biomechanical properties of lung parenchyma preceded the 
initiation and progression of certain lung diseases [17, 90]. However, the ability to quantify and 
localize pulmonary disease onset and progression at a regional level using in vivo studies is 
currently limited. Gold-standard spirometry-based estimates are the current state of the art 
approach used for overall  chronic disease characterization [91]  but do not explicitly characterize 
regional lung biomechanical information [92]. While computed tomography (CT), specifically 
4DCT, is commonly used for lung radiotherapy imaging and treatment planning purposes, it does 
not present a quantitative characterization of the lung biomechanical properties [93].    
To learn patient-specific lung biomechanical properties within the radiotherapy context, this study 
investigates the application of elastography using 4DCT scans of the human lung. We hypothesize 
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that such an approach will enable lung tissue elastic properties to be estimated using conventional 
radiotherapy imaging modalities. A critical step in furthering the uses elastography within the 
radiotherapy context is the need to quantitatively validate the lung elasticity measurements. Once 
validated, these properties can be used for advancing lung cancer treatment planning and delivery, 
and monitoring treatment response.  
The lung elastography approach was previously described in Chapter 3.  For application of the 
elastography approach in this study, the ground-truth tissue behavior was characterized from the 
4DCT datasets. 4D displacement vector fields (DVF) obtained from deformable image registration 
were employed as a boundary constraint to guide the elastography process [94]. A key component 
of this study is the quantitative validation of the estimated lung elastography distributions. Since 
4DCT scans have data for every phase of the breathing cycle, validation is performed by analyzing 
mid-exhalation. 
The rest of the chapter is organized as follows: Section 4.2 introduces the methods employed for 
the elastography and the validation processes. Section4.3 presents the qualitative results of the 
deformable image registration, elastography, and validation process, while section 4.4 presents a 
numerical analysis of the results. Section 4.5 presents a discussion of the results and highlights the 
areas for continued research, and section 4.5 concludes this chapter.  
4.2 Methods 
Our elastography process focused on the effective Young’s modulus (E) estimation for each voxel 
of lung tissue using 4DCT lung data. Figure 4-1 shows a flow chart summarizing the elasticity 
estimation. First, the end-inhalation and the end-exhalation breathing phases from the 4DCT lung 
images were registered using an optical flow deformable image registration (DIR) algorithm. The 
lung DVF was obtained for every voxel of the end-exhalation breathing phase. The biomechanical 
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model was then assembled using the end-exhalation lung geometry along with a random elasticity 
distribution as the initial elasticity value. Using the ground-truth lung DVF, the elasticity 
distribution was optimized. Spatial elasticity and displacement error distributions were obtained 
and validated.  
 
Figure 4-1: Flow chart showing 4DCT elasticity estimation process 
In this section, we first briefly present the DIR technique used to obtain the ground-truth DVF. 
Next, we present the constitutive model used for representing tissue biomechanics in order to solve 
the inverse elasticity problem. We then present the optimization process used in the iterative 
elasticity estimation. This is followed by a discussion of the convergence criteria used for the 
optimization process. We then describe the image similarity metrics used in our study to 
characterize the quantitative accuracy of the estimated elasticity combined with the constitutive 
model. We conclude the section with a discussion of the validation study. 
4.2.1 Deformable image registration  
The model-guided elasticity approach presented in this study relies on displacement values 
extracted from DIR of 4DCT datasets. The lung is a challenging organ to register and requires DIR 
due to the large deformation caused by respiration. A patient cohort of 15 4DCT datasets that were 
acquired using 5DCT protocol (IRB# 11-000620-CR-00004) was employed for the elasticity 
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estimation [95-97]. The patient cohort consisted of lung cancer patients undergoing SBRT at 
UCLA. The average age of the patients was 66, six of the patients were male, and nine were female. 
The 4DCT scans were acquired on Siemens Definition Flash, Siemens Biograph 64, and Siemens 
Definition AS 64 scanners with 1 mm slice thickness.  
The left and right lungs were segmented using an intensity-based thresholding approach [98].  
Segmented end-inhalation (85th percentile breathing amplitude) were deformably registered to the 
spatial domain of the end-exhalation (15th percentile breathing amplitude) breathing phases using 
a well-validated in-house multi-level optical flow DIR algorithm [94]. This registration algorithm 
has been well-validated for both the lung and head and neck anatomies [99, 100]; therefore, we 
trust the resulting DVF to be an effective representation of the ground-truth lung motion. The 
registered DVF for each voxel will be taken to be the effective ground-truth displacement, 
henceforth denoted as simply ground-truth, for the elasticity estimation process.  
4.2.2 Constitutive model 
The model presented in this section is focused on computing the lung tissue deformation for a 
given lung boundary  displacement arising from the ground-truth DVF, as previously demonstrated 
in [59]. The model has been previously described in [52, 60] and specifically applied to the lungs 
in [61, 101]. This approach is appropriate for our current study since its applicability has been 
systematically investigated [101]. For clarity purposes, a brief description of the constitutive 
equations for the forward model [52] is presented here.  
4.2.2.1 Model geometry. The biomechanical lung model was assembled from the 4DCT end-
exhalation images. The model geometry was represented by finite element nodes corresponding to 
the center of each voxel in the end-exhalation image. Lung tissue, an elastic material, was viewed 
as a series of these finite mass elements coupled with linear elastic connections to adjacent mass 
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elements in deformation space. This was to ensure a physically realistic deformation. Rest length 
and orientation of each connection were then documented and assigned an initial effective Young’s 
modulus and a Poisson’s ratio of 0.43 [62-64].   
4.2.2.2 Model physics. In our approach, linear elastic constitutive laws were implemented because 
linear elastic representations have been found to be effective in describing normal lung tissue 
deformations typically observed in 4DCT-based lung motion [65]. Additionally, a study 
investigating lung tumor motion during external beam radiotherapy found that a hyperelastic 
constitutive law performed very similarly to linear elastic constitutive law at deformation 
magnitudes found within the lungs during normal breathing [64].  
The model is actuated due to changes in boundary constraints, which subsequently calculates 
corrective forces on each mass element for given boundary constraints. In our approach, we 
compute the boundary constraints from the lung boundary DVF. The corresponding forces on each 
mass element were calculated as described in §2.2.1.2.  
4.2.3 Inverse elasticity formulation 
For clarity, the simplifying notation that will be used in this chapter is listed in Table 4-1.  
Table 4-1: Notation and description for resultant terms utilized in the manuscript 
Notation Description 
D𝑉𝐹𝐷𝐼𝑅,𝐴 
Ground-truth end-exhalation to end-
inhalation DIR DVFs 
D𝑉𝐹𝐷𝐼𝑅,𝐵  
Ground-truth end-exhalation to mid-
exhalation DIR DVFs 
D𝑉𝐹𝑀𝑜𝑑𝑒𝑙,𝐴 
Model-generated end-exhalation to 
end-inhalation DVFs 
D𝑉F𝑀𝑜𝑑e𝑙,𝐵  
Model-generated end-exhalation to 
mid-exhalation DVFs 
𝐸𝐴 
Effective elasticity distribution 
obtained from minimizing error 
between 𝐷𝑉𝐹𝐷𝐼𝑅,𝐴  and 𝐷𝑉𝐹𝑀𝑜𝑑𝑒𝑙,𝐴 
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The inverse elasticity problem was formulated as a parameter-optimization problem with an 
objective to determine the elasticity parameter that would minimize the difference between the 
ground-truth DVFs (𝐷𝑉𝐹𝐷𝐼𝑅,𝐴) and those computed by the constitutive model, as described in 
§2.2.2. Solving this inverse elasticity problem was carried out in two steps : 1) estimating the DVF 
for every voxel of tissue for a given elasticity distribution and changes in boundary constraints, 
and 2) optimizing the elasticity distribution to best reproduce the 𝐷𝑉𝐹𝐷𝐼𝑅,𝐴 .  
In the first step, we applied the lung boundary conditions, and the interior mass elements were 
allowed to deform according to the elastic constitutive forces within the model, as described in 
§2.2.1.2 above. For the second step, the iterative scheme for estimating the elastic distribution is 
based on the inverse relationship between Young’s modulus and displacement. Given an initial 
Young’s modulus distribution, the constitutive model computed mass-element displacements [70]. 
These displacements were then compared with 𝐷𝑉𝐹𝐷𝐼𝑅,𝐴, and the effective Young’s modulus was 
iteratively updated until the difference between the above two displacement maps was minimal. 
New displacements values were generated for each iteration by updating the effective Young’s 
modulus distribution as described in §2.2.2.1.  
After the elasticity was updated, the biomechanical model was then reset to the initial un-deformed 
rest position, and the boundary constraints were re-applied. The reconstruction process was 
repeated until a suitable stopping (convergence) criteria was reached. Upon convergence, the 
resultant elasticity estimation (𝐸𝐴) is recorded along with the resultant deformation vector for each 
voxel (𝐷𝑉𝐹𝑀𝑜𝑑𝑒𝑙,𝐴). 
4.2.4 Convergence metrics 
The convergence metrics utilized in this study are a critical component to interpreting the results. 
At each iteration of the elasticity estimation, the resultant model DVF,  𝐷𝑉𝐹𝑀𝑜𝑑𝑒𝑙,𝐴, were 
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compared to 𝐷𝑉𝐹𝐷𝐼𝑅,𝐴. The number of voxels that converged within a certain 𝜖 value of ground-
truth was quantified as follows: 
𝑐𝑎 = {
1 ∶   ‖|𝑑𝑎| − |𝑑𝑎,0|‖ <  𝜖 
0 ∶                    𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒
                  ( 4-1 ) 
𝑝𝜖 =
∑ 𝑐𝑎
𝑛
1
𝑛
.     ( 4-2 ) 
In Equation (4-1), (𝜖) represents the L2-norm of the DVF for each voxel 𝑎 and 𝑐𝑎 represents the 
error for each voxel. The percent accuracy 𝑝𝜖 was then tabulated by summing the 𝑐𝑎 over all 𝑛 
voxels in lung volume 𝑉 using Equations (4-1) and (4-2). For elastography purposes, the iterative 
process was stopped when 𝑝𝜖 ≥ 0.95. The maximum iteration limit was set to be 100.  
Factors that impact the convergence criteria are determined by image resolution and range of DVF 
values. In our case, the image resolution was limited to 1 cubic mm, which led to a  𝜖1 = 1 mm. 
Image resolution is also impacted by the signal in the underlying tissue. Higher signal-to-noise 
(SNR) is generally observed in blood vessels due to the high contrast and constant structure during 
deformation, while parenchymal tissue exhibits lower SNR. For this reason, accuracy will be 
considered for voxels representing blood vessels and parenchymal tissue separately. The voxels 
representing the two substructures were segmented using an intensity threshold of -500 HU [102].  
Since lung deformation can vary widely between patients and breathing phases, we also formulated 
a convergence criteria, where the percent of voxels converged within 10% of the maximum 
deformation, or 𝜖2 = 0.1 ∗ maxa (|𝑑𝑎|). For each 4DCT dataset, we computed the minimum value 
among 𝜖1 and 𝜖2, and employed that for the optimization process. However, once the elasticity 
estimation converged, the results were evaluated according to both convergence criteria.  
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4.2.5 Image similarity metrics for quantitative evaluation  
While the convergence criteria provided a quantitative way to assess the elasticity estimation 
accuracy, an additional metric was necessary to ensure the precision of the estimated elasticity. 
Specifically, we wanted to ensure that 𝐸𝐴  and 𝐷𝑉𝐹𝑀𝑜𝑑𝑒𝑙,𝐴  could be used to warp the end-exhalation 
image to closely represent the end-inhalation image. In addition, the usage of image similarity 
metrics could quantify the accuracy of the ground-truth data. The image similarity metrics will be 
quantified for both the estimation and validation datasets. The results will be compared for 
significant difference using the student’s t-test. For this purpose, three different image similarity 
metrics were utilized.  
4.2.5.1 Structural Similarity Index Metric. The Structural Similarity Index Metric (SSIM) was 
the first image similarity metric we investigated. SSIM has been previously investigated for the 
lung, and examines structural changes that more closely correlate with a visual evaluation rather 
than differences that do not contribute to perceived image quality, which is important for lung 
[103-105].  
The SSIM [106] is formulated as follows:  
𝑆𝑆𝐼𝑀(𝑥, 𝑦) =
(2𝜇𝑥𝜇𝑦+𝑐1)(2𝜎𝑥𝑦+𝑐2)
(𝜇𝑥
2+𝜇𝑦
2+𝑐1)(𝜎𝑥
2+𝜎𝑦
2+𝑐2)
    ( 4-3 ) 
The SSIM can vary between -1 and 1, where a score of 1 indicates perfect similarity using the 
equation below. The parameters of Equation (4.3) include spatial patches extracted from two 
images 𝑥 and 𝑦, the mean of the voxel intensities in 𝑥 and 𝑦 (𝜇), the variance of the intensities in 
the 𝑥 and 𝑦 (𝜎), and the covariance (𝜎𝑥𝑦).  
4.2.5.2 Normalized Cross Correlation. Another image similarity metric that was used to assess 
the results of our study was normalized cross-correlation (NCC). NCC is a simple but effective 
similarity measure that is invariant to brightness and contrast variations [107]. NCC has been 
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previously used to compare similarity of medical lung images in [107] and has the advantage that 
it is less sensitive to linear changes in amplitude of grayscale values. NCC is often used to 
overcome intensity changes caused by tissue compression difference between different breathing 
phases [108]. Like SSIM, NCC values range from a perfect match of 1 to a completely anti-
correlated match of -1. The equation for calculating the NCC is shown as 
𝑁𝐶𝐶(𝑥, 𝑦) =  𝐶𝑥𝑦(?̂?, ?̂?) =  ∑ 𝑥(𝑖, 𝑗), ?̂?(𝑖, 𝑗),𝑖,𝑗∈𝑅      ( 4-4 ) 
where 𝑥 and ?̂? are intensity normalized warped end-exhalation and end-inhalation images.  
4.2.5.3 Mutual Information. The final image similarity metric that we used was mutual 
information (MI), which is a symmetric and nonnegative similarity measure of entropy between 
two images that takes high values for similar images. Maximization of MI indicates complete 
correspondence between two images. MI assumes no prior functional relationships between the 
images, but rather a statistical relationship that can be evaluated by analyzing the images’ joint 
entropy [109]. Although MI is normally applied to multimodal registration, it is often commonly 
used for lung alignment [110]. 
Assuming two images 𝑥 and 𝑦, the mutual information is computed by comparing the image 
entropy values (i.e. a measure of how well-structured the common histogram is) as follows: 
𝑀𝐼(𝑥, 𝑦) = 𝐻(𝑥) + 𝐻(𝑦) −  𝐻(𝑥, 𝑦)    ( 4-5 ) 
where 𝐻(𝑥, 𝑦) is the joint entropy 
– ∑ 𝑝𝑥𝑦(𝑥, 𝑦) 𝑙𝑜𝑔 𝑝𝑥𝑦(𝑥, 𝑦)𝑥,𝑦      ( 4-6 ) 
and 𝐻(𝑥) and 𝐻(𝑦) are the individual entropies 
 − ∑ 𝑝𝑥(𝑥) 𝑙𝑜𝑔 𝑝𝑥(𝑥)𝑥 .         ( 4-7 ) 
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4.2.6 Validation study 
A key part of our focus is to validate the estimated elasticity using clinical datasets. However, 
patient-specific elasticity distributions have not been previously documented in the literature. For 
quantitative validation purposes, we employed a mid-exhalation breathing phase from the 4DCT 
dataset that was not used for the elasticity reconstruction. An illustration of the lung deformation 
differences seen between the estimation dataset and the validation dataset is shown in Figure 4-2 
below. The end-exhalation segmented CT is shown in (a). Figure 4-2(b) shows the magnitude of 
displacement between the end-exhalation and end-inhalation breathing phases used in the elasticity 
estimation, while Figure 4-2(c) shows the magnitude of displacement between the end-exhalation 
and mid-exhalation breathing phases used in the validation study.  
 
Figure 4-2: Comparison of the breathing phases utilized for elasticity estimation. Source end-exhalation image is 
shown in (a). The displacement between end-exhalation and end-inhalation is shown in (b), and the displacement 
between end-exhalation and mid-exhalation is shown in (c). 
The accuracy of the elasticity distribution 𝐸𝐴  derived from end-inhalation breathing data was 
quantified by its’ ability to also represent the mid-exhalation breathing data. Specifically, the mid-
exhalation breathing image dataset was first registered to the end-exhalation breathing phase using 
the optical flow DIR algorithm. These DVFs were then recorded as 𝐷𝑉𝐹𝐷𝐼𝑅,𝐵 . The elasticity 
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information ( 𝐸𝐴 ) estimated using 𝐷𝑉𝐹𝐷𝐼𝑅,𝐴 was applied to the biomechanical lung model 
according to the boundary conditions described above with lung surface displacement now 
prescribed by 𝐷𝑉𝐹𝐷𝐼𝑅,𝐵 , which generated 𝐷𝑉𝐹𝑀𝑜𝑑𝑒𝑙,𝐵 . The 𝐷𝑉𝐹𝑀𝑜𝑑𝑒𝑙,𝐵  were then compared to 
the  𝐷𝑉𝐹𝐷𝐼𝑅,𝐵 , and the accuracy was reported according to the convergence criteria. As an 
alternative means of quantifying and describing the validation results, image similarity measures 
were employed to compare end-exhalation images warped with both 𝐷𝑉𝐹𝐷𝐼𝑅,𝐵and 𝐷𝑉𝐹𝑀𝑜𝑑𝑒𝑙,𝐵to 
the validation mid-exhalation images. Our hypothesis is that the image similarity measures for the 
𝐷𝑉𝐹𝐷𝐼𝑅,𝐵  and 𝐷𝑉𝐹𝑀𝑜𝑑𝑒𝑙,𝐵  will be similar to those of 𝐷𝑉𝐹𝐷𝐼𝑅,𝐴  and 𝐷𝑉𝐹𝑀𝑜𝑑𝑒𝑙,𝐴.   
4.2.7 Implementation details 
The computational complexity of iteratively updating a high-resolution finite element model [52] 
until convergence was countered using a GPU cluster that consisted of 32 NVIDIA TitanX GPUs 
interconnected by an Infiniband backbone. The GPU cluster allowed the elasticity estimation for 
each patient lung dataset to converge in around 2 hours of computation time. The numpy and scikit 
packages of Python 2.7 were used for numerical analysis in this manuscript [111].  
4.3 Qualitative results 
In this section, we first present the qualitative DIR results, followed by the elasticity estimation 
results for all the 15 datasets. Finally, we present the qualitative results of the validation process.  
4.3.1 Deformable image registration 
The accuracy of the DIR results is critical in order to ensure the DIR’s validity as ground-truth 
data for the elastography procedure. Figure 4-3 illustrates an example of the deformable image 
registration results for a 2D-slice of the left (a & b) and right (c & d) lung. Figure 4-3(a & c) show 
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an overlay of the end-exhalation image in green and end-inhalation image in red. The 
misalignments between slices are depicted in red (features that are only seen in end-inhalation 
image) and green (features that are only seen in the end-exhalation image). Significant motion can 
be observed between the two images in each case. Figure 4-3(b & d) show an overlay of the end-
exhalation image warped using 𝐷𝑉𝐹𝐷𝐼𝑅,𝐴, and the end-inhalation, illustrating the high accuracy at 
which our in-house optical flow DIR algorithm can calculate DVFs. The maximum 𝐷𝑉𝐹𝐷𝐼𝑅,𝐴 was 
observed to be between 6 and 31 mm, while the maximum 𝐷𝑉𝐹𝐷𝐼𝑅,𝐵was observed to be between 
2 and 10 mm.  
 
Figure 4-3: Deformable image registration results for sample left (a & b) and right (c & d) 2D lung slice. (a & c) 
overlay of end-exhalation in green and end-inhalation in red (b & d) overlay of  DVF_(DIR,A)-warped end-
exhalation and end-inhalation. 
4.3.1.1 Elasticity estimation results and accuracy. Over all 15 patient lung datasets, 89.91 ± 4.85 
% of voxels converged within 𝜖2 . To illustrate elasticity results and correlate these results to 
displacement accuracy, Figure 4-4 show the displacement accuracy corresponding with a resultant 
elasticity map for a 2D-slice of a left patient lung.  
Figure 4-4(a) shows the ground-truth displacement in mm (𝐷𝑉𝐹𝐷𝐼𝑅,𝐴), while Figure 4-4(b) shows 
the model displacement also in mm (𝐷𝑉𝐹𝑀𝑜𝑑𝑒𝑙,𝐴). Figure 4-4(c) shows the displacement error 
between Figures 4-4(a) and 4-4(b), with error greater than 1 mm (𝜖1) highlighted in purple and 
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error greater than 1.2 mm (𝜖2) highlighted in blue. Finally,  Figure 4-4(d) shows the optimized 
elasticity map, 𝐸𝐴, in kPa. It can be seen that the 𝐷𝑉𝐹𝐷𝐼𝑅,𝐴 and 𝐷𝑉𝐹𝑀𝑜𝑑𝑒𝑙,𝐴are very similar, with 
low error illustrated in Figure 4-4(c). The minimal displacement error supports the validity of the 
elasticity estimated for this case.  Regions of low motion correspond to regions of lower elasticity; 
this is due to our underlying assumption guiding the elasticity update process. Though the 
displacement distributions are relatively smooth, the resultant elasticity distribution varies from 
voxel to voxel. As no ground-truth elasticity distributions are available for absolute elasticity 
accuracy calculations, validation was performed using mid-exhalation breathing phase 4DCT data. 
The results of the validation process will be qualitatively evaluated in the following section. 
 
Figure 4-4: 2D-slice illustrating (a) ground-truth displacement 𝐷𝑉𝐹𝐷𝐼𝑅,𝐴, (b) model displacement 𝐷𝑉𝐹𝑀𝑜𝑑𝑒𝑙,𝐴, (c) 
displacement error between (a) and (b) with error greater than 𝜖1and 𝜖2 highlighted in purple and blue, and (d) 
resultant elasticity distribution 
4.3.1.2 Validation. On average, the validation datasets converged with 87.13 ± 10.62% of voxels 
within 𝜖1. To illustrate the validation process and results, we present Figure 4-5. Figure 4-5(a) 
shows the 𝐷𝑉𝐹𝐷𝐼𝑅,𝐴 for a 2D slice of the right lung in mm. Figure 4-5(b) shows the 𝐸𝐴estimated 
from the 𝐷𝑉𝐹𝐷𝐼𝑅,𝐴 in 4-5(a) for the corresponding slice. The validation displacement for a 2D slice 
of the right lung (𝐷𝑉𝐹𝐷𝐼𝑅,𝐵) is shown in mm in Figure 4-5(c). Figure 4-5(d) shows the resultant 
model displacement in mm after the lung biomechanical model is deformed with the 𝐸𝐴  seen in 
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Figure 4-5(b) (𝐷𝑉𝐹𝑀𝑜𝑑𝑒𝑙,𝐵). Figure 4-5(e) illustrates the displacement error between 4-5(c) and 4-
5(d), with error greater than 0.4 mm, ϵ2, highlighted in blue. While a cluster in the center of the 
slice shown in 4-5(e) had error higher than ϵ2, a majority of the voxels converged with a high 
accuracy, illustrating the estimated elasticity’s validity in representing the 𝐷𝑉𝐹𝐷𝐼𝑅,𝐵. The decrease 
in ϵ2 due to the decrease in maximum lung displacement can also explain the higher error seen in 
Figure 4-5(e). These results will be analyzed further in the following section. 
 
Figure 4-5: 2D-slice illustrating (a) end-inhalation ground-truth displacement 𝐷𝑉𝐹𝐷𝐼𝑅,𝐴 in mm , (b) estimated 
elasticity 𝐸𝐴 in kPa, (c) mid-exhalation ground-truth 𝐷𝑉𝐹𝐷𝐼𝑅,𝐵 in mm, (d) mid-exhalation model 𝐷𝑉𝐹𝑀𝑜𝑑𝑒𝑙,𝐵 in mm, 
and (e) error between (a) and (b) with error greater than 0.4 mm highlighted in blue. 
4.4 Quantitative Evaluation 
In this section, we first present the image similarity measures for the DIR,  followed by a numerical 
analysis of the elasticity estimation and validation results.  
4.4.1 DIR 
The quantitative image similarity of the DIR was documented for two image pairs: a) the 
𝐷𝑉𝐹𝐷𝐼𝑅,𝐴 -warped end-exhalation and end-inhalation images, and b) 𝐷𝑉𝐹𝐷𝐼𝑅,𝐵 -warped end-
exhalation and mid-inhalation images. Table 4-2 summarizes the results for both a) and b), 
respectively.  
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On average for a),  image pairs had an SSIM of 0.88, NCC of 0.99 and an MI of 1.94, indicating 
a high similarity. This illustrates the high accuracy of the 𝐷𝑉𝐹𝐷𝐼𝑅,𝐴 that were used as ground-truth 
throughout the elastography process. For the validation DIR b),  image pairs had an average SSIM 
of 0.89, NCC of 0.99, and MI of 1.81. These numbers are not significantly different (p > 0.05) 
from the SSIM, NCC, and MI values of a), confirming our hypothesis and illustrating the accuracy 
of the 𝐷𝑉𝐹𝐷𝐼𝑅,𝐵  used to validate the elastography process. 
Table 4-2: Image similarity metrics SSIM, NCC, and MI  for a sample of patient initial end-inhalation to end-
exhalation registration as well as validation  end-inhalation to mid-exhalation registration 
ID DVFDIR, A-warped end-exhalation and end-inhalation 
DVFDIR, A-warped end-
exhalation and end-inhalation 
 SSIM NCC MI SSIM NCC MI 
1 0.90 0.99 1.92 0.91 0.98 2.01 
2 0.88 0.98 2.01 0.88 0.98 2.00 
3 0.88 0.99 2.01 0.89 0.99 1.95 
4 0.86 0.99 2.01 0.88 0.99 2.14 
5 0.83 0.98 2.14 0.86 0.96 1.81 
6 0.86 0.99 2.04 0.88 0.99 1.76 
7 0.87 0.98 1.91 0.88 0.98 1.64 
8 0.87 0.99 1.86 0.89 0.99 1.63 
9 0.91 0.99 1.73 0.93 0.99 1.69 
10 0.87 0.99 2.07 0.87 0.99 1.97 
11 0.88 0.99 1.85 0.89 0.99 1.72 
12 0.90 0.99 1.61 0.92 0.99 1.49 
13 0.88 0.99 2.03 0.89 0.99 1.79 
14 0.88 0.99 1.96 0.90 0.99 1.70 
15 0.87 0.99 1.87 0.88 0.99 1.66 
Avg 0.87 0.99 1.94 0.89 0.99 1.80 
 
4.4.2 Elasticity estimation results and accuracy 
The quantitative results of our elasticity estimation for the 15 patient lung datasets are now 
presented. Table 4-3 indicates the average elasticity, displacement, displacement error, and 𝜖2 
accuracy for each patient lung dataset. Overall, 89.91 ± 4.85% of voxels converged within the 
prescribed ϵ2. All patient datasets converged with greater than 80% of voxels within ϵ1 or ϵ2. The 
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average elasticity ranged from 4.91 kPa to 7.66 kPa. Variations in the lung physiological factors, 
such as range of motion and total lung volume, did not affect the accuracy, indicating the 
applicability of the elastography process to a wide range of patients. 
Table 4-3: Average elasticity, displacement, error, and overall accuracy for each patient investigated in this study 
ID 
Average 
elasticity 
(kPa) 
Average 
displacement 
(mm) 
Average 
error 
(mm) 
Average 𝝐𝟐 
 accuracy 
(%) 
1 7.66 5.22 0.74 89.43 
2 5.87 1.62 0.23 97.75 
3 6.23 2.14 0.40 90.64 
4 4.91 2.39 0.38 94.37 
5 7.07 6.41 0.91 92.63 
6 6.37 4.14 0.68 84.38 
7 6.72 4.30 0.72 85.01 
8 6.79 4.76 0.75 89.39 
9 6.45 4.12 0.83 83.68 
10 5.17 4.84 0.62 90.78 
11 5.37 3.09 0.78 80.95 
12 6.14 4.96 0.63 94.26 
13 7.25 3.93 0.61 92.53 
14 6.20 5.01 0.81 87.29 
15 5.46 3.11 0.44 95.55 
Avg 6.24 4.00 0.63 89.91 
 
As mentioned above, two convergence criteria were investigated to better quantify the accuracy of 
the model generated elasticity. Table 4-4 denotes the 𝜖1and 𝜖2 convergence percentages broken 
down by underlying tissue types for the 15 4DCT patient datasets. Maximum deformation has also 
been included in the table to illustrate the difference in deformation between patients. It can be 
seen that the voxels representing blood vessels had a slightly higher accuracy than the parenchymal 
voxels, though it was not significant when looking at the accuracy with regards to 𝜖2.  
The higher accuracy can be attributed to the higher signal-to-noise ratio in the blood vessels when 
compared to the parenchymal tissue. This illustrates that though local image noise contributes 
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towards estimation error as expected, the accuracy of the parenchymal tissue is still within a 
clinically applicable error range. 
Table 4-4: Voxel convergence and maximum deformation for a sample of patient 4DCT datasets 
  Blood Vessels Parenchyma 
ID 
Max 
DV𝐹𝑀𝑜𝑑𝑒𝑙,𝐴 
(mm) 
𝜖1 
accuracy 
(%) 
𝜖2 
accuracy 
(%) 
𝜖1 
accuracy 
(%) 
𝜖2 
accuracy 
(%) 
1 20.30 80.85 90.32 78.93 89.32 
2 6.31 98.03 86.86 97.74 85.51 
3 8.58 93.83 92.02 89.26 85.63 
4 12.12 94.03 95.83 90.96 94.30 
5 26.31 75.73 93.87 71.74 92.47 
6 14.85 89.31 93.10 75.17 83.89 
7 15.68 85.75 90.55 74.07 84.70 
8 19.97 87.12 92.52 79.69 89.18 
9 17.32 85.33 90.49 69.24 83.41 
10 16.99 90.19 95.24 76.72 90.61 
11 18.58 95.16 98.27 89.55 98.12 
12 20.32 88.25 95.29 79.38 94.20 
13 15.53 82.37 90.90 78.58 92.82 
14 21.11 82.68 91.00 73.72 87.08 
15 15.59 94.20 97.27 88.14 95.43 
Av 16.57 88.19 92.91 80.86 89.77 
 
The SSIM, NCC, and MI metrics were used to quantify the similarity between the ground-truth 
end-inhalation and 𝐷𝑉𝐹𝑀𝑜𝑑𝑒𝑙,𝐴 -deformed end-exhalation images. Table 4-5 shows the SSIM, 
NCC, and MI for these results. On average, the end-inhalation and 𝐷𝑉𝐹𝑀𝑜𝑑𝑒𝑙,𝐴-deformed end-
exhalation images had an SSIM of 0.89, NCC of 0.97, and an MI of 1.83, indicating high similarity 
regardless of structural or intensity changes between end-exhalation and end-inhalation images. 
These numbers were not significantly different from the DIR results shown in Table 4-2, indicating 
that the accuracy of the elasticity estimation correlates to the accuracy of the underlying ground-
truth data. 
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Table 4-5: Image similarity metrics SSIM, NCC, and MI  comparing  patient ground-truth end-inhalation images to 
DVFModel,A  deformed end-exhalation images 
ID SSIM NCC MI 
1 0.95 0.99 1.85 
2 0.91 0.97 1.97 
3 0.91 0.98 1.86 
4 0.87 0.96 2.12 
5 0.92 0.98 1.97 
6 0.90 0.98 1.94 
7 0.92 0.98 1.88 
8 0.92 0.99 1.90 
9 0.91 0.98 1.73 
10 0.93 0.99 2.12 
11 0.90 0.97 1.74 
12 0.94 0.99 1.54 
13 0.92 0.99 1.93 
14 0.92 0.98 1.81 
15 0.92 0.98 1.61 
Av 0.92 0.98 1.86 
 
4.4.3 Validation  
The quantitative results of the validation study for the 15 patient lung datasets are now presented.  
On average, the validation datasets converged with 87.13 ± 10.62% of voxels within 𝜖1. Table 4-
6 denotes the convergence percentages reported according to the two different 𝜖 values for the 
validation datasets. The convergence percentages have been separated based on the underlying 
tissue types. The maximum deformation is also shown. 
When compared to Table 4-4, Table 4-6 shows differences in maximum deformation values. On 
average, the deformation between end-inhalation and end-exhalation breathing phases was 16.57 
mm, while the deformation between end-inhalation and mid-exhalation was 6.51 mm. Because the 
maximum deformation was significantly lower for the validation datasets, the 𝜖2  accuracy 
decreased. As seen in Table 4-4, the blood vessels had higher accuracy than the parenchymal 
tissue. Again, this can be explained by the higher signal-to-noise ratio in the blood vessels as 
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compared to the parenchymal tissue. This indicates that the validation error is still skewed by the 
underlying image quality, which is consistent with the initial results. However, the significantly 
smaller magnitudes of 𝐷𝑉𝐹𝐷𝐼𝑅,𝐵  exerted more influence on the overall accuracy of the elasticity 
estimation than the SNR.  
Table 4-6: Convergence percentages for validation datasets 
  Blood Vessels Parenchyma 
ID 
Max 
𝐷𝑉𝐹𝑀𝑜𝑑𝑒𝑙,𝐵 
(mm) 
𝜖1 
accuracy 
(%) 
𝜖2 
accuracy 
(%) 
𝜖1 
accuracy 
(%) 
𝜖2 
accuracy 
(%) 
1 4.90 96.17 88.44 92.31 77.01 
2 2.24 94.93 84.92 90.87 56.41 
3 3.34 93.74 84.38 82.48 58.64 
4 4.14 88.13 77.06 78.86 50.81 
5 8.85 89.90 87.99 94.77 92.70 
6 4.83 96.47 90.49 95.00 75.34 
7 9.56 87.88 74.08 72.13 70.10 
8 7.08 85.97 83.77 69.06 62.89 
9 6.94 83.20 77.40 69.64 58.20 
10 8.58 86.31 85.40 55.45 51.88 
11 8.50 97.11 97.31 89.63 89.33 
12 9.83 85.07 85.42 71.15 71.11 
13 5.81 98.39 91.79 96.36 79.63 
14 7.26 94.06 89.60 83.67 72.21 
15 5.72 96.16 93.04 99.04 97.66 
Av 6.51 91.57 86.07 82.70 70.93 
 
Finally, image similarity was investigated for the validation results. Table 4-7 shows the SSIM, 
NCC, and MI results for the validation model. The end-inhalation and 𝐷𝑉𝐹𝑀𝑜𝑑𝑒𝑙,𝐵-deformed mid-
exhalation images had an SSIM of 0.80, NCC of 0.95, and an MI of 1.85. These numbers are not 
significantly different from the image similarity achieved in Table 4-5 (p > 0.05), validating the 
accuracy and robustness of the elasticity estimation.  
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Table 4-7: Image similarity metrics SSIM, NCC, and MI comparing validation mid-exhalation images to DVFModel, 
B-deformed end-exhalation images to DVFModel, A-deformed end-exhalation images 
ID SSIM NCC MI 
1 0.87 0.97 1.90 
2 0.72 0.86 1.96 
3 0.79 0.91 1.88 
4 0.72 0.91 1.86 
5 0.92 0.99 1.71 
6 0.80 0.98 2.00 
7 0.80 0.93 1.73 
8 0.79 0.90 1.75 
9 0.77 0.95 2.00 
10 0.76 0.93 2.16 
11 0.88 0.96 1.61 
12 0.86 0.98 1.78 
13 0.78 0.97 2.05 
14 0.83 0.98 1.93 
15 0.86 0.98 1.77 
Av 0.81 0.95 1.87 
 
4.5 Discussion 
In this chapter, we presented the results of a lung elastography process performed on 15 4DCT 
patient datasets. A physics-based biomechanical constitutive model was used as a forward model 
to solve the inverse elasticity problem. Lung DVFs from end-inhalation to end-exhalation 
breathing phases were obtained from an in-house optical flow DIR algorithm. The lung boundary 
displacements were then employed as boundary constraints for the forward model, while the inner 
voxels of the biomechanical model were allowed to deform according to linear elastic material 
properties.  
Using 15 clinical 4DCT datasets, this study indicated that maximum lung deformation ranged from 
6 to 31 mm and 89.91 ± 4.85% of voxels converged within the prescribed metrics. In addition, 
SSIM, NCC, and MI image similarity metrics showed high similarity between both the end-
inhalation and 𝐷𝑉𝐹𝐷𝐼𝑅,𝐴 -warped end-exhalation registration images, and end-inhalation and 
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𝐷𝑉𝐹𝑀𝑜𝑑𝑒𝑙,𝐴-warped end-exhalation experimental results, with average values of 0.89, 0.98, and 
1.90, respectively for the DIR results. Similarly, we observed average values of 0.85, 0.97, and 
1.83 for the model generated results.  
The potential of 4DCT-based lung elastography to be used within a clinical radiotherapy workflow 
required extensive quantitative validation. Mid-exhalation 4DCT datasets were used as validation 
datasets so that the elasticity results could be validated in a radiotherapy clinically-relevant 
manner. The maximum lung deformation of the validation datasets ranged from 2 – 10 mm, and 
87.13 ±  10.62% of voxels converged within 1 mm of ground-truth deformation. Our results 
indicated that convergence percentages for each of the subjects during the elastography and 
validation process were similar, citing the quantitative nature with which the process can be used 
within the context of clinical radiotherapy. The accuracy was observed to be independent of the 
subject’s lung DVF magnitude, thereby indicating the applicability of such measurements to a 
wide range of patients and breathing phases.  
The average elasticity values obtained for the patient cohort ranged from 4.91 to 7.66 kPa. These 
values are similar to those seen in the literature [72], especially for patients with diseased lungs 
[112]. As no ground-truth elasticity distributions are available for accuracy calculations, the 
accuracy of the elasticity estimation is dependent of the accuracy of the DIR technique and ground-
truth DVF values. While we are confident in the capability of our in-house optical flow DIR 
algorithm, future work will investigate in vivo tissue sample experiments and US/MR elastography 
techniques for the lung for further verification and validation purposes.  
We currently foresee two challenges to the elastography methodology implementation within a 
radiotherapy setup: image artifacts and computational complexity. Firstly, the lung elastography 
approach discussed in this study is sensitive to image artifacts in the 4D image dataset. SNR 
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differences due to the underlying tissue slightly affected the elasticity estimation, though the 
parenchymal accuracy was still greater than 80%.  In this study, a 5D imaging protocol was used 
to acquire the 4DCT images, which eliminated potential elasticity estimation errors arising from 
4D imaging artifacts, irregular breathing, and hyperelastic lung behavior. Though we expect 5DCT 
methods to become more prevalent, in the future, we will investigate ways to ensure elasticity 
estimation accuracy for 4DCT datasets that are inherent with image artifacts. We envision machine 
learning techniques as an approach for predicting initial elastic material properties that will be 
refined with our biomechanical model. The complexity of the inverse elasticity estimation is a 
computationally intensive problem.  The implementation of the methodology on a GPU cluster 
allowed for the calculation of patient-specific lung elasticity distributions to be completed in about 
2 hours.  
We foresee a wide range of clinical applications for our elastography method. The novel lung 
elastography method utilized here is able to directly relate tissue elasticity with the lung tissue 
deformation derived from clinical radiotherapy datasets. The elasticity information obtained 
through this methodology can be used to characterize response to radiotherapy and the 
functionality of the lung tissue on a voxel-by-voxel basis. Functional lung information can lead to 
patient-specific radiotherapy treatment options. Several authors have reported methods for 
functional imaging of the lungs for radiation treatment. One example is ventilation imaging, which 
is generated from the DIR of 4DCT datasets [8, 113, 114]. Ventilation imaging is based on the 
Jacobian of DVFs, which describe the lung motion. However, ventilation imaging does not take 
into account the underlying biomechanical properties of the lung tissue [115]. Lung elastography 
provides critical information about the biomechanical properties of tissue, which have been shown 
to be related to the underlying lung function and disease. We expect elastography to provide 
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complementary information to current functional imaging techniques. Future work will investigate 
comparing and integrating elastography and ventilation imaging methods to more fully describe 
lung function.  
Beyond the context of radiotherapy, the elasticity distributions can be used to assess degree of 
disease in COPD patients, track disease progression, and differentiate between tissue affected by 
changes in the stiffness, for example, bronchitis and emphysema. Future work will focus on 
describing and characterizing the lung tissue of patients with different stages of COPD, obtaining 
more scan time points, and correlating changes in elasticity over time with radiotherapy and 
disease progression. This will be preliminarily addressed in Chapter 7.  
4.6 Conclusion 
In this study, we presented the results of a lung elastography study using 4DCT deformation 
vectors. Patient-specific ground-truth deformation values between end-inhalation and end-
exhalation breathing were obtained for each voxel of lung tissue using optical flow deformable 
image registration. The methodology employed a constitutive physics-based biomechanical model 
of the lungs that was iteratively deformed according to patient-specific lung boundary constraints. 
An inverse analysis consisting of a modified Gauss-Newton based binary search optimization 
scheme was utilized to update the spatial elasticity distribution of the lung tissue according to the 
discrepancy between ground-truth and model deformation. Our analysis showed that an average 
of 89.91 ± 4.85% of voxels converged within a prescribed error metric of 10% of maximum 
deformation.  SSIM, NCC, and MI image similarity metrics indicated high similarity between 
model results and ground-truth deformation. A validation dataset of mid-exhalation breathing 
phase deformation data converged with 87.13 ± 10.62% of voxels within 1 mm of ground-truth 
deformation. These results indicate the quantitative accuracy of the elasticity estimation process. 
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The 4DCT lung elastography methodology investigated here can easily be implemented within a 
radiotherapy workflow and has potential to improve patient-specific lung cancer radiotherapy 
treatment options. To further the applications of the elastography methodology, the next chapter 
will investigate the accuracy of elastography results using reduced dose CT scans.  
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CHAPTER 5: DETERMINE IF LOW-DOSE CT SCANS CAN 
PRODUCE RELIABLE ELASTOGRAPHY RESULTS. 
Systematic feasibility analysis of performing elastography 
using reduced dose CT lung image pairs 
A version of this chapter is currently being prepared for submission to Medical Physics 
5.1 Introduction 
COPD is a major cause of disability and the third leading cause of death in the United States [116].  
COPD refers to a large group of incurable lung diseases characterized by the persistent reduction 
of lung function. Changes in lung function are associated with changes in lung tissue 
biomechanical properties; for example, diseases of the lung that alter lung function often do so by 
altering the amounts of elastin and collagen of parenchymal tissue, leading to changes in tissue 
elasticity  [19]. Excised tissue studies have shown that localized changes in the biomechanical 
properties of lung parenchyma precede the initiation and progression of certain lung diseases, 
including cancer [17, 50]. Knowing the tissue biomechanical properties using in-vivo techniques 
is emerging as a critical component for improving treatment efficacy and the patient’s quality of 
life. While computed tomography (CT), is commonly used for lung imaging, it does not explicitly 
present a quantitative characterization of the lung biomechanical properties [93].  
Elastography has the potential to inform diffuse lung disease phenotype characterization and 
staging and treatment response monitoring [117]. In our preliminary work, we demonstrated a 
novel elastography approach using virtual lung phantoms (Chapter 3) [101]. This methodology 
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was quantified and validated for lung cancer radiation therapy CT scans reconstructed using a 
published breathing motion model (Chapter 4) [118].  
Our elastography estimation method used multiple fast helical CT scans, each delivering 1.2 mSv 
to the lungs. The original protocol utilized 25, 40 mAs scans, but Thomas et al and O’Connell, et 
al determined that minima of 10 and 6 scans would be required for ungated and prospectively gated 
protocols, corresponding to a total effective dose of 12 mSv and 7.2 mSv, respectively [119, 120]. 
Mettler, et al showed that the published dose range for routine diagnostic CT scans ranges from 
4.0 mSv to 18.9 mSv, with an average of 7 mSv [121]. Currently, SPIROMICS studies have 
employed an effective imaging dose as low as 4.9 mSv in their protocols for acquiring image pairs 
[122]. Our current technique delivers exposures similar to routine diagnostic CT studies. 
Diagnostic CT studies are used for human image interpretation while the scans acquired for 
elastography estimation are used to determine the motion and distortion characteristics of lung 
tissues during breathing. Therefore, we assessed elastography quality using simulated reduced 
dose CT scans.  
5.2 Materials and Methods 
This study used a cohort of CT datasets of 8 radiotherapy patients that were acquired under IRB # 
11-000620-CR-00004 at UCLA [95]. The patients underwent a series of 25 fast low dose helical 
CT scans. The scans were co-registered using DEEDs and the deformation vector fields, along 
with the breathing amplitude and rate, were used to develop patient-specific breathing motion 
models (termed 5DCT models) [95]. Exhalation and inhalation, defined as the 5th and 85th 
percentile tidal volume, were reconstructed using the 5DCT model. Unlike the published 5DCT 
approach, where multiple deformed scans are averaged to reduce noise, only a single CT scan was 
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deformed to represent these tidal volumes to maintain the noise characteristics of the original fast 
helical (1.2 mSv) scans, termed the baseline scans. 
5.2.1 Low dose CT simulation 
Noise was injected in the image domain of the baseline scans to simulate the effects of lower dose 
scanning. As lowering the tube current is the most direct way of achieving radiation dose reduction, 
different tube currents were simulated as a way of replicating the additional noise of lower dose 
scans [123]. The noise injection process used forward projection to estimate raw data [124], 
calculated appropriate photon statistics, and finally back projected added and filtered noise. The 
details of this method are described in the Appendix. 
For each patient dataset, noise was injected to represent CT scans acquired with reduced tube 
current-time products of 30, 25, and 20 mAs. The lower limit of 20 mAs was selected to match the 
lower end of lung cancer screening and emphysema detection programs [123].   
5.2.2 Image registration 
The model-guided elasticity approach presented in this study relies on DVFs extracted from 
deformable image registration (DIR) of exhalation and inhalation breathing phases. The lungs were 
segmented using an intensity thresholding approach, and the two breathing phases were 
deformably registered using a well-validated in-house multi-level optical flow DIR algorithm [94]. 
The DVFs of the baseline images were taken to be the ground-truth displacement for the elasticity 
estimation process. 
5.2.3 Elasticity estimation 
The elasticity estimation process has been systematically studied and validated for the lung in [101, 
118]; for clarity, the process will be summarized briefly here. The inverse elasticity problem was 
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formulated as a parameter-optimization problem with an objective to determine the elasticity 
parameter that would minimize the difference between ground-truth (registration) DVFs and those 
computed by a constitutive biomechanical model [52]. Solving the inverse elasticity problem was 
conducted in two steps: 1) estimating the DVF for every voxel of lung tissue for a given elasticity 
distribution and boundary constraint using a biomechanical model, and 2) optimizing the elasticity 
distribution to best reproduce the registration ground-truth DVF.  
The elasticity results derived for the baseline CT scans will be considered ground-truth and used 
for comparison to the lower mAs results.  
5.2.4 Quantitative analysis 
As a first measure of quantitative analysis, the displacement results from each of the lower mAs 
model-guided elasticity estimations were evaluated and compared with those obtained with the 
baseline CT scans. The comparison was first performed using average and maximum values. 
Absolute error between the distributions was then calculated by subtracting the lower mAs DVFs 
from the baseline DVFs. We then computed the number of voxels whose estimated DVF errors 
were less than 0.5 mm or 1 mm. Equivalent analyses were conducted for the elasticity estimates, 
with an error threshold of 0.5 kPa or 3 kPa. 
For further elasticity analysis, underlying elasticity values were split into low elasticity, 
representing voxels with elasticity values between 1 and 3 kPa, mid elasticity, representing voxels 
with elasticity values between 3 and 6 kPa, and high elasticity, representing voxels with elasticity 
values greater than 6 kPa, subgroups. The error within each of the elasticity ranges is relevant since 
parenchymal tissue, specifically diseased parenchymal tissue, is known to have low elasticity 
values. 
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In addition to the previous evaluation, the Normalized cross-correlation (NCC) image similarity 
metric was used to further assess the results of our study. NCC was explained in §4.2.5.2 in the 
previous chapter.  
5.3 Results 
5.3.1 Low dose CT simulation 
Figure 5-1 shows an example of a baseline exhalation lung scan (a), a simulated 30 mAs lung scan 
(b), and a simulated 20 mAs lung scan. The reduced dose images are noisier than the baseline 
image, as expected.  
 
Figure 5-1: Example of exhalation baseline (a), 30 mAs (b), and 20 mAs (c) scans 
5.3.2 Image registration 
An example of the registration results for both a baseline and 20 mAs scan pair is shown in Figure 
5-2. Figure 5-2(a & c) show the exhalation superimposed with inhalation. Mismatches can be seen 
between the exhalation and inhalation images, especially near the base of the lung. Figure 5-2(b & 
d) show the overlay between the warped exhalation and inhalation images. The registration 
accounts for the lung deformation well, with little mismatch seen between the warped end-
exhalation and end-inhalation images, for both the baseline and reduced mAs scans. The 
registration accuracy visually appears to be similar, regardless of injected noise.  
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Figure 5-2: Example of registration for baseline (a & b) and 20 mAs (c & d) CT scans. (a&c) show the exhalation in 
green overlain with inhalation in red. (b & d) show the warped exhalation in green with inhalation in red 
5.3.3 Quantitative analysis 
Table 5-1 shows the maximum and average displacements for the baseline, and simulated reduced 
mAs scans for all patients. For each dataset, the model-generated displacement vectors were 
compared with the registration-generated ground-truth displacement vectors, and the average 
displacement error and percent of voxels with error less than 1 mm and 0.5 mm were tabulated.  
Table 5-1: Displacement results for original, and dose reduced scans 
Average 
Maximum  
Displacement 
(mm) 
Average 
Displacement 
(mm) 
Average 
Displacement 
Error (mm) 
Error < 1 
mm 
(%) 
Error < 0.5 
mm 
(%) 
Baseline 
(40 mAs) 13.79 4.89 0.42 ± 0.31 84.02 65.08 
30 mAs 12.01 4.08 0.52 ± 1.52 85.03 65.27 
25 mAs 13.72 4.27 0.53 ± 1.53 84.96 63.91 
20 mAs 12.46 4.21 0.56 ±1.56 84.00 62.08 
 
For each reduced mAs value, the corresponding percent differences relative to baseline were 
tabulated, as shown in Table 5-2. It can be seen that the displacement metrics obtained for all three 
mAs levels were quite similar to the baseline scans. The error increased most at 20 mAs, but none 
of the differences were statistically significance.  
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Table 5-2: Percent difference between the values for the baseline and reduced mAs scans 
Percent 
differences 
(%) 
Maximum 
Displacement 
(%) 
Average 
Displacement 
(%) 
Error < 0.5 
mm 
(%) 
30 mAs 12.85 16.39 0.30 
25 mAs 0.44 12.61 1.80 
20 mAs 9.62 13.76 4.61 
 
 
Figure 5-3: Estimated elasticity distribution in kPa for baseline CT scan (a). Absolute difference between baseline 
and 30 mAs (b), 25 mAs (c),  and 20 mAs  (d) scans.  
Figure 5-3(a) shows the estimated elasticity distributions for the baseline CT scan. Figure 5-3(b - 
d) shows the absolute elasticity difference between baseline scan and the 30 mAs (b), 25 mAs (c), 
and 20 mAs (d) scans. On average, the error was less than 0.62 kPa, which is small compared to 
the average lung elasticity of 6.59 kPa. This is further illustrated in Table 5-3 below. Table 5-3 
quantitates the elasticity error between that estimated from the baseline and reduced mAs scans. 
Maximum elasticity error, average elasticity error, and error less than 0.5 and 3 kPa are listed for 
each dose reduction. The elasticity error increases as the dose is reduced, however even with a 
current-time product of 20 mAs, the average elasticity error remained less than 0.76 kPa. A two-
sample t-test showed that all of the tabulated values for the simulated 20 mAs scans were not 
significantly different than the baseline elasticity values.   
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Table 5-4 shows the percentages of voxels in which the low dose elasticity estimations converged 
within 1 kPa of the baseline elasticity estimation results, binned by underlying elasticity value. It 
can be seen that the high elasticity bin had the most error. Since lung diseases, such as diffuse lung 
disease and COPD, are known to be associated with lower than normal values, this result supports 
the fact that low dose CT elastography can be performed accurately for these patients.    
Table 5-3: Elasticity error results between the baseline estimated elasticity and reduced mAs estimated elasticity. 
 
Maximum 
Elasticity Error 
(kPa) 
Average 
Elasticity Error 
(kPa) 
Error < 0.5 kPa 
(%) 
Error < 3 kPa 
(%) 
30 mAs 7.25 0.65 75.56 92.44 
25 mAs 6.96 0.71 71.46 92.27 
20 mAs 7.40 0.76 68.07 91.70 
 
Table 5-4: Elasticity errors for low, mid, and high elasticity bins for each low mAs simulation. 
 
Low elasticity 
error < 1 kPa 
(%) 
Mid elasticity 
error < 1 kPa  
 (%) 
High elasticity 
error < 1 kPa  
(%) 
Average 95.81 94.13 63.81 
30 mAs 96.85 94.95 66.86 
25 mAs 95.67 94.11 63.99 
20 mAs 94.91 93.32 60.59 
 
Table 5-5 shows the NCC values between a) the reduced mAs and baseline ground-truth 
displacement, b) the reduced mAs and baseline estimated elasticity distributions, and c) the 
reduced mAs ground-truth and model displacement. The reduced mAs displacement values were 
similar to the baseline displacement values, with similarity decreasing with decreased mAs as 
expected. However, the estimated elasticity distributions were similar in all cases, as were the 
ground-truth and model displacements for each mAs reduction. This demonstrates that low dose 
CT-based model displacements can be used to characterize lung tissue deformations during 
breathing.  
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Table 5-5: Image similarity metrics between the baseline and reduced mAs ground-truth displacement, baseline and 
reduced mAs elasticity, and reduced mAs ground-truth and model displacement 
NCC 
Low mAs 
displacement v. 
baseline 
displacement 
Low mAs estimated 
elasticity v baseline 
estimated elasticity 
Low mAs ground-
truth displacement v 
low mAs model 
displacement 
30 mAs 0.987 0.977 0.986 
25 mAs 0.984 0.975 0.986 
20 mAs 0.984 0.973 0.985 
 
A two-sample t-test shows that the NCC values for 30 mAs, 25 mAs, and 20 mAs were not 
significantly different, illustrating that current-time product could be reduced to as low as 20 mAs 
and still provide equivalent elastography results.  
5.4  Discussion 
In this study, low mAs CT scans were simulated using a noise injection process in order to 
determine the effect of noise on our lung elastography process. Simulated scans with tube current-
time products representing 30 mAs, 25 mAs, and 20 mAs were investigated. The results of the 
baseline scans and low mAs simulated scans were not significantly different, indicating that low 
dose CT scans could produce reliable elastography results. Since the baseline scans were taken 
with mAs of 40 mAs and an effective dose of 1.2 mSv, this suggests that the effective dose could 
be reduced to about 0.6 mSv per scan while still obtaining useful elastographic information.  
We foresee a few limitations to this study. Firstly, the noise injection code assumed no tube current 
modulation, which is not typically employed in radiation therapy but is often employed for 
diagnostic purposes. The algorithms to select tube current modulation are proprietary and depend 
on the capability of the x-ray generator, which place limits on the slew rate of the tube current. 
The lack of modulation creates increased noise at the top or bottom of the image as the shoulders 
or abdomen starts to appear. However, as the parenchymal tissue is located near the center of the 
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image on the chest CT, we believe these artifacts will not affect the parenchymal registration 
process.  Secondly, the quality of the elastography results depend on the quality of the deformable 
image registration, which is affected by the addition of noise. There is a need to investigate 
registration algorithms that are more robust to high imaging noise, which will be addressed in 
future work. Thirdly, we employed image domain-based noise injection which is not as accurate 
as noise injection in the raw data domain [125]. As shown in the Appendix, the image domain 
based noise injection generated results that closely match experimental data. Future work will 
focus on extending the noise injection technique to the raw data domain, and performing more 
water tank scans to ensure the accuracy of the results. 
5.5 Conclusions 
Our study suggests that pairs of CT scans acquired with as little as 20 mAs each could be used to 
reliably perform elastography, exposing the patient to a total dose of 1.2 mSv, substantially less 
than the average diagnostic CT effective dose. These results indicated the feasibility of performing 
elastography using low mAs CT scans, expanding the potential of CT-based elastography.  
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CHAPTER 6: UTILIZE BIOMECHANICAL MODEL AND 
DEFORMATION VECTOR FIELDS TO OBTAIN LIVER 
ELASTICITY INFORMATION FROM 4D IMAGING. 
Estimation and validation of patient-specific liver elasticity 
distributions derived from 4DMR for radiotherapy purposes 
A version of this chapter has been submitted for publication as a manuscript to Biomedical Physics and Engineering 
Express 
6.1 Introduction 
Hepatocellular carcinoma (HCC) is one of the most common malignancies, and the third most 
common cause of cancer-related death worldwide [126, 127]. Surgical resection and liver 
transplantation are the primary treatment methodologies, however strict criteria limit the pool of 
eligible patients for both cases. HCC has  a poor prognoses, with a 5-year survival rate of less than 
12% due to a combination of late diagnosis and lack of efficient therapies for advanced stages 
[128]. Stereotactic body radiotherapy (SBRT) has been used to treat patients with HCC who are 
not eligible for other treatments [129]. SBRT uses advances in imaging and conformal 
radiotherapy to deliver ablative, high dose radiation in order to optimize local control. Radiation-
induced liver disease (RILD) is a significant limiting factor in the use of SBRT because there are 
no effective treatments or predictors [127]. Most patients with HCC have pre-existing cirrhosis or 
hepatitis, which increases their risk of RILD [130]. Baseline liver function is thought to be the 
most important factor associated with risk of RILD [126]. Pre-treatment visualization of liver 
function in vivo is necessary in order to expand the use of SBRT for HCC. 
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The liver plays a role in metabolism, synthesis, secretion, immunity, and many other functions 
[131]. Liver disease, including cirrhosis, fibrosis and tumors, can disrupt the functions of the liver 
by altering the biomechanical properties of the tissue, most notably by changing the tissue stiffness 
[132, 133]. Clinically, elastography provides a measurement of liver stiffness and is a predictor 
for HCC [134]. Magnetic resonance elastography (MRE) can noninvasively and quantitatively 
assess the elasticity characteristics of soft tissue [132]. Liver stiffness measured by MRE has been 
shown to correlate well with histologic staging of fibrosis and differentiation of benign and 
malignant liver lesions [135]. However, current MRE techniques require equipment that is not 
typically available within a radiotherapy setup. 
Recently, an MR guided radiation therapy (MRgRT) system (MRIdian System™, ViewRay™, 
Cleveland, OH, USA) was introduced in the field of radiotherapy (RT) [136].  The ViewRay 
system integrates a 0.35T MRI with three Cobalt-60 sources, which allows for simultaneous MRI 
acquisition and treatment delivery for a variety of malignancies [137]. The superior soft tissue 
contrast from Viewray’s on-board MRI enables soft tissue based gated RT and on-line adaptive 
RT. Both techniques are especially helpful for treating thoracic and abdominal tumors by 
accounting for intra-fractional and inter-fractional motion. In this study, we present a novel 
elastography process for estimating liver tissue elasticity using 0.35 T 4DMRI to observe liver 
deformation in each respiratory cycle during patient simulation. The rest of this chapter is 
organized as follows: section 6.2 introduces the methods employed for the deformable imaging 
registration, elasticity estimation, validation, and quantitative evaluation. Section 6.3 presents the 
qualitative and quantitative results of the deformable image registration, elastography, and 
validation processes. Section 6.4 presents a discussion of the results and highlights the areas for 
continued research, while section 6.5 concludes the chapter.  
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6.2 Methods 
Our elastography process focuses on estimating the effective Young’s modulus for each voxel of 
liver tissue using 4DMR liver data. Figure 5-1 shows a flow chart summarizing the elasticity 
estimation. First, phase 1 and phase 8 datasets from the 4DMR liver images were registered using 
an optical flow deformable image registration (DIR) algorithm [94]. Liver deformation vectors 
(DVFs) were obtained for every voxel of liver tissue. The biomechanical model was then 
assembled using segmented phase 1 liver geometry and a randomly initialized elasticity 
distribution. Using the ground-truth liver DVFs, the elasticity distribution was optimized. The 
inverse elasticity problem was formulated as a parameter-optimization problem with an objective 
to determine the elasticity parameter that would minimize the difference between the ground-truth 
deformation and the deformation computed by a biomechanical model. The biomechanical model 
and inverse elasticity estimation was implemented on a GPU cluster, which allowed the elasticity 
estimation for each patient dataset to converge in around 2 hours. Spatial elasticity and 
displacement error distributions were then obtained and validated. 
 
Figure 6-1: Flow chart describing the liver elastography process. Two 4DMR liver phases are registered and 
ground-truth deformation vectors are obtained. A biomechanical model is used to obtain an optimal elasticity 
estimation and error analysis. 
In this section, we first briefly present the 4DMR acquisition process and the DIR technique used 
to obtain the ground-truth DVF. Next, we present the constitutive model and convergence criteria 
used for the elasticity estimation process. We then describe a technique that was used to validate 
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the estimated elasticity. We conclude the section with a discussion of the metrics used to evaluate 
the quantitative accuracy of the elasticity estimation and validation results.    
6.2.1 4DMRI acquisition. 
The study was approved by our institutional review board and each patient provided written 
informed consent. Eleven patients with tumors in the liver treated on Viewray were included in 
our study. The MRI study was performed immediately after high resolution 3D MRI simulation 
acquisition. The 4DMRI sequence parameters are: TE/TR=3.0/6.0ms; bandwidth=400Hz/pixel; 
FA=110q; field-of-view=500x350x200mm, resolution=1.3x1.3x1.8mm3, acquisition time = 7min.  
No specific breathing instruction was given to the subjects during the MRI exam. 
6.2.2 Deformable image registration. 
The model-guided elasticity approach presented in this chapter relies on displacement values 
extracted from DIR of 4DMR datasets. 4DMR datasets were acquired from 4DMR ViewRay 
(MRIdian System™, ViewRay™, Cleveland, OH, USA) scans taken within a radiotherapy setup. 
The 4DMR datasets were separated into phases according to diaphragm position. The liver was 
segmented and phase 1 datasets, corresponding to end inspiration,  and phase 8 datasets, 
corresponding to end expiration, were then deformably registered using a well-validated in-house 
multi-level optical flow DIR algorithm [94]. The resulting DVFs were taken to be the ground-truth 
displacement for the elasticity estimation process. For the rest of the chapter, the phase 8 datasets 
will be considered the source images, the phase 1 datasets will be considered target images,  and 
the phase 8 datasets deformed according the ground-truth DVFs will be considered warped images. 
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6.2.3 Elasticity estimation.  
The inverse elasticity problem was formulated as a parameter-optimization problem with an 
objective to determine the elasticity parameter that would minimize the difference between 
ground-truth DVFs and those computed by a constitutive biomechanical model, as described in 
the previous chapters. Solving the inverse elasticity problem was carried out in two steps: 1) 
estimating the DVF for every voxel of liver tissue for a given elasticity distribution and boundary 
constraint using the biomechanical model, and 2) optimizing the elasticity distribution to best 
reproduce the ground-truth DVF. These steps will be further explained in the following sections. 
6.2.3.1 Biomechanical model. The first step requires a forward biomechanical constitutive model. 
The model presented in this section is focused on computing the liver tissue deformation for a give 
boundary constraint arising from the ground-truth DVF. This model has been previously described 
for the head and neck, breast, and lung anatomies in [52, 60, 101, 118] but will be summarized 
briefly here. This approach is appropriate for our current study since it’s applicability has been 
systematically investigated for breathing motion, which is the main factor in diaphragm-induced 
liver deformations [138].  
The biomechanical liver model was assembled from the segmented 4DMR phase 8 dataset. Our 
approach uses linear elastic constitutive laws that were implemented because of the quasi-static 
tissue response of liver tissue to small diaphragm-induced deformations [139]. The elasticity 
optimization process was repeated similarly to that described in chapters 2, 3, and 4.  
6.2.4 Quantitative evaluation and validation.  
The convergence metrics utilized in this study are critical to interpreting the results. At each 
iteration of the elasticity estimation, the resultant model DVF was compared to the ground-truth 
DVF. The percent accuracy, 𝑝𝜖 was then tabulated as described in §4.2.4. The convergence criteria 
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was formulated to be 1 mm, the current standard for DIR-based targeting errors for liver SBRT 
dose planning purposes [140].  
An additional error metric was necessary in order to ensure the precision of the estimated elasticity. 
Specifically, we needed to ensure that the estimated elasticity and displacement distributions could 
be used to warp the phase 1 liver dataset to closely represent the phase 8 image. Furthermore,  the 
accuracy of the ground-truth data needed to be more fully quantified. For this purpose, normalized 
cross-correlation was used as an imaging metric to quantify accuracy between both the target and 
warped images along with the model-deformed and ground-truth deformed images. Normalized 
cross-correlation was used because it has been found to be an accurate similarity measurement for 
the registration of soft tissue, and is unaffected by intensity changes [141]. 
A key part of our focus is to validate the estimated elasticity using clinical datasets. However, 
patient-specific elasticity distributions have not been previously documented in the literature. For 
validation purposes, deformation vectors from the phase 4 datasets (representing mid-expiration 
breathing phase) that were not used for the elasticity estimation were employed. The accuracy of 
the elasticity distribution derived from phase 1 and phase 8 datasets was quantified by its’ ability 
to also represent the phase 4 liver data. To further ensure the quantitatively evaluate the precision 
of the DIR and the estimated elasticity, normalized cross-correlation (NCC) was used as an image 
similarity metric between two sets of images for both the estimation and validation process: first 
between the target and warp images used in the deformable image registration, and second between 
the target image and model-deformed images. 
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6.3 Results 
In this section, we first present the qualitative DIR results, followed by qualitative elasticity 
estimation and validation results. Finally, we present the quantitative results for the respective 
sections.  
6.3.1 Deformable image registration.  
The accuracy of the DIR results is necessary to ensure the validity of the ground-truth deformation 
data. Figure 6-2 illustrates an example of the DIR for a 2D-slice of 4DMR data. Figure 6-2(a) 
shows the source data (phase 8 dataset) in red overlain with the target (phase 1) data in green. 
Mismatches can be seen between the source and target, especially near the diaphragm and liver 
boundaries. Figure 6-2(b) shows the target data is red overlain with the warped source data in 
green. It can be seen that the registration accounts for the liver deformation well, with little 
mismatch seen between the target and warp images. The extent of the registration accuracy will 
be further quantified in a following section.  
 
Figure 6-2: Example of the registration results achieved with our in-house optical flow algorithm. The source (red) 
and target (green) were registered (a), resulting in the warped image that is overlain with the target in (b).  
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6.3.2 Elasticity estimation. 
Figure 6-3 shows the displacement accuracy corresponding with a resultant elasticity map for a 
2D-slice of patient liver. Figure 6-3(a) shows the source image of a segmented liver. Figure 6-3(b) 
shows the ground-truth displacement derived from DIR in mm, while Figure 6-3(c) shows the 
optimized model displacement, also in mm. Figure 6-3(d) shows the displacement error between 
6-3(b) and 6-3(c), with error greater than 1 mm highlighted in blue. Finally, Figure 6-3(e) shows 
the optimized elasticity distribution.  The low error supports the validity of the error estimation. 
Furthermore, regions of high elasticity correspond to apparent liver lesions seen in Figure 6-3(a).  
 
Figure 6-3: Example of elasticity estimation results. (a) source, (b) ground-truth displacement in mm, (c) model 
displacement in mm, (d) displacement error in mm, and (e) estimated elasticity in kPa 
6.3.3 Quantitative evaluation and validation.  
Table 6-1 indicates the average elasticity, displacement, and accuracy for both the estimation and 
validation for each patient dataset.. Overall, 95% of voxels converged within 1 mm of ground-
truth. The average elasticity ranged from 2.69 kPa to 6.42 kPa. The maximum deformation ranged 
from 3.73 mm to 9.04 mm. Variations in the liver  physiological factors, such as range of motion, 
did not affect the accuracy, indicating the applicability of the elastography process to a wide range 
of patients.  
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As no ground-truth elasticity distributions are available for absolute elasticity accuracy 
calculations, validation was performed using phase 4 (representing mid-expiration breathing 
phase) 4DMR liver data. To illustrate the validation process and results, we present Figure 6-4. 
Table 6-1: Elasticity estimation and validation results for 11 patient datasets 
 Estimation Validation 
Patient Elasticity (kPa) 
Maximum 
Displacement 
[142](mm) 
Error < 1 mm       
(%) 
Maximum 
Displacement 
(mm) 
Error < 1 mm   
(%) 
1 5.88 9.04 71.34 7.88 53.10 
2 2.69 5.10 98.88 5.08 97.94 
3 5.91 4.96 97.61 3.05 86.94 
4 6.16 6.29 94.64 3.76 91.42 
5 4.90 6.30 98.97 5.83 85.61 
6 6.26 8.60 99.13 6.56 88.22 
7 6.42 6.61 96.17 5.71 95.07 
8 5.80 7.64 96.35 5.73 69.92 
9 4.44 3.73 100 2.79 100 
10 5.28 3.99 99.98 2.59 99.584 
11 5.06 6.34 96.61 6.20 76.67 
AVG 5.34 6.23 95.43 5.02 85.86 
 
 
Figure 6-4: Example of validation results. (a) estimated elasticity, (b) validation displacement, (c) model 
displacement using estimated elasticity for a scaled number of iterations, and (d) displacement with error greater 
than 0.3 mm highlighted in blue.   
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Figure 6-4(a) shows the elasticity estimated from the ground-truth displacement vectors. Figure 6-
4(b) shows the validation displacement acquired from deformable image registration between 
phase 1 and phase 4 images. Figure 6-4(c) shows the resultant model displacement in mm after the 
liver biomechanical model is deformed with the elasticity seen in Figure 6-4(a). Figure 6-4(d) 
shows the displacement error between (b) and (c), with error greater than 0.3 mm highlighted in 
blue. A majority of the voxels converged with high accuracy, illustrating the estimated elasticity’s 
validity in representing different 4DMR phases. The validation results are also quantitated in Table 
6-1; maximum deformation ranges from 2.59 to 7.88 mm, and average accuracy is 86%. 
Finally, image similarity results are presented in Table 6-2 below. On average, the deformable 
image registration had an accuracy of around 0.97 for both the estimation and validation processes. 
The resultant model-deformation represented the ground-truth deformation with a similarity of 
0.97 for the estimation process and 0.90 for the validation process.  
Table 6-2: Image similarity metric normalized cross-correlation between target (phase 1) and warp (deformed phase 
8) data and optimized model deformation and ground-truth deformation for both estimation and validation results 
 Estimation Validation 
 Target → Warp Model DVF → Ground-truth DVF Target → Warp 
Model DVF → 
Ground-truth DVF 
1 0.941 0.978 0.952 0.866 
2 0.966 0.861 0.967 0.779 
3 0.982 0.972 0.977 0.931 
4 0.979 0.944 0.977 0.795 
5 0.974 0.993 0.973 0.947 
6 0.972 0.982 0.977 0.949 
7 0.974 0.953 0.972 0.896 
8 0.973 0.994 0.984 0.912 
9 0.963 0.993 0.965 0.952 
10 0.954 0.995 0.961 0.916 
11 0.966 0.990 0.973 0.971 
Average 0.968 0.969 0.971 0.901 
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6.4 Discussion 
In this chapter, we presented the results of a liver elastography process performed on 11 4DMR 
datasets. A physics-based biomechanical model was used to solve the inverse elasticity problem. 
Liver DVFs from the registration of phase 1 and phase 8 diaphragm positions were obtained using 
an in-house optical flow DIR algorithm. Liver boundary displacements were employed as 
boundary constraints, while the inner liver tissue voxels were allowed to deform according to linear 
elastic material properties.  
On average, 95% of voxels for 11 patients converged within 1.0 mm of ground-truth deformation. 
Maximum deformation ranged from 3.73 to 9.04 mm for the estimation cohort. The average 
elasticity ranged from 2.69 to 6.42 kPa. The average values found here correspond well with those 
found in the current work in the field [135, 143, 144]. In addition, an image similarity metric 
showed high similarity between the phase 8 and warped phase 1 registration and experimental 
results, with values of 0.97 and 0.97 respectively. Overall, these results suggest that liver 
elastography can be performed using ViewRay 4DMR datasets for a wide range of patients. 
The potential of 4DMR liver elastography to be used in the clinic requires extensive validation. 
Phase 4 datasets were obtained as a validation cohort so that the elasticity results could be validated 
in a clinically-relevant manner. The maximum deformation ranged from 2.59 to 7.88 mm for the 
validation cohort, and 86% of voxels converging within 1 mm of clinical ground-truth 
deformation. An image similarity metric again showed high similarity between phase 4 and warped 
phase 1 registration and validation model results, with values of 0.97 and 0.90 respectively. Future 
work will investigate obtaining MRE data for patients so the elasticity distributions can be more 
explicitly and quantitatively validated. 
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We foresee two main limitations to the methodology presented here. First, the linear elastic 
constitutive model employed in the biomechanical model might be overly simplistic for describing 
the diaphragm-induced motion of diseased liver tissue. Future studies will focus on expanding to 
a non-linear constitutive model. Secondly, since the ViewRay implementation at UCLA is 
relatively new, we only had access to a small number of patients. Future work will focus on 
collecting more patients for further studying the elastography process along with a multi-modal 
validation.   
6.5 Conclusion 
The 95% convergence of the elastography technique presented here indicates the potential for 
integrating liver elastography directly within the radiotherapy workflow. Elastography of the liver 
anatomy using (Viewray) 0.35 T MR Scanners has not yet been developed and validated. The 
elastography process described in this chapter can be implemented within the radiotherapy 
treatment setup without the need for additional imaging modalities. Elastography information 
acquired within the radiotherapy setup can lead to improved tissue sparing radiotherapy treatment 
plans and more precise monitoring of treatment response.  
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CHAPTER 7: DETERMINE IF LUNG ELASTICITY 
INFORMATION PROVIDES USEFUL FUNCTIONAL 
INFORMATION FOR RADIOTHERAPY PATIENTS 
A novel imaging biomarker based on patient-specific lung 
elasticity for characterizing the degree of COPD of lung 
radiotherapy patients  
A version of this chapter has been submitted for publication as a manuscript to The British Journal of Radiology 
7.1 Introduction 
Despite the heterogeneity of COPD phenotypes, diagnosis is based on symptoms and presence of 
fixed airflow obstruction, which do not fully reflect the heterogeneous pathophysiological 
conditions observed in COPD [145] [146, 147]. There is an emerging role for quantitative 
computed tomography (CT) to assess lung structure and function in the evaluation of pulmonary 
emphysema [148, 149]. A common method employed for the detection and quantification of the 
lung function is lung densitometry, where voxels with less than -950 HU are classified as 
emphysematous tissue; this is measured by the relative area of voxels less than -950 HU and known 
as RA950 [150, 151]. A clear limitation of this method stems from the fact that COPD 
pathophysiology is related to changes in the tissue mechanics, which are not fully represented by 
a single quantitative CT [19].  
There is a need to characterize COPD pathophysiology by considering the lung tissue mechanics. 
Peers have investigated characterizing lung function using only the deformation vector fields by 
computing the voxel-by-voxel expansion and contraction [146]. However, voxel expansion and 
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contraction may not fully explain the complex dynamics of the lungs. Lung function is closely 
related to the mechanical properties of the lung parenchyma [152]. COPD is characterized by 
damaged lung tissues with altered mechanical properties and ventilation profiles [153]. For 
example, the destruction of collagen and elastin fibers in emphysematous tissue decreases the 
strength and elastic recoil of the tissue, subsequently reducing the elastic modulus [154, 155]. 
Although the link between lung mechanics and disease initiation and progression has been 
established, the ability to noninvasively assess disease progression through mechanical property 
(i.e. elasticity) changes at a regional level has not been investigated. Currently, elastography exists 
across several modalities including MR and ultrasound, but has not yet been investigated for 
COPD patients [156] [29].  
4DCT images are pertinent for lung elastography as they encapsulate lung tissue motion during 
breathing [157]. They are also routinely acquired for lung cancer patients that receive radiation 
therapy [68]. Since a significant portion of lung cancer patients also have some level of COPD, 
analyzing their 4DCT images for lung elastography could yield critical information regarding the 
lung tissue elasticity for COPD affected regions. The result of such lung elastography is novel for 
the field of COPD diagnosis and treatment.  
We present a 4DCT-based lung elastography procedure for evaluating lung tissue elasticity in 
COPD patients undergoing lung radiotherapy treatment. We further correlate the spatial 
distribution of lung tissue elasticity with the inherent GOLD severity criteria to validate the 
diagnostic and staging ability of the lung tissue elasticity. From the estimated elasticity 
distributions, we derived a novel imaging biomarker, YM1-3 that is comparable to the quantitative 
diagnostic results seen with RA950. The results presented in this chapter support our hypothesis 
that lung tissue elasticity could lead to an effective biomarker for characterizing spatial lung 
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pathophysiological changes and its heterogeneity can be used for the quantitative evaluation of 
functional lung regions. In addition, the biomarker presented in this study demonstrates the 
potential for mechanics-derived elasticity as a biomarker for COPD. 
7.2 Methods 
7.2.1 Data 
A set of 13 patient 4DCT datasets were retrospectively obtained using a novel protocol designed 
to mitigate image artifacts at UCLA from October 2012 to August 2016 [101]. The patient datasets 
were acquired with patient consent and approval from the Institutional Review Board of UCLA 
(IRB #11-000620-CR-00004). The patient cohort consisted of lung cancer patients undergoing 
SBRT at UCLA. The average age of the patients was 66, five of the patients were male, and eight 
were female. The 4DCT scans were acquired  pre-treatment with the same acquisition protocol on 
Siemens Definition Flash, Siemens Biograph 64, and Siemens Definition AS 64 scanners with 1 
mm slice thickness. Pulmonary function tests were available for all 13 of the patients.  
7.2.2 Elastography 
7.2.2.1 Biomechanical model. The primary aim of the lung elasticity evaluation for COPD patients 
was to determine if patient disease status could be correlated with underlying tissue elasticity 
derived from the 4DCT geometry, boundary conditions, and the deformation vector fields. 
Integrating the three above-mentioned components using a biomechanical framework enabled to 
precise characterization of lung tissue elasticity [118]. A biomechanical model that has been well 
validated using head and neck, breast, and lung datasets was used as a forward model to solve the 
inverse elasticity problem [52, 101]. Biomechanical property estimations are generated using 
iterative inverse deformation methods that use biomechanical models to estimate the linear 
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elasticity that duplicates the image dataset deformations [158]. The geometry of the biomechanical 
model was instantiated using end-exhalation lung datasets, where every image voxel corresponded 
to a finite element within the model.  
7.2.2.2 Elasticity estimation. For the estimation process, an initial density-guided linear elastic 
distribution was assigned to the biomechanical lung model, associating a discrete elasticity value 
to every lung tissue voxel.  For each patient, end-inhalation and end-exhalation breathing phases 
were first registered using an in-house optical flow DIR algorithm [94]. The displacement of each 
voxel was taken to be the ground-truth. The inverse elasticity problem was formulated as a 
parameter-optimization problem with an objective to determine the elasticity that would minimize 
the difference between the ground-truth displacement and that computed by the biomechanical 
model. Lung boundary displacements obtained from the DIR algorithm were used as boundary 
condition for the elastography analysis to deform the biomechanical model to represent end-
inhalation geometry. For changes in the lung boundary, the inner voxels biomechanically 
deformed according to the linear elastic forces within the biomechanical model. The Euclidean 
distance between the initial and final position for each voxel was taken to be the model deformation 
for that voxel.  
7.2.2.3 Parameter optimization. A detailed description of the inverse elasticity estimation and 
underlying parameter optimization has been discussed in [101]. For clarity, we present a brief 
description of the parameter optimization process. Solving the inverse elasticity problem was 
carried out by (a) computing the displacement vector field for every voxel of lung tissue for a given 
elasticity distribution (as discussed above), and (b) optimizing the elasticity distribution that best 
reproduced the ground-truth [70]. The tissue elasticity was iteratively updated and optimized and 
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the resulting displacement was then compared with the ground-truth DIR displacement until 
convergence [118].  
7.2.3 Lung elasticity evaluation for COPD patients 
To evaluate the correlation of disease status with underlying elasticity,  the patients were first 
classified by an experienced physician with a score of 0 – 4 according to the GOLD 2017 standard, 
where 0 corresponds to no limitation and 4 to very severe airway limitation [159]. The physician 
had no prior knowledge of the elasticity metrics of the patients. The corresponding 4DCT patient 
datasets were used to estimate the tissue elasticity and assessed for their ability to discriminate 
patient COPD status with the following three experiments:  
7.2.3.1 Experiment 1: Documenting spatial changes in the elasticity for COPD patients. The 
spatial elasticity distributions will be analyzed, as COPD should not present homogeneously. In 
addition, to quantify whether elasticity will provide any more information than traditional 
displacement, correlations between the tissue displacements and elasticity distributions were 
analyzed. For similar reasons, correlations between intensity and elasticity distributions were also 
analyzed.  
7.2.3.2 Experiment 2: Investigating changes in elasticity distribution for different stages of 
COPD patients. An increase in the GOLD criteria reflects a decrease in the lung function – these 
changes should be evident in the underlying elasticity. Parenchymal voxels were segmented using 
an intensity thresholding approach [160]. Average elasticity values for parenchymal tissue were 
correlated with the GOLD criteria to observe for any changes in the lung function. Elasticity 
histograms were generated for all GOLD scores and also analyzed for change in lung tissue 
function.  
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7.2.3.3 Experiment 3: Comparing an elasticity-derived biomarker to RA950. While the elasticity 
estimation gives a distribution of values, for diagnostic purposes it is convenient to have a binary 
indicator of disease. A binary COPD classification was first determined based on the GOLD score; 
a score of 0 or 1 corresponded to a non-COPD (normal) classification (value of 0) and a score 
greater than 2 corresponded to a COPD classification (value of 1) [161]. These values are listed 
explicitly in Table 7-1 below.  
Table 7-1: Gold score and binary COPD classification for each patient that had pulmonary function testing 
information available. 
Patient ID GOLD score Binary COPD Classification 
1 1 0 
2 1 0 
3 2 1 
4 3 1 
5 4 1 
6 0 0 
7 2 1 
8 4 1 
9 2 1 
10 2 1 
11 2 1 
12 0 0 
13 2 1 
 
Using these classification methods, 9 of the patients that were included in this study were then 
classified as having COPD (GOLD 2-4). First, the voxel-to-voxel correlation of the elasticity with 
RA950 was investigated, to determine if the elasticity information could serve as a proxy for COPD 
diagnosis. Second, a binary elasticity threshold was empirically derived to discriminate patient 
COPD status. The relative area of voxels with an elasticity less than the binary elasticity threshold 
or Young’s modulus, YM1-3,  was compared to the conventional RA950 imaging metric using a 
confusion matrix and ROC analysis.  
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7.3 Results 
Overall, 89.35 ± 8.16% of voxels converged within 10% of the maximum deformation.  
Table 7-2: Convergence results of elasticity estimation study for parenchymal tissue 
Patient ID Convergence percentage of voxels     
< 10% maximum deformation (%) 
1 92.85 
2 89.32 
3 94.11 
4 94.70 
5 78.75 
6 85.51 
7 85.63 
8 94.30 
9 92.47 
10 89.18 
11 90.61 
12 92.82 
13 87.08 
Average 87.32 
 
Table 7-2 denotes the convergence percentage for each of the patients for parenchymal tissue. 
87.32 ± 4.61% of parenchymal voxels converged within 10% of maximum deformation. The high 
convergence of the parenchymal tissue motivates the use of the elasticity results for the remainder 
of the experiments. 
7.3.1 Experiment 1: Documenting spatial changes in elasticity for COPD patients.  
Figure 7-1 (a) shows the ground-truth displacement for a 2D slice of non-COPD patient lung, while 
figure 7-1(b) shows the resultant elasticity distribution. Figure 7-1(c & d) show the ground-truth 
deformation and elasticity maps, respectively, for a COPD patient with impaired lung function.  
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Figure 7-1: 2D slices showing ground-truth displacement (a & c) and reconstructed elasticity distributions (b & d) 
for normal (a & b) and COPD (c & d) patients respectively. 
The patients shown here were chosen in such a way that their maximum ground-truth deformation 
values were similar. However, the elasticity distributions differ significantly, demonstrating the 
ability of the proposed method to discriminate normal versus diseased patients. The elasticity of 
the COPD patient (Figure 7-1(d)) is much lower than that of the non-COPD patient (Figure 7-
1(b)), which was expected since COPD is known to affect elastin and collagen in diseased tissue 
[154], leading to a decrease in strength and elasticity. This supports the hypothesis that the 
elasticity estimation discussed here can provide useful functional information, which is explored 
in Experiment 2. 
We now present the elasticity distribution as a function of the displacement magnitude as well as 
the voxel intensity. Table 7-3 denotes the correlation coefficient between both a) displacement and 
elasticity distributions and b) the intensity and elasticity distributions for each patient.  
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Table 7-3: Displacement and elasticity correlation along intensity and elasticity correlation results 
Patient ID 
 
Correlation 
between 
displacement and 
elasticity 
 
Correlation 
between intensity 
and elasticity 
1 0.14 0.76 
2 0.02 0.78 
3 0.03 0.61 
4 0.12 0.87 
5 0.02 0.91 
7 0.11 0.69 
7 0.08 0.83 
8 0.04 0.89 
9 0.22 0.26 
10 0.06 0.80 
11 0.02 0.86 
12 0.11 0.72 
13 0.15 0.85 
Average 0.09 0.76 
 
On average, the correlation between elasticity and displacement is low with a Pearson correlation 
coefficient of 0.09. The low correlation suggests that elasticity is independent of the displacement. 
Therefore, deriving functional information solely from displacement-based metrics may not be a 
good representation of the underlying pathophysiology. The correlation between elasticity and 
intensity was better, with an average coefficient of 0.76. This supports the hypothesis that elasticity 
is related to intensity and can be used to complement intensity-derived metrics, such as RA950, 
while still providing additional functional information. This will be further explored in Experiment 
3.  
7.3.2 Experiment 2: Investigating changes in elasticity distribution for different stages of 
COPD patients.  
Table 7-4 denotes maximum deformation and average elasticity, both for all lung tissue and 
parenchymal tissue only, for the patients stratified by GOLD score. It can be seen that, although 
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maximum deformation did not have a correlation with the GOLD criteria, average elasticity varied 
with decreasing lung function. Furthermore, parenchymal average elasticity decreased with 
decreasing lung function, strongly suggesting that elasticity can provide functional lung 
information.  
Table 7-4: Maximum deformation and average elasticity for GOLD score groups of patients 
Patient Averages Maximum Deformation (mm) 
Average Elasticity 
(kPa) 
Average Parenchymal 
Elasticity (kPa) 
All 17.52 6.24 5.87 
GOLD 0 10.05 6.55 5.28 
GOLD 1 18.30 6.79 7.28 
GOLD 2 22.82 6.33 6.06 
GOLD 3 19.19 4.32 4.34 
GOLD 4 8.92 4.40 4.43 
 
While average elasticity relates to a decrease in lung function, the average is a high-level 
representation the whole physiology. To evaluate whether the distribution of the elasticity 
information correlates with lung function, a histogram of the elasticity results for the groups of 
patients with GOLD status 0 - 4 is shown in Figure 7-2.  The peak of elasticity for the patients with 
normal lung function (GOLD 0 – 1) is significantly further to the right than those patients with 
COPD (GOLD 2 – 4), which corresponds to the average elasticity values seen in Table 7-3 above. 
The histograms illustrate that the shift between non-COPD and COPD patients isn’t gradual. 
Specifically, an increase in the GOLD status was characterized by an increase in the number of 
voxels with an elasticity between 1 and 3 kPa, and a significant decrease in the number of voxels 
with an elasticity between 4 and 8 kPa. This can be understood by the fact that COPD patients are 
known to have damaged lung tissue with decreased collagen and elastin content.  
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Figure 7-2: Histogram of elasticity values for patients with GOLD scores ranging from 0 (top) to 4 (bottom) 
Using this information, we derived a novel elasticity-based imaging biomarker that represents the 
percentage of parenchymal voxels within 1-3 kPa. Specifically, a new mechanics-based imaging 
biomarker, YM1-3, represents the percentage of voxels of parenchymal tissue with an elasticity 
between 1 and 3 kPa. The range of voxels with elasticity between 1 and 3 kPa, will be explored in 
Experiment 3 below.  
7.3.3 Experiment 3: Comparing an elasticity-derived biomarker to RA950.  
A visual representation of the RA950 imaging biomarker is shown along with the corresponding 
elastic modulus distributions in Figure 7-3. Figures 7-3 (a-e) show source CT images with HU 
values less than -950 HU highlighted in red, a visual approximation of RA950. Figures 7-3 (f-j) 
show the corresponding elasticity distributions for the same slices. Slices are shown for patients 
with GOLD 0 (a, f) through GOLD 4 (e, j) status. It can be seen that the regions highlighted in red 
correspond to the lower elasticity regions in purple and dark blue. Furthermore, the prevalence of 
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low intensity regions and the lowered elasticity regions increased with the GOLD status, 
illustrating that a decrease in the lung function corresponded with a decrease in both intensity and 
elasticity values.  
 
Figure 7-3: Illustration of source CT with HU values less than -950 HU highlighted in red shown for a GOLD 0 (a), 
GOLD 1 (b), GOLD 2 (c), GOLD 3 (d), and GOLD 4 (e) patient. Elasticity distributions for same patients are shown 
in (f - j) 
The voxels with an elasticity between 1 and 3 kPa are compared to a visual representation of RA950 
in Figure 7-4.  Figure 7-4(a) depicts a source CT image with voxel intensity of less than -950 
highlighted in red to illustrate RA950.  Figure 7-4(b) shows the reconstructed elasticity distribution, 
with voxel elasticity between 1 and 3 kPa also highlighted in red. These values were derived from 
the histogram in Figure 7-2. Many of the highlighted regions overlap between Figures 7-4(a) and 
7-4(b), demonstrating the potential of low elasticity values to be indicative of impaired lung 
function.   
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Figure 7-4: The conventional RA950 imaging metric and an initial elasticity derived imaging metric for the same 2-
D slice of a patient left lung. 
To further illustrate the diagnostic potential of an elasticity COPD metric, a confusion matrix 
was used to compare the diagnostic capabilities of YM1-3 versus RA950 and is shown for each 
metric respectively in Figure 7-5 below.  
 
Figure 7-5: (a) RA950 for each patient and (b) YM1-3  for each patient. Patients with confirmed COPD are denoted 
with red stars 
Patients with confirmed COPD are denoted with a red asterisk, while patients with normal lung 
function are denoted with a blue dot. Figure 7-5(a) shows the average RA950 value for each patient. 
We adopted a 5% value of average RA950 as a threshold for densitometrically defined emphysema 
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[162-164]. Figure 7-5(b) shows the average YM1-3 for each patient, with the same patient labels as 
in Figure 7-5(a). A threshold YM1-3 of 2% was empirically derived to define emphysema. The 
upper left quadrant of each figure illustrates the true positives, the right upper quadrant illustrates 
false positives, the lower left quadrant illustrates false negatives, and the lower right quadrant 
illustrates true negatives. It can be seen that using a diagnostic criteria derived from RA950 results 
in only 4 true positives, while the remaining COPD patients are misclassified as non-COPD. 
Conversely, using the elasticity diagnostic criteria, 8 of the 9 COPD patients are correctly 
classified.  All non-COPD patients are correctly classified with RA950 while 1 non-COPD patient 
is misclassified with the elasticity metric.  
The statistical measures used to evaluate the two metrics are shown in Table 7-5. The YM1-3 metric 
had a significantly (p < 0.05) higher accuracy than RA950. YM1-3 was more sensitive as a COPD 
metric than RA950, but RA950 was more specific. Specificity describes the extent to which reported 
positives represent the condition of interest. YM1-3 was less specific than RA950 because of the 
patient who would be falsely identified as COPD-positive, seen in the upper right quadrant of 
Figure 7-5(b). To evaluate a single metric independent of threshold, the area under the ROC curve 
(AUROC) was investigated and is also listed in Table 7-5. The AUROC is higher for YM1-3 when 
compared to RA950, which indicated that, for the cases evaluated here, YM1-3 classified the patient 
cases better than the conventional densitometric metric, RA950. This demonstrates  that the 
elasticity is a superior indicator of the underlying lung pathophysiology.  
Table 7-5: Statistical measures used to analyze prediction accuracy of the conventional RA950 versus YM1-3 
Metric RA950 YM1-3 
Accuracy 0.7142 0.8571 
Sensitivity 0.5 0.875 
Specificity 1 0.833 
AUROC 0.875 0.917 
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In summary, the aforementioned three experiments demonstrate the ability of lung tissue elasticity 
to serve as a spatial quantification of  disease extent. Furthermore, we demonstrated the ability of 
the mechanics-based imaging biomarker YM1-3 to guide the diagnosis and staging procedures for 
COPD patients. 
7.4 Discussion 
In this chapter, we investigated lung tissue elasticity as a potential imaging biomarker for COPD 
diagnosis using a set of 13 patients. Accuracy of the elasticity estimation was demonstrated by the 
high convergence percentages. The elasticity distributions allowed for the depiction of functional 
lung regions based on lung deformation biomechanics. The mechanics-based biomarker (YM1-3) 
investigated in this study shows promise for evaluating disease staging and progression, with 
results similar to and exceeding that of RA950 based scoring of COPD.   
While the novel mechanics-based metric shows great promise for COPD diagnosis and staging, 
we would like to highlight two limitations of the current work. First, the input data stems from 
4DCT, which is not conventionally used for COPD patients because of its inherently high imaging 
dose. Currently, SPIROMICS studies have employed an effective imaging dose of 3.2 mSv in their 
protocols for acquiring the total lung capacity [122]. We anticipate that, with an increasing scope 
of application for 4DCT in COPD diagnosis and staging, imaging experts will focus on reducing 
the imaging dose to a level that is within the imaging limits for COPD. For instance, prospective 
and low dose scanning techniques are being investigated by peers for reducing the 4DCT imaging 
dose. Once the dose can be reduced for the assessment of COPD, elastography performed using 
the reduced dose scans (Chapter 5) can be used for a longitudinal assessment of COPD progression 
and better differentiation of the degree and type of COPD.  
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Second, the biomechanical model employs a linear elastic approach for the lung elastography. 
While the linear elastic model is shown to be applicable for COPD lungs during normal breathing, 
we anticipate that for representing the full range of breathing motion, we will need to employ a 
hyperelastic process [165]. Furthermore, as MR elastography techniques mature and become more 
applicable to the lungs, the model-guided elastography will be validated and the YM1-3 metric will 
need to be updated accordingly. 
From a radiotherapy perspective, the development of functional tissue-sparing treatment plans 
guided by the elasticity information will be investigated preliminarily in Chapter 8. A limitation 
of the patient datasets used in this study is  the small sample size that was collected in a 
radiotherapy setting, so functional information was a byproduct of the radiology reports and no 
data was available as a healthy control. Future work will focus on collecting and analyzing 
mainstream COPD data to further evaluate the diagnostic potential. Furthermore, we will 
investigate the development of a clinical protocol to focus on explicitly validating lung regions 
affected by COPD with a pulmonary radiologist. 
In summary, a novel imaging biomarker was developed using a physics-based biomechanical 
model and 4DCT-driven lung elastography. A preliminary imaging biomarker for COPD was 
assessed in comparison to the conventional RA950 and performed favorably. The resultant elasticity 
distributions gained from our methodology can be used to identify functional regions of 
parenchymal tissue, leading to patient-specific treatment options and guiding pulmonary 
physicians as to the early management of COPD.  
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CHAPTER 8: INCORPORATE FUNCTIONAL AND 
BIOMECHANICAL INFORMATION INTO TREATMENT 
PLANNING. 
Incorporating lung tissue elasticity into function preserving 
lung SBRT treatment planning 
A version of this chapter is being prepared for submission to the British Journal of Radiology 
 8.1 Introduction 
Traditionally the standard of care for lung cancer is surgical resection or radiotherapy [166]. 
However, these options are often complicated by the presence of co-morbidities, such as COPD or 
poor respiratory function. Stereotactic body radiotherapy (SBRT) is increasingly accepted as a 
course of treatment for lung cancer patients who are medically inoperable or declined surgery 
[167]. SBRT involves precise delivery of ablative doses of radiation over a few fractions.  
Radiation pneumonitis (RP) is a common dose limiting toxicity that impacts the treatment of 
patients with lung cancer. Symptomatic radiation pneumonitis occurs in about 30% of patients 
irradiated with normal fractionation, and about 9 - 28% of patients treated with SBRT [168]. The 
high level of radiation exposure during radiotherapy is the primary cause of radiation pneumonitis, 
but reduced lung function is known to increase the risk of the pulmonary toxicity [7, 169].  
Radiotherapy that avoids high-functional lung regions might reduce pulmonary toxicity [4, 170, 
171]. The parameters V20 (volume of lung receiving 20 Gy of dose) and mean lung dose (MLD) 
are commonly used as predictors of radiation pneumonitis [172, 173]. However, dose-volume 
statistics (such as V20 and MLD) alone are not reliable predictors of radiation-induced change in 
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pulmonary function [3]. Dose-function statistics such as fV20 (volume of functional lung receiving 
20 Gy of dose) and fMLD (functional mean lung dose) have been shown to improve toxicity 
prediction after radiotherapy [6]. Therefore, determining pre-radiotherapy lung function maps in 
order to minimize radiation damage to the healthy lung is of significant current interest.  
To reduce pulmonary toxicity, we hypothesize that it would be clinically beneficial to spare as 
much functional normal tissue as possible while still ensuring adequate target coverage. This 
requires knowledge of pulmonary spatial-functional distributions. The derivation of spatial 
distributions of lung function has been previously proposed using perfusion and ventilation 
imaging [6-8, 146]. However, the regional physiologic accuracy has not been validated for 
ventilation imaging, and the use of perfusion imaging is limited by the need for separate imaging 
sessions or fusion in radiotherapy planning.  
Recently, a new biomechanical parameter, the elastic modulus of lung tissue, has been investigated 
as a way to characterize the functionality of lung tissue [174, 175]. A methodology has been 
developed to estimate the elastic modulus of lung tissue using 4DCT scans acquired during the 
radiotherapy workflow (Chapters 3 & 4) [176, 177]. Elasticity information obtained from 4DCT 
can be used to characterize response to radiotherapy and functionality of lung tissue on a voxel-
by-voxel basis [176]. 4DCT-based elastography provides both anatomical and functional 
information in one scan. Because 4DCT scans are acquired as part of routine care for lung cancer 
patients, calculating functional information from 4DCT provides spatial functional information 
without added dosimetric or monetary cost to the patient.  This study will investigate the use of 
elasticity information for retrospectively deriving functional lung contours for SBRT treatment 
planning purposes. SBRT is uniquely suited to functional avoidance planning because the steeper 
dose gradients ensure preferential dose deposition outside of functional tissue areas [178].  
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8.2 Methods 
8.2.1 Data 
A set of 7 4DCT datasets were retrospectively obtained from patients treated at UCLA from 
October 2012 to August 2016. The patient datasets were acquired with patient consent and 
approval from the Institutional Review Board of UCLA (IRB #11-000620-CR-00004). The patient 
cohort consisted of lung cancer patients undergoing SBRT at UCLA. The average age of the 
patients was 66, five of the patients were male, and eight were female. The 4DCT scans were 
acquired before treatment with the same acquisition protocol on Siemens Definition Flash, 
Siemens Biograph 64, and Siemens Definition AS 64 scanners with 1 mm slice thickness. Artifacts 
were removed using a novel 5DCT imaging protocol [101]. Pulmonary function tests and patient 
treatment planning documentation were obtained for all patients. Patient COPD stage was 
classified by an experience physician based on GOLD 2017 criteria. One patient was classified as 
stage I COPD, four were classified as stage II, one was classified as stage III, and one was 
classified as stage IV. All patients were treated at UCLA with SBRT: 5 were treated to a 
prescription dose of 54 Gy with 3 fractions of 18 Gy, and 2 were treated to a prescription dose of 
50 Gy with 4 fractions of 12.5 Gy.  
8.2.2 Derivation of functional information 
Functional information was derived from spatial distribution of elasticity estimated from the 
motion observed during 4DCT. A detailed description of the inverse elasticity estimation and 
underlying parameter optimization has been discussed in [101, 176]. For clarity, we present a brief 
description of the elasticity estimation process here. 
8.2.2.1 Elasticity estimation. A biomechanical model that has been well validated using head and 
neck, breast, and lung datasets was used as a forward model to solve the inverse elasticity problem 
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[52, 101]. Lung elasticity was characterized by integrating 4DCT geometry, boundary conditions, 
and deformation vector fields within a biomechanical framework [118]. Biomechanical property 
estimates were generated using iterative inverse deformation methods to estimate the linear 
elasticity that duplicates the image dataset deformations [158]. For each patient, end-inhalation 
and end-exhalation breathing phases were first registered using an in-house optical-flow 
deformable image registration (DIR) algorithm and the resultant deformation vector fields (DVFs) 
were considered ground-truth [94]. The inverse elasticity problem was formulated as a parameter-
optimization problem with the objective to determine the elasticity that would minimize the 
difference between the ground-truth displacement and that computed by the biomechanical model. 
Solving the inverse elasticity problem was executed by (a) computing the displacement vector 
field for every voxel of lung tissue for a given elasticity distribution and (b) optimizing the 
elasticity distribution that best reproduced the ground-truth [70]. The tissue elasticity was 
iteratively updated and optimized and the resulting displacement was then compared with the 
ground-truth DIR displacement until convergence [118].  
8.2.2.2 Functional contouring. Functional lung tissue was defined to be parenchymal voxels with 
elasticity between 4 and 8 kPa [177]. Functional lung regions were masked and subsequently 
contoured. A k-means clustering algorithm was used to derive clusters, and those with a diameter 
of less than 2 voxels were removed. The masked clusters were then outlined and the contours were 
added to the radiotherapy structure set and loaded along with the planning CT and original 
treatment plan into Eclipse v 13.6 treatment planning software (Varian Medical Systems).  
8.2.3. Dosimetric evaluation 
A key knowledge gap exists in determining whether clinically delivered radiotherapy plans deliver 
dose to functional lung regions. For these purposes, clinically delivered treatment dose information 
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was acquired, and the dose and elasticity distributions were mapped to each other. The dose 
volume histograms (DVH) were calculated for the full and functional lung volumes. For each 
patient, dose volume and dose function metrics, such as MLD, V5, V10, V20 (or the percentage of 
lung tissue voxels receiving 5, 10, or 20 Gy of dose) and fMLD, fV5, fV10, and fV20 (the percentage 
of functional voxels receiving 5, 10, or 20 Gy of dose), were calculated and compared.    
8.2.4 Retrospective elasticity derived functional avoidance treatment planning 
8.2.4.1 Planning. For consistency, both clinical and functional avoidance plans were created for 
this study. Patients were re-planned both with and without functional avoidance parameters so that 
the plan differences stemming solely from the functional avoidance technique could be observed. 
Planning was done using Eclipse External Beam Planning v.13.6 (Varian Medical Systems). 
Patients were planned to be treated on the Novalis TX with two beam volumetric modulated arc 
therapy (VMAT). The beam angles were fixed for both the clinical and functional avoidance plans. 
To be accepted, both plans had to meet the normal tissue and target coverage constraints 
established according to RTOG 0618 Lung SBRT Dose Volume Objectives  for a prescription of 
3 x 18 Gy [179] or MD Anderson Lung SBRT Dose Volume Objectives for a prescription of 4 x 
12.5 Gy [180]. Functional avoidance treatment plans were designed to selectively avoid irradiating 
highly-functional lung regions and meet specific dose function constraints while maintaining target 
coverage and meeting constraints associated with organs at risk (OARs) [113]. The constraints are 
shown in Table 8-1 below. It should be noted that the constraints for the 4 x 12.5 prescription 
included more specific volume constraints that were used for planning purposes, but for brevity, 
have not been included in Table 8-1. The lung dose function constraints were estimated on a case-
by-case basis in such a way as to minimize the dose to functional tissue. Samples of lung dose-
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function constraints are indicated by an asterisk in Table 8-1 below. Both clinical and functional 
plans were deemed acceptable once they met every guideline the prescription required.  
Table 8-1: Dose constraints for SBRT 
 RTOG 3 x 18 Gy [179] MD Anderson 4 x 12.5 Gy [180] 
 Volume (%) Dose (Gy) Priority Volume (%) Dose (Gy) Priority 
PTV 95 54 150 95 50 150 
 0 61 100 0 55 100 
Cord 0 18 80 0 25 80 
Esophagus 0 27 80 0 35 80 
Heart 0 30 80 0 45 80 
Trachea 0 30 80 0 35 80 
Bronchus 0 30 80 0 38 80 
Lung 10 20 90 12 20 90 
Functional lung* 10 10 120 10 10 120 
 20 5 100 20 5 100 
 
8.2.4.2 Plan evaluation. To quantify the impact of functional planning versus anatomical planning, 
both dose volume and dose function metrics were investigated [181]. Dosimetric parameters will 
include V5 – V30 and mean lung dose (MLD) and the dose function metrics will include functional 
V5 – V30 (fV5-30) and functional mean lung dose (fMLD). Mean dose to PTV (normalized to 
prescription dose), PTV dose homogeneity (maximum dose to PTV/minimum dose to PTV), 
conformity index (treated volume/PTV), and maximum OAR doses will also be evaluated to 
determine plan quality. 
8.3. Results 
8.3.1 Derivation of functional information 
As mentioned in §8.2.2 above, functional information was derived from voxel by voxel elasticity 
distributions for each patient and functional voxels were said to be those with an elasticity value 
between 4 and 8 kPa, an approximation based on results in the literature [50] and empirically 
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derived from our preliminary results [177]. Table 8-2 lists the COPD stage (classified based on 
GOLD 2017), average elasticity in kPa, and percentage of lung tissue that is functional for each 
patient included in this study. It can be seen that the average elasticity is higher for the patients 
with early (stage I and II) COPD, and that the percentage of functional tissue tends to decrease 
with increasing COPD stage. 
Table 8-2: Functional information for early and late stage COPD patients, including average elasticity in kPa, and 
percentage of functional lung tissue 
COPD Stage Average Elasticity (kPa) 
Functional Tissue  
(%) 
Early (GOLD 1 – 2) 6.58 13.21 
Late (GOLD 3 – 4) 4.235 10.67 
 
3.2 Dosimetric evaluation  
Figure 8-1 shows a dose map of the original clinical plan for a 2D slice of a patient with early stage 
(GOLD stage II) COPD. The functional lung tissue is contoured in orange. The functional tissue 
is located close to the target, resulting in significant functional tissue dose. Figure 8-2 shows the 
dose volume histogram (DVH) for full lung and functional lung volumes, along with PTV and ITV 
target volumes, for the same patient. The functional lung receives slightly more dose 
percentagewise than the full lung volume. 
Table 8-3 shows the V20, fV20, MLD and fMLD metrics for all patients with early and late stage 
COPD. While V20 and MLD differed between disease stages, fV20 and fMLD differed significantly 
more. This suggests that early stage COPD patients might be better suited for functional tissue-
sparing treatment plans. However, since dose is accumulated in functional tissue in both early and 
late stage patients, it is necessary to see if functional avoidance treatment planning can be 
accomplished for all stages of disease.  
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Figure 8-1: Dose wash of patient shown along with contours for functional lung as defined using elasticity 
 
Figure 8-2: Dose volume histogram (DVH) for patient full lung and functional lung volumes, ITV, and PTV 
 
Table 8-3: V20, MLD, fMLD, and fV20 metrics from clinically-delivered plans for all patients with early and late 
stage COPD 
Patient COPD 
stage 
V20  
(%) 
fV20 
(%) 
MLD 
(Gy) 
fMLD 
(Gy) 
Early Stage 9.67 10.77 7.40 8.42 
Late stage 3.24 0.92 3.14 1.53 
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3.3 Functional avoidance treatment planning 
8.3.3.1 Planning. New clinical and functional avoidance treatment plans were created for each 
patient using according the guidelines shown in §8.2.4.1 above. In every case, the functional plans 
met the normal tissue constraints as well as or better than the clinical plans.  
An example of both clinical and functional treatment plans for a patient with early stage COPD is 
shown in Figure 8-3 below. The clinical plan, shown in Figure 8-3(a), treats the PTV (pink contour) 
without regard to the location of the functional lung tissue (orange contour). The functional plan, 
shown in Figure 8-3(b), treats the PTV with the same coverage while successfully avoiding most 
of the functional lung tissue.  
An example of both the clinical and functional treatment plans for a patient with late stage COPD 
is shown in Figure 8-4. As seen in Figure 8-3, the clinical plan, shown in Figure 8-4(a), treats the 
PTV (pink contour) without regard to the location of the functional lung tissue (orange contour) 
while the functional plan, shown in Figure 8-4(b), treats the PTV with the same coverage while 
successfully avoiding the functional lung tissue. However, because this patient is in the later stages 
of COPD, the amount of functional tissue is significantly reduced as compared to the patient seen 
in Figure 8-3.  
These figures indicate the functional lung tissue can be successfully avoided if taken into 
consideration in the treatment planning stage for both early and late stage COPD patients.  
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Figure 8-3: Dose wash comparison for clinical (a) and functional (b)  treatment plans for early stage COPD patient 
 
 
Figure 8-4: Dose wash comparison for clinical (a) and functional (b) treatment plans for late stage COPD patient 
8.3.3.2 Plan evaluation. Both the clinical and functional avoidance plans were evaluated 
according to the criteria mentioned in §8.2.4.2 above. First, DVH’s were looked at as a comparison 
for the total lung and functional lung for the clinical and functional plans. Figure 8-5 shows the 
DVH’s for an early stage and a late stage COPD patient.  
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Figure 8-5: DVH comparison between clinical and functional plans for early stage COPD and late stage COPD 
patient. The total lung is represented in blue, functional lung in orange. The clinical plan is represented by triangular 
markers, while the functional plan is represented with squares. 
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For the early stage patient, it can be seen that while the total lung is slightly spared in the functional 
plan as compared to the clinical plan, the functional lung is spared considerably. For the late stage 
COPD patient, there is only slight sparing of both the functional and total lung tissue. It should be 
noted that the ITV and PTV coverage was very similar between the two plans.  This illustrates that 
functional avoidance planning may not make as much of a difference for late stage COPD patients 
– however functional avoidance plans for late stage patients are still feasible and produce quality, 
if less substantial, improvements.  
Dose volume and dose function metrics for both clinical and functional plans are shown in Table 
8-4 for all patients. The metrics were grouped by COPD stage so that clinical and functional 
metrics can be easily compared. It can be seen that, in general, both dose volume and dose function 
metrics improved in the functional avoidance plans, regardless of patient disease stage. Dose 
function metrics improved more significantly as compared to dose volume metrics.  
 
Table 8-4: Dose volume and dose function metrics for both clinical and functional plans for all patients 
Patient Plan V20 (%) 
V10 
(%) 
V5 
(%) 
MLD 
(Gy) 
fV20 
(%) 
fV10 
(%) 
fV5 
(%) 
fMLD 
(Gy) 
1 Clinical 6.79 16.89 24.01 5.19 1.21 2.48 4.02 1.27 
1 Functional 6.25 16.44 23.96 5.05 0.31 2.17 3.78 1.13 
2 Clinical 1.11 3.36 8.21 1.63 1.71 6.64 15.19 2.54 
2 Functional 0.79 2.81 7.24 1.52 1.17 5.43 13.18 2.35 
3 Clinical 5.36 12.77 18.11 4.04 0.52 0.93 1.47 0.71 
3 Functional 5.42 12.59 17.92 4.03 0.49 0.93 1.49 0.69 
4 Clinical 2.22 6.04 12.88 2.29 0.00 0.58 3.52 0.70 
4 Functional 2.22 5.62 11.23 2.26 0.00 0.00 1.16 0.52 
5 Clinical 2.01 6.61 15.31 2.95 0.11 9.83 28.11 3.87 
5 Functional 2.07 5.09 11.06 2.71 0.00 2.08 11.12 2.84 
6 Clinical 3.90 10.76 17.24 3.63 5.03 26.23 38.37 6.43 
6 Functional 3.81 10.27 17.41 3.60 2.66 13.91 27.97 4.66 
7 Clinical 4.48 11.91 23.93 9.69 2.33 12.13 30.38 6.99 
7 Functional 4.67 11.39 22.40 9.64 1.78 10.70 25.00 6.42 
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Table 8-5: Plan quality metrics for both clinical and functional plans for all patients 
Patient Plan PTV Dose Homogeneity 
Mean Dose 
to PTV 
Conformity 
Index 
1 Clinical 2.91 1.11 1.03 
1 Functional 3.24 1.11 1.00 
2 Clinical 1.27 1.07 1.00 
2 Functional 1.40 1.09 1.00 
3 Clinical 1.29 1.07 0.98 
3 Functional 1.30 1.06 0.97 
4 Clinical 1.18 1.06 1.00 
4 Functional 1.19 1.07 1.00 
5 Clinical 1.19 1.05 0.98 
5 Functional 1.19 1.05 0.98 
6 Clinical 1.30 1.07 0.99 
6 Functional 1.30 1.06 1.01 
7 Clinical 1.31 1.08 0.99 
7 Functional 1.52 1.08 1.00 
 
Plan quality was evaluated by looking at maximum OAR dose, PTV dose homogeneity, 
normalized mean dose to PTV, and conformity index. Maximum OAR dose did not exceed clinical 
limits for both clinical and functional plans of all patients. Furthermore, maximum OAR dose, 
while increased slightly in some functional sparing cases, was not significantly different between 
clinical and functional sparing plans. Table 8-5 lists the dose homogeneity, normalized mean dose 
to PTV, and conformity index results for both clinical and functional plans for all patients. It can 
be seen that all three metrics did not change significantly between clinical and functional plans, 
indicating that plan quality was preserved even in functional avoidance situations.  
8.4 Discussion 
Elasticity information derived from 4DCT was used retrospectively to create contours of 
functional lung tissue for 7 lung SBRT patients with various stages of COPD. In reviewing the 
clinical treatment plans, it was seen that significant dose accumulation occurred in functional lung 
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regions, especially for early stage patients. This indicated the potential for dosimetric sparing of 
functional lung tissue.  
In our study, clinical plans were recreated for each patient, along with functional avoidance 
treatment plans. Functional lung avoidance was achieved by creating clinically acceptable SBRT 
plans that met all OAR constraints and an additional functional avoidance constraint while 
preserving target dose coverage,  homogeneity and conformity. Both functional and total lung 
dosimetry decreased when the functional lung tissue was taken into consideration as compared to 
the general clinical plans.  
Functional avoidance SBRT plans were created for all patients with both early and late stage 
COPD. Functional avoidance plans were more effective for early stage COPD patients, as more 
functional tissue was available for sparing. However, functional lung avoidance was still achieved 
for late stage COPD patients. Because late stage patients have very little functional tissue, it might 
be clinically beneficial to spare as much as possible in order to preserve quality of life.  While 
future prospective studies will be necessary to assess this conclusion, we believe functional lung 
avoidance will be useful for all lung SBRT patients, regardless of COPD status. 
We foresee three possible limitations to this study. First, the patient population utilized in this 
retrospective study was quite small, limiting the statistical significance of the results. Future work 
will need to retrospectively expand the data size before moving towards prospective studies. 
Secondly, while tissue elasticity derived from 4DCT has been correlated to function, it has not 
been associated to more widely utilized functional imaging methods. Furthermore, the elasticity 
thresholding used to stratify the functional tissue also needs to be validated with more established 
methodologies. Finally, although lung function can be reduced irreversibly by radiation therapy, 
the tumor can also be responsible for reduced lung function. A potential limitation is that lung 
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volumes that may have received functionally-modified, (perhaps slightly amplified) dose may 
regain function after treatment. Our results do indicate that using functioanl avoidance techniques 
for SBRT, both the overall lung dose and the functional lung dose can be reduced.  Prospective 
clinical trials will be necessary to determine whether treatment results, such as survival and 
complications, are improved using functional avoidance treatment planning. 
In conclusion, functional contours were derived from 4DCT-based elasticity estimation for 7 lung 
SBRT patients. It was determined that the delivered plans resulted in significant dose to functional 
lung tissue for early stage COPD patients. A retrospective study was performed that re-planned 
the clinical plans for each patient. Functional avoidance plans using the elasticity-guided 
functional contours were also developed that had similar target coverage, met the normal tissue 
constraints, and resulted in less dose to functional lung tissue. Based on these results, with the 
knowledge of lung tissue elasticity and function, it is possible to develop functional tissue sparing 
SBRT plans that could result in improved patient quality of life after radiotherapy treatment.  
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CHAPTER 9: CONCLUSIONS 
Summary of Work 
The projects discussed in this dissertation present solutions for obtaining functional information 
using images and deformation information acquired within the radiotherapy workflow for breast, 
lung, and liver anatomies. Algorithms were developed to accurately estimate elasticity information 
from gravity-induced and breathing-induced deformation seen with CT image pairs and 4DMR. 
For the lung, the elasticity information estimated in these projects was successfully related to lung 
function and used to develop functional avoidance lung radiotherapy treatment plans. These works 
ultimately provide a therapeutic tool that can be used to reduce functional tissue toxicity for the 
lung, liver, and breast anatomies.  
Chapter 2 describes the development of a GPU-based inverse elasticity estimation algorithm for 
gravity-induced breast deformations between supine and prone postures. The inverse analysis 
consisted of a gradient-based binary search optimization scheme coupled with a fast-simulated 
annealing algorithm that updated the spatial elasticity distribution until convergence occurred. This 
algorithm was systematically investigated using virtual breast phantoms. Our analysis showed  a 
97 ± 4 % accuracy in the elasticity estimation of virtual homogenous breast tissue with embedded 
tumor.  
In chapter 3, the elasticity estimation algorithm was refactored to account for the breathing-
induced motion of the lung anatomy using virtual lung phantoms and simulated breathing 
deformation values. A novel locally heterogeneous convergence magnification technique was 
applied in order to gain elasticity information from the subtle deformation of the interior voxels of 
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the lungs. Our analysis showed an average of 92 ± 5% of voxels converged within 1 kPa of the 
ground-truth elasticity and within 0.5 mm of ground-truth deformation. 
In chapter 4, the lung elasticity estimation algorithm was extended to 15 patient 5DCT datasets. 
Patient-specific ground-truth deformation values between end-inhalation and end-exhalation 
breathing were obtained for each voxel of lung tissue using optical flow deformable image 
registration. Our analysis showed that an average of 90 ± 5% of voxels converged within a 
prescribed error metric of 10% of maximum deformation.  A validation dataset of mid-exhalation 
breathing phase deformation data converged with 87 ± 11% of voxels within 1 mm of ground-
truth deformation. These results indicate the quantitative accuracy of the elasticity estimation 
process. 
Chapter 5 determined the feasibility of performing elastography using lower dose scans. For these 
purposes, simulated tube current-time products of 30 mAs, 25 mAs, and 20 mAs were generated 
for 8 patients. The elastography results of the lower mAs scans were not significantly different 
than the original results, illustrating that mAs (and thus imaging dose) can be reduced by as much 
as 50% while still producing CT images that are useful for elastography purposes.  
In Chapter 6, the elasticity estimated algorithm was extended to 4DMR scans of the liver. This 
was a natural extension, as the liver motion stems from the breathing-induced motion of the 
diaphragm and elastography of the liver anatomy using (Viewray) 0.35 T MR Scanners has not 
yet been developed and validated. The 95  ± 8% convergence of the elastography technique 
presented here indicates the potential for integrating liver elastography directly within the 
radiotherapy workflow.  
While the methodology provided accurate, organ-specific elasticity  distribution estimations for 
the lung and liver anatomies, the connection between elasticity and organ function remained 
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abstract. Chapter 7 related the pulmonary elasticity distribution to the function of the lung tissue 
for 13 patients with COPD diagnoses. A preliminary imaging biomarker for COPD was assessed 
in comparison to the densitometry metric RA950 and performed favorably.  
In chapter 8, the elasticity distributions were used to identify functional regions of parenchymal 
tissue for 7 lung SBRT patients. Clinically-delivered plans resulted in significant dose to functional 
lung tissue for early stage COPD patients. Functional avoidance plans were developed using the 
elasticity-guided functional tissue contours that met normal tissue and target coverage constraints 
similarly to re-planned clinical treatment plans, while delivering less dose to functional lung tissue. 
These results suggest that, with the knowledge of lung tissue elasticity, it is possible to develop 
functional tissue sparing SBRT that could result in a decrease in lung toxicity after radiotherapy 
treatment.  
While the methodologies presented here have been fully validated using simulations and 
retrospective patient studies, a few obstacles remain on the road to clinical implementation. Future 
directions that could overcome the obstacles for each of the projects are presented in the next 
section.  
Future Directions 
In order to expand the elasticity estimation methodology to the radiotherapy clinic, three major 
overarching challenges need to be addressed for the lung, liver, and breast anatomies. First, due to 
the large breast tissue deformation between the prone and supine position and the complex 
mechanics of diseased lung and liver tissue, the linear elastic constitutive laws utilized in this study 
may need to be extended to the hyperelastic regime. The impact of different strain rates on 
elasticity assumptions and estimations will also need to be investigated. The current imaging 
protocols may need to be modified in order to better describe hyperelastic tissue behavior; for 
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example, the incorporation of additional CT scans, fast helical CT scans, or MR elastography 
techniques could provide more useful deformation information. Secondly, due to the time 
constraints that are commonplace in clinical radiotherapy practice, the methodology will need to 
be implemented in a multi-GPU framework. GPU clusters could be employed to enable the 
estimation process to be completed within acceptable computation times. The implementation of 
the methods presented here on a GPU cluster will continue to ensure that the elasticity information 
can be available within a reasonable radiotherapy timeline. And finally, the works presented here 
focused on developing and implementing the elastography methodology on pristine datasets – i.e. 
simulations and 5DCT datasets. The influence of common radiotherapy imaging artifacts, such as 
those seen in 4DCT, needs to be more fully investigated.  
Specifically for the breast anatomy, a deformable image registration technique needs to be 
developed that provides accurate ground-truth data and a one-to-one correspondence between 
breast tissue in the prone and supine positions. For the liver, MRE data should be obtained as a 
validation dataset for 4DMR liver elastography techniques. More patient data needs to be collected 
for further studying the elastography process. Longitudinal studies could be utilized to investigate 
elasticity changes seen during radiation-induced liver injury during SBRT. For the lung, future 
work should investigate using deformation data from multiple breathing stages to estimate 
elasticity distributions more quickly. In vivo tissue experiments and US/MR elastography 
techniques could be investigated for further verification and validation purposes.  
To integrate the functional elasticity information into the treatment planning workflow, a 
retrospective study with a larger patient population will need to be conducted. The elastic threshold 
of functional lung tissue needs to be determined via more thorough numerical analyses. A clinical 
protocol should be developed that focuses on explicitly validating lung regions affected by 
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pulmonary disease by a pulmonary radiologist. More scan time points will need to be obtained, 
and changes in elasticity over time need to be correlated with radiotherapy and disease progression. 
Elastography and ventilation imaging methods could be integrated to more fully describe lung 
function. Eventually, elastography guided functional lung planning could be integrated into an 
adaptive radiotherapy workflow to facilitate the sparing of functional lung tissue.  
When expanding the lung elastography methodology beyond the radiotherapy clinic, total lung 
capacity and functional residual capacity scans can be acquired for COPD patients to further 
evaluate the diagnostic potential. The resultant elasticity distributions gained from our 
methodology could be used to determine degree of hyperinflation and air trapping in COPD 
patients, to longitudinally assess the degree and progression of disease in COPD patient, and to 
differentiate between tissue affected with bronchitis and emphysema, leading to patient-specific 
treatment options. 
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APPENDIX A 
Noisy data injection 
The 4DCT scan consisted of a series of individual 3D CT scans at different time points. Noise was 
injected at each time point independently and on each slice independently, neglecting the cone 
angle of the system and assuming it is similar to a fan-beam geometry. 
Each slice was forward projected to estimate the attenuation of each ray, and we included the effect 
of a bowtie filter that was added following the attenuation profile described in [182], which was 
for a different system. We assumed that the scanner used a rebin-to-parallel reconstruction scheme 
to preserve noise uniformity and hence sampled rays in a parallel beam fashion.  
The number of photons incident on the detector was calculated by estimating that 1.8 * 106 
photons/mm2-mAs arrived at the detector in the absence of attenuation for a typical spectrum at 
120 kVp [183]. The number of photons was then multiplied by an efficiency factor E that 
incorporates effects such as geometric efficiency, added noise from scatter or Swank factor. E was 
selected by comparison to experimental measurements, explained later. This noise-addition 
sinogram was then filtered by a smoothing function s(x) to match the noise power spectrum. This 
noise-addition sinogram was then reconstructed and added to the original image to synthesize the 
reduced dose CT scan. An important limitation of this study is that the DICOM files record only 
an average mAs, whereas commercial scanners today used tube current modulation. Hence, our 
simulations implicitly assume constant tube current. In order to provide a conservative estimate of 
possible dose reduction, we assumed that the original scans were noiseless. 
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The efficiency factor E and smoothing function s(x) were tuned to reconstructions of a water 
cylinder scanned at the same protocol as the clinical series. The water cylinder image was binarized 
(thresholded to either -1000 or 0 HU) to create a simulated noiseless water cylinder, and noise was 
injected into the binarized water cylinder to simulate the noise in the experimental measurements. 
The 1D noise power spectrum was calculated for comparison. The calculation of the noise power 
spectrum (NPS) has been described in greater detail elsewhere [184, 185] but briefly, 7 adjacent 
slices were averaged to alleviate through-plane correlations, a series of square ROIs with side 
length 31 mm and each positioned 30 mm from the center of the water cylinder were defined, and 
their Fourier transforms were taken after mean subtraction to create the NPS. These NPS 
measurements were averaged and binned in the radial direction to produce 1D NPS. To match the 
simulated NPS with experimental NPS, we selected an efficiency factor of E = 59% and a Gaussian 
smoothing filter with standard deviation of 0.43 channels. 
Figure A1 shows the experimental versus simulated noise in a water cylinder, and figure A2 shows 
the estimated noise power spectra. Agreement of the noise power spectra is moderate at low 
frequencies, presumably due to the presence of structured noise. The spatial distribution of the 
noise as seen in figure A1 is somewhat different, possibly because we used a generic bowtie filter 
profile that may not match this scanner.  
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Figure A1: Left) Experimental reconstruction of water cylinder. [27] Simulated injection of noise. Average of 7 
slices. WW = 100 HU. 
 
 
Figure A2: Comparison of noise power spectra from simulated and experimental data. 
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